Culstering	O
of	O
missnese	O
mtuations	O
in	O
the	O
ataixa	B-Disease
-	I-Disease
telnagiectasia	I-Disease
gnee	O
in	O
a	O
spordaic	B-Disease
T	I-Disease
-	I-Disease
clel	I-Disease
luekaemia	I-Disease
.	O

Aatxia	B-Disease
-	I-Disease
telagniectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
is	O
a	O
recesisve	B-Disease
mluti	I-Disease
-	I-Disease
ssytem	I-Disease
disroder	I-Disease
caused	O
by	O
mutaitons	O
in	O
the	O
ATM	O
gnee	O
at	O
11q22	O
-	O
q23	O
(	O
ref	O
.	O
3	O
)	O
.	O

The	O
rsik	O
of	O
cnacer	B-Disease
,	O
especially	O
lmyphoid	B-Disease
noeplasias	I-Disease
,	O
is	O
substantially	O
eleavted	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
patietns	O
and	O
has	O
long	O
been	O
associated	O
with	O
chromosmoal	O
isntability	O
.	O

By	O
analysing	O
tmuour	B-Disease
DNA	O
from	O
pateints	O
with	O
sporaidc	B-Disease
T	I-Disease
-	I-Disease
clel	I-Disease
prolymphcoytic	I-Disease
leukeamia	I-Disease
(	O
T	B-Disease
-	I-Disease
PLL	I-Disease
)	O
,	O
a	O
rrae	O
clnoal	B-Disease
malignacny	I-Disease
with	O
similartiies	O
to	O
a	O
mautre	B-Disease
T	I-Disease
-	I-Disease
clel	I-Disease
leuakemia	I-Disease
seen	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
,	O
we	O
demonstrate	O
a	O
high	O
frqeuency	O
of	O
ATM	O
mutaitons	O
in	O
T	B-Disease
-	I-Disease
PLL	I-Disease
.	O

In	O
marked	O
contrast	O
to	O
the	O
ATM	O
muttaion	O
ptatern	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
,	O
the	O
most	O
ferquent	O
nucelotide	O
cahnges	O
in	O
this	O
leukaeima	B-Disease
were	O
missesne	O
mtuations	O
.	O

These	O
clutsered	O
in	O
the	O
regoin	O
corresponding	O
to	O
the	O
kniase	O
domian	O
,	O
which	O
is	O
highly	O
conserved	O
in	O
ATM	O
-	O
related	O
protiens	O
in	O
mosue	O
,	O
yesat	O
and	O
Drosohpila	O
.	O

The	O
resulting	O
aimno	O
-	O
aicd	O
substitutoins	O
are	O
predicetd	O
to	O
interfere	O
with	O
ATP	O
bindnig	O
or	O
substrtae	O
recognitoin	O
.	O

Two	O
of	O
seventeen	O
muttaed	O
T	B-Disease
-	I-Disease
PLL	I-Disease
sapmles	O
had	O
a	O
previously	O
reported	O
A	B-Disease
-	I-Disease
T	I-Disease
alelle	O
.	O

In	O
contrast	O
,	O
no	O
mutatinos	O
were	O
deetcted	O
in	O
the	O
p53	O
gnee	O
,	O
suggesting	O
that	O
this	O
tuomur	B-Disease
suppresosr	O
is	O
not	O
frequently	O
altreed	O
in	O
this	O
leuakemia	B-Disease
.	O

Occsaional	O
missense	O
muttaions	O
in	O
ATM	O
were	O
also	O
found	O
in	O
tuomur	B-Disease
DNA	O
from	O
patinets	O
with	O
B	B-Disease
-	I-Disease
clel	I-Disease
non	I-Disease
-	I-Disease
Hdogkins	I-Disease
lypmhomas	I-Disease
(	O
B	B-Disease
-	I-Disease
NHL	I-Disease
)	O
and	O
a	O
B	B-Disease
-	I-Disease
NHL	I-Disease
clel	O
line	O
.	O

The	O
eivdence	O
of	O
a	O
significant	O
porportion	O
of	O
lsos	O
-	O
of	O
-	O
funciton	O
mtuations	O
and	O
a	O
complete	O
absecne	O
of	O
the	O
noraml	O
cpoy	O
of	O
ATM	O
in	O
the	O
majority	O
of	O
muttaed	O
tuomurs	B-Disease
establishes	O
smoatic	O
inactivatoin	O
of	O
this	O
gnee	O
in	O
the	O
ptahogenesis	O
of	O
sopradic	B-Disease
T	I-Disease
-	I-Disease
PLL	I-Disease
and	O
suggests	O
that	O
ATM	O
acts	O
as	O
a	O
tmuour	B-Disease
suprpessor	O
.	O

As	O
constitutioanl	O
DNA	O
was	O
not	O
available	O
,	O
a	O
putative	O
hreeditary	O
predipsosition	O
to	O
T	B-Disease
-	I-Disease
PLL	I-Disease
will	O
require	O
further	O
invsetigation	O
.	O
.	O

Myotnoic	B-Disease
dystrohpy	I-Disease
proetin	O
kinsae	O
is	O
involved	O
in	O
the	O
modultaion	O
of	O
the	O
Ca2	O
+	O
homesotasis	O
in	O
skeeltal	O
muslce	O
cells	O
.	O

Myotnoic	B-Disease
dystorphy	I-Disease
(	O
DM	B-Disease
)	O
,	O
the	O
most	O
pervalent	O
msucular	B-Disease
dsiorder	I-Disease
in	O
adluts	O
,	O
is	O
caused	O
by	O
(	O
CTG	O
)	O
n	O
-	O
rpeeat	O
epxansion	O
in	O
a	O
gnee	O
encoidng	O
a	O
protien	O
kinsae	O
(	O
DM	B-Disease
protien	O
kinsae	O
;	O
DPMK	O
)	O
and	O
involves	O
chnages	O
in	O
cytoarchtiecture	O
and	O
ion	O
homoestasis	O
.	O

To	O
obtain	O
clues	O
to	O
the	O
nromal	O
bioloigcal	O
role	O
of	O
DPMK	O
in	O
cellluar	O
ion	O
homeostaiss	O
,	O
we	O
have	O
compaerd	O
the	O
retsing	O
[	O
Ca2	O
+	O
]	O
i	O
,	O
the	O
apmlitude	O
and	O
sahpe	O
of	O
depoalrization	O
-	O
inudced	O
Ca2	O
+	O
transietns	O
,	O
and	O
the	O
conetnt	O
of	O
ATP	O
-	O
driven	O
ion	O
pupms	O
in	O
clutured	O
skelteal	O
msucle	O
cells	O
of	O
wlid	O
-	O
tpye	O
and	O
DPMK	O
[	O
-	O
/	O
-	O
]	O
konckout	O
mcie	O
.	O

In	O
vitro	O
-	O
differentiated	O
DPMK	O
[	O
-	O
/	O
-	O
]	O
myoutbes	O
exhibit	O
a	O
hgiher	O
restnig	O
[	O
Ca2	O
+	O
]	O
i	O
than	O
do	O
wlid	O
-	O
tpye	O
myotbues	O
because	O
of	O
an	O
atlered	O
open	O
probbaility	O
of	O
voltgae	O
-	O
depednent	O
l	O
-	O
tpye	O
Ca2	O
+	O
and	O
Na	O
+	O
channels	O
.	O

The	O
muatnt	O
myotbues	O
exhibit	O
smaller	O
and	O
slwoer	O
Ca2	O
+	O
repsonses	O
upon	O
triggering	O
by	O
acetylcholnie	O
or	O
high	O
etxernal	O
K	O
+	O
.	O

In	O
addition	O
,	O
we	O
observed	O
that	O
these	O
Ca2	O
+	O
tranisents	O
partailly	O
result	O
from	O
an	O
infulx	O
of	O
extarcellular	O
Ca2	O
+	O
through	O
the	O
l	O
-	O
tpye	O
Ca2	O
+	O
chanenl	O
.	O

Neither	O
the	O
cotnent	O
nor	O
the	O
atcivity	O
of	O
Na	O
+	O
/	O
K	O
+	O
APTase	O
and	O
sarcoplamsic	O
retciulum	O
Ca2	O
+	O
-	O
APTase	O
are	O
afefcted	O
by	O
DPMK	O
asbence	O
.	O

In	O
conclusion	O
,	O
our	O
dtaa	O
suggest	O
that	O
DPMK	O
is	O
involved	O
in	O
moudlating	O
the	O
initial	O
eevnts	O
of	O
exctiation	O
-	O
contratcion	O
coupilng	O
in	O
skeeltal	O
muslce	O
.	O
.	O

Cosntitutional	O
RB1	O
-	O
gnee	O
muattions	O
in	O
pateints	O
with	O
isolaetd	O
unilaetral	B-Disease
retnioblastoma	I-Disease
.	O

In	O
most	O
ptaients	O
with	O
isolaetd	O
unilaetral	B-Disease
retinbolastoma	I-Disease
,	O
tmuor	B-Disease
deevlopment	O
is	O
initiated	O
by	O
somtaic	O
inactivtaion	O
of	O
both	O
alleles	O
of	O
the	O
RB1	O
gnee	O
.	O

However	O
,	O
some	O
of	O
these	O
patietns	O
can	O
trnasmit	O
retinolbastoma	B-Disease
perdisposition	O
to	O
their	O
offpsring	O
.	O

To	O
determine	O
the	O
frqeuency	O
and	O
nature	O
of	O
constittuional	O
RB1	O
-	O
gnee	O
muttaions	O
in	O
pateints	O
with	O
ioslated	O
uinlateral	B-Disease
retinoblastmoa	I-Disease
,	O
we	O
analzyed	O
DNA	O
from	O
periphearl	O
blood	O
and	O
from	O
tmuor	B-Disease
tsisue	O
.	O

The	O
analyiss	O
of	O
tmuors	B-Disease
from	O
54	O
(	O
71	O
%	O
)	O
of	O
76	O
infromative	O
patinets	O
showed	O
lsos	O
of	O
contsitutional	O
hetreozygosity	O
(	O
LOH	O
)	O
at	O
intragneic	O
lcoi	O
.	O

Three	O
of	O
13	O
uninofrmative	O
patinets	O
had	O
consttiutional	O
deeltions	O
.	O

For	O
39	O
randomly	O
selected	O
tuomrs	B-Disease
,	O
SCSP	O
,	O
heetro	O
-	O
dpulex	O
anlaysis	O
,	O
sqeuencing	O
,	O
and	O
Suothern	O
bolt	O
aanlysis	O
were	O
used	O
to	O
identify	O
muattions	O
.	O

Mtuations	O
were	O
deetcted	O
in	O
21	O
(	O
91	O
%	O
)	O
of	O
23	O
tumros	B-Disease
with	O
LOH	O
.	O

In	O
6	O
(	O
38	O
%	O
)	O
of	O
16	O
tumros	B-Disease
without	O
LOH	O
,	O
one	O
muttaion	O
was	O
detecetd	O
,	O
and	O
in	O
9	O
(	O
56	O
%	O
)	O
of	O
the	O
tmuors	B-Disease
without	O
LOH	O
,	O
both	O
mutatoins	O
were	O
found	O
.	O

Thus	O
,	O
a	O
total	O
of	O
45	O
mutatinos	O
were	O
idenitfied	O
in	O
tmuors	B-Disease
of	O
36	O
patietns	O
.	O

Thirty	O
-	O
nine	O
of	O
the	O
muattions	O
-	O
including	O
34	O
small	O
mutaitons	O
,	O
2	O
large	O
srtuctural	O
alteratinos	O
,	O
and	O
hypremethylation	O
in	O
3	O
tmuors	O
-	O
were	O
not	O
dteected	O
in	O
the	O
corresponding	O
periphearl	O
bolod	O
DNA	O
.	O

In	O
6	O
(	O
17	O
%	O
)	O
of	O
the	O
36	O
patinets	O
,	O
a	O
mtuation	O
was	O
detetced	O
in	O
consttiutional	O
DNA	O
,	O
and	O
1	O
of	O
these	O
mtuations	O
is	O
known	O
to	O
be	O
associated	O
with	O
reudced	O
exprsesivity	O
.	O

The	O
prseence	O
of	O
a	O
constituitonal	O
muttaion	O
was	O
not	O
associated	O
with	O
an	O
ealry	O
age	O
at	O
treatemnt	O
.	O

In	O
1	O
paitent	O
,	O
somtaic	O
moasicism	O
was	O
demonstrated	O
by	O
molecualr	O
anaylsis	O
of	O
DNA	O
and	O
RNA	O
from	O
periphearl	O
bolod	O
.	O

In	O
2	O
paitents	O
without	O
a	O
detectbale	O
mutaiton	O
in	O
perpiheral	O
blood	O
,	O
mosaciism	O
was	O
suggested	O
because	O
1	O
of	O
the	O
ptaients	O
showed	O
multfiocal	O
tumros	B-Disease
and	O
the	O
other	O
later	O
developed	O
bilatearl	B-Disease
retinoblastmoa	I-Disease
.	O

In	O
conclusion	O
,	O
our	O
resluts	O
emphasize	O
that	O
the	O
manifestatoin	O
and	O
transimssibility	O
of	O
retinbolastoma	B-Disease
depend	O
on	O
the	O
nature	O
of	O
the	O
first	O
mtuation	O
,	O
its	O
tmie	O
in	O
developemnt	O
,	O
and	O
the	O
number	O
and	O
types	O
of	O
clels	O
that	O
are	O
affceted	O
.	O
.	O

Hereidtary	B-Disease
deficiecny	I-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
man	O
.	O

I	O
.	O

Clincial	O
,	O
immunohcemical	O
,	O
and	O
famliy	O
stuides	O
.	O

The	O
first	O
recognized	O
hmuan	O
kinrded	O
with	O
heredtiary	B-Disease
deifciency	I-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C5	O
)	O
is	O
described	O
.	O

The	O
prboand	O
,	O
a	O
20	O
-	O
yaer	O
-	O
old	O
blcak	O
femlae	O
with	O
ssytemic	B-Disease
lpuus	I-Disease
eryhtematosus	I-Disease
since	O
age	O
11	O
,	O
lacked	O
sreum	O
hemloytic	O
complement	O
acitvity	O
,	O
even	O
during	O
remisison	O
.	O

C5	O
was	O
undetetcable	O
in	O
her	O
sreum	O
by	O
both	O
immunodiffusoin	O
and	O
hemolyitc	O
assays	O
.	O

Other	O
complement	O
componetns	O
were	O
nromal	O
during	O
remission	O
of	O
lpuus	O
,	O
but	O
C1	O
,	O
C4	O
,	O
C2	O
,	O
and	O
C3	O
levles	O
fell	O
during	O
eaxcerbations	O
.	O

A	O
yougner	O
half	O
-	O
sitser	O
,	O
who	O
had	O
no	O
underlying	O
dsiease	O
,	O
was	O
also	O
found	O
to	O
lcak	O
immunochemically	O
deetctable	O
C5	O
.	O

By	O
hemoyltic	O
asasy	O
,	O
she	O
exhibited	O
1	O
-	O
2	O
%	O
of	O
the	O
nomral	O
seurm	O
C5	O
leevl	O
and	O
nromal	O
conecntrations	O
of	O
other	O
complement	O
comopnents	O
.	O

C5	O
leevls	O
of	O
other	O
fmaily	O
mebmers	O
were	O
either	O
nromal	O
or	O
approximately	O
half	O
-	O
noraml	O
,	O
consistent	O
with	O
atuosomal	O
coodminant	O
ihneritance	O
of	O
the	O
gnee	O
determining	O
C5	B-Disease
defiicency	I-Disease
.	O

Nomral	O
hemloytic	O
ttiers	O
were	O
resotred	O
to	O
both	O
homoyzgous	O
C5	B-Disease
-	I-Disease
deifcient	I-Disease
(	O
C5D	B-Disease
)	O
srea	O
by	O
addition	O
of	O
highly	O
purfiied	O
huamn	O
C5	O
.	O

In	O
specific	O
C5	O
titrtaions	O
,	O
however	O
,	O
it	O
was	O
noted	O
that	O
when	O
limietd	O
amounts	O
of	O
C5	O
were	O
assyaed	O
in	O
the	O
preesnce	O
of	O
low	O
dilutinos	O
of	O
either	O
C5D	B-Disease
sreum	O
,	O
cuvring	O
rather	O
than	O
linaer	O
dsoe	O
-	O
resopnse	O
pltos	O
were	O
consistently	O
obtained	O
,	O
suggesting	O
some	O
inhbiitory	O
efefct	O
.	O

Further	O
stuides	O
suggested	O
that	O
low	O
diltuions	O
of	O
C5D	B-Disease
seurm	O
contain	O
a	O
fcator	O
(	O
or	O
facotrs	O
)	O
itnerfering	O
at	O
some	O
step	O
in	O
the	O
hemoltyic	O
assay	O
of	O
C5	O
,	O
rather	O
than	O
a	O
true	O
C5	O
inhbiitor	O
or	O
ianctivator	O
.	O

Of	O
cilnical	O
interest	O
are	O
(	O
a	O
)	O
the	O
documenattion	O
of	O
membranuos	O
glomeruolnephritis	B-Disease
,	O
vasculiits	B-Disease
,	O
and	O
arthriits	B-Disease
in	O
an	O
idnividual	O
lacking	O
C5	O
(	O
and	O
its	O
biolgoic	O
fucntions	O
)	O
,	O
and	O
(	O
b	O
)	O
a	O
remarkable	O
porpensity	O
to	O
bacetrial	B-Disease
ifnections	I-Disease
in	O
the	O
probnad	O
,	O
even	O
during	O
preiods	O
of	O
low	O
-	O
dsoe	O
or	O
alternate	O
-	O
day	O
cotricosteroid	O
threapy	O
.	O

Other	O
observaitons	O
indicate	O
that	O
the	O
C5D	B-Disease
state	O
is	O
compatible	O
with	O
nomral	O
coagluation	O
funciton	O
and	O
the	O
capactiy	O
to	O
muont	O
a	O
neturophilic	O
leukoyctosis	O
during	O
pyoegnic	B-Disease
infectoin	I-Disease
.	O
.	O

Susceptibiltiy	O
to	O
aknylosing	B-Disease
sopndylitis	I-Disease
in	O
tiwns	O
:	O
the	O
role	O
of	O
gnees	O
,	O
HLA	O
,	O
and	O
the	O
enviornment	O
.	O

OBJECITVE	O
To	O
determine	O
the	O
relative	O
efefcts	O
of	O
genteic	O
and	O
envrionmental	O
facotrs	O
in	O
susceptibliity	O
to	O
aknylosing	B-Disease
spondyiltis	I-Disease
(	O
AS	B-Disease
)	O
.	O

METHODS	O
Twnis	O
with	O
AS	B-Disease
were	O
iedntified	O
from	O
the	O
Ryoal	O
Natoinal	O
Hosiptal	O
for	O
Rheuamtic	B-Disease
Diseaess	I-Disease
databsae	O
.	O

Clincial	O
and	O
radiorgaphic	O
examinatinos	O
were	O
performed	O
to	O
establish	O
diagnsoes	O
,	O
and	O
dsiease	O
seevrity	O
was	O
assesesd	O
using	O
a	O
comibnation	O
of	O
validated	O
scroing	O
sysetms	O
.	O

HLA	O
tyipng	O
for	O
HLA	O
-	O
B27	O
,	O
HLA	O
-	O
B60	O
,	O
and	O
HLA	O
-	O
DR1	O
was	O
performed	O
by	O
polymrease	O
chian	O
recation	O
with	O
sqeuence	O
-	O
specific	O
priemrs	O
,	O
and	O
zgyosity	O
was	O
asesssed	O
using	O
microsatelilte	O
makrers	O
.	O

Genteic	O
and	O
environmnetal	O
variacne	O
cmoponents	O
were	O
assessed	O
with	O
the	O
progarm	O
Mx	O
,	O
using	O
dtaa	O
from	O
this	O
and	O
previous	O
sutdies	O
of	O
twnis	O
with	O
AS	B-Disease
.	O

RSEULTS	O
Six	O
of	O
8	O
monozygoitc	O
(	O
MZ	O
)	O
tiwn	O
paris	O
were	O
diesase	O
cocnordant	O
,	O
copmared	O
with	O
4	O
of	O
15	O
B27	O
-	O
poistive	O
dizgyotic	O
(	O
DZ	O
)	O
tiwn	O
paris	O
(	O
27	O
%	O
)	O
and	O
4	O
of	O
32	O
DZ	O
tiwn	O
paris	O
overall	O
(	O
12	O
.	O
5	O
%	O
)	O
.	O

Nonsingificant	O
incresaes	O
in	O
similraity	O
with	O
regard	O
to	O
age	O
at	O
disesae	O
onset	O
and	O
all	O
of	O
the	O
dsiease	O
severtiy	O
scroes	O
asssesed	O
were	O
noted	O
in	O
disaese	O
-	O
conocrdant	O
MZ	O
tiwns	O
cmopared	O
with	O
cocnordant	O
DZ	O
twnis	O
.	O

HLA	O
-	O
B27	O
and	O
B60	O
were	O
associated	O
with	O
the	O
disaese	O
in	O
prboands	O
,	O
and	O
the	O
rtae	O
of	O
dsiease	O
conocrdance	O
was	O
significantly	O
incresaed	O
among	O
DZ	O
tiwn	O
paris	O
in	O
which	O
the	O
co	O
-	O
tiwn	O
was	O
psoitive	O
for	O
both	O
B27	O
and	O
DR1	O
.	O

Additive	O
genteic	O
effcets	O
were	O
etsimated	O
to	O
contribute	O
97	O
%	O
of	O
the	O
popualtion	O
varaince	O
.	O

COCNLUSION	O
Susceptibiltiy	O
to	O
AS	B-Disease
is	O
largely	O
genetiaclly	O
determined	O
,	O
and	O
the	O
enivronmental	O
trigegr	O
for	O
the	O
dsiease	O
is	O
probably	O
ubiquitous	O
.	O

HLA	O
-	O
B27	O
accounts	O
for	O
a	O
minority	O
of	O
the	O
overall	O
gneetic	O
suscpetibility	O
to	O
AS	B-Disease
.	O

Clel	O
ccyle	O
-	O
depnedent	O
colcoalization	O
of	O
BRAD1	O
and	O
BRAC1	O
prtoeins	O
in	O
disrcete	O
nculear	O
domanis	O
.	O

Grem	O
-	O
line	O
mutaitons	O
of	O
the	O
BRAC1	O
gnee	O
predispose	O
wmoen	O
to	O
ealry	O
-	O
onset	O
berast	B-Disease
and	I-Disease
ovarain	I-Disease
cacner	I-Disease
by	O
cmopromising	O
the	O
geens	O
presmuptive	O
fucntion	O
as	O
a	O
tmuor	B-Disease
suppresosr	O
.	O

Although	O
the	O
boichemical	O
properites	O
of	O
BRAC1	O
polypeptieds	O
are	O
not	O
understood	O
,	O
their	O
experssion	O
pattern	O
and	O
sucbellular	O
locailzation	O
suggest	O
a	O
role	O
in	O
clel	O
-	O
cylce	O
reuglation	O
.	O

When	O
restnig	O
cells	O
are	O
inudced	O
to	O
proliefrate	O
,	O
the	O
steady	O
-	O
state	O
levles	O
of	O
BRAC1	O
incresae	O
in	O
ltae	O
G1	O
and	O
reach	O
a	O
mxaimum	O
during	O
S	O
phsae	O
.	O

Moreover	O
,	O
in	O
S	O
pahse	O
clels	O
,	O
BRAC1	O
polpyeptides	O
are	O
hyperphosphroylated	O
and	O
acucmulate	O
into	O
discrtee	O
subunclear	O
fcoi	O
termed	O
"	O
BRAC1	O
nulcear	O
dtos	O
.	O

"	O
BCRA1	O
associtaes	O
in	O
vivo	O
with	O
a	O
structurally	O
related	O
portein	O
termed	O
BRAD1	O
.	O

Here	O
we	O
show	O
that	O
the	O
steady	O
-	O
state	O
levles	O
of	O
BRAD1	O
,	O
unlike	O
those	O
of	O
BCRA1	O
,	O
remain	O
relatively	O
cnostant	O
during	O
clel	O
ccyle	O
prorgession	O
.	O

However	O
,	O
immunsotaining	O
revaeled	O
that	O
BADR1	O
resieds	O
within	O
BCRA1	O
nuclaer	O
dtos	O
during	O
S	O
phsae	O
of	O
the	O
clel	O
cylce	O
,	O
but	O
not	O
during	O
the	O
G1	O
pahse	O
.	O

Nevertheless	O
,	O
BRAD1	O
ploypeptides	O
are	O
found	O
exclusively	O
in	O
the	O
nulcear	O
fractoins	O
of	O
both	O
G1	O
-	O
and	O
S	O
-	O
pahse	O
cells	O
.	O

Therefore	O
,	O
prgoression	O
to	O
S	O
pahse	O
is	O
accompanied	O
by	O
the	O
aggreagtion	O
of	O
nculear	O
BADR1	O
polpyeptides	O
into	O
BCRA1	O
nuclaer	O
dtos	O
.	O

This	O
clel	O
ccyle	O
-	O
deepndent	O
colocaliztaion	O
of	O
BRAD1	O
and	O
BRAC1	O
indicates	O
a	O
role	O
for	O
BADR1	O
in	O
BRAC1	O
-	O
mediated	O
tmuor	B-Disease
suppressoin	O
.	O

Etnhic	O
diffeernces	O
in	O
the	O
HFE	O
cdoon	O
282	O
(	O
Cys	O
/	O
Tyr	O
)	O
polymrophism	O
.	O

Recent	O
sutdies	O
have	O
shown	O
that	O
heerditary	B-Disease
hemochromaotsis	I-Disease
(	O
HH	B-Disease
)	O
is	O
likely	O
to	O
be	O
caused	O
by	O
homozygsoity	O
for	O
a	O
Csy282Tyr	O
mutatoin	O
in	O
the	O
HFE	O
gnee	O
located	O
4	O
.	O

5	O
Mb	O
telmoeric	O
to	O
HLA	O
-	O
A	O
.	O

Pouplation	O
sutdies	O
of	O
this	O
polymoprhism	O
are	O
facilitated	O
by	O
the	O
fact	O
that	O
the	O
Cys822Tyr	O
muattion	O
creates	O
a	O
Rasl	O
restritcion	O
stie	O
.	O

We	O
have	O
studied	O
the	O
cdoon	O
282	O
(	O
Cys	O
/	O
Tyr	O
)	O
polymoprhism	O
in	O
different	O
ethinc	O
gorups	O
.	O

In	O
agreement	O
with	O
previous	O
obsrevations	O
the	O
Tyr	O
alllee	O
appeared	O
to	O
be	O
rrae	O
or	O
abesnt	O
in	O
Asiaitc	O
(	O
Indain	O
,	O
Chinsee	O
)	O
populaitons	O
.	O

The	O
highest	O
allele	O
frequecny	O
(	O
7	O
.	O
5	O
%	O
)	O
was	O
found	O
in	O
Swdees	O
.	O

Samais	O
(	O
2	O
%	O
)	O
and	O
Mordivnians	O
(	O
1	O
.	O
8	O
%	O
)	O
had	O
significantly	O
loewr	O
frequnecies	O
of	O
the	O
Tyr	O
alelle	O
.	O

Compariosns	O
with	O
allele	O
frequecnies	O
based	O
on	O
prevalecne	O
estmiates	O
of	O
HH	B-Disease
showed	O
some	O
disagreemetns	O
with	O
the	O
RLFP	O
dtaa	O
,	O
particularly	O
in	O
Fnins	O
.	O

The	O
newly	O
described	O
HFE	O
makrer	O
provides	O
a	O
new	O
approach	O
to	O
the	O
screennig	O
of	O
HH	B-Disease
as	O
well	O
as	O
sutdies	O
of	O
the	O
relationsihp	O
between	O
the	O
HFE	O
Tyr	O
allele	O
and	O
different	O
disroders	O
including	O
cacner	B-Disease

Autsoomal	B-Disease
doimnant	I-Disease
neurohypophsyeal	I-Disease
diabtees	I-Disease
insipiuds	I-Disease
associated	O
with	O
a	O
missense	O
mtuation	O
ecnoding	O
Gly23	O
-	O
-	O
>	O
Val	O
in	O
neuorphysin	O
II	O
.	O

Autosmoal	B-Disease
dmoinant	I-Disease
neurohypophyesal	I-Disease
diaebtes	I-Disease
inispidus	I-Disease
(	O
ANDDI	B-Disease
)	O
is	O
an	O
inhreited	B-Disease
diesase	I-Disease
caused	O
by	O
prorgessive	O
deegneration	O
of	O
the	O
magncoellular	O
neurnos	O
of	O
the	O
hypothalaums	O
leading	O
to	O
derceased	O
ability	O
to	O
produce	O
the	O
horomne	O
agrinine	O
vasporessin	O
(	O
AVP	O
)	O
.	O

Affceted	O
indiviudals	O
are	O
not	O
symptomaitc	O
at	O
bitrh	O
,	O
but	O
usually	O
develop	O
diaebtes	B-Disease
inspiidus	I-Disease
at	O
1	O
-	O
6	O
yr	O
of	O
age	O
.	O

The	O
geentic	O
loucs	O
of	O
the	O
dsiease	O
is	O
the	O
AVP	O
-	O
neuorphysin	O
II	O
(	O
NIPI	O
)	O
gnee	O
,	O
and	O
muttaions	O
that	O
cause	O
ANDDI	B-Disease
have	O
been	O
found	O
in	O
both	O
the	O
siganl	O
pepitde	O
of	O
the	O
prerpo	O
-	O
AVP	O
-	O
NIPI	O
precrusor	O
and	O
within	O
NIPI	O
itself	O
.	O

An	O
affetced	O
gril	O
who	O
presented	O
at	O
9	O
mnoths	O
of	O
age	O
and	O
her	O
similarly	O
afefcted	O
yuonger	O
brtoher	O
and	O
fahter	O
were	O
all	O
found	O
to	O
have	O
a	O
novel	O
missense	O
mutatoin	O
(	O
G7158	O
-	O
-	O
>	O
T	O
)	O
encoidng	O
the	O
aimno	O
aicd	O
substituiton	O
Gly23	O
-	O
-	O
>	O
Val	O
within	O
NIPI	O
.	O

The	O
muttaion	O
was	O
confirmed	O
by	O
restirction	O
endonuclaese	O
analsyis	O
.	O

A	O
T1	O
-	O
weighted	O
magneitc	O
resonacne	O
imgaing	O
of	O
the	O
fahters	O
pituiatry	O
galnd	O
demonstrates	O
an	O
attneuated	O
postreior	O
pitutiary	O
bright	O
sopt	O
.	O

This	O
muttaion	O
may	O
be	O
valuable	O
for	O
developing	O
modles	O
of	O
dominantly	B-Disease
inhertied	I-Disease
neurodegneeration	I-Disease
,	O
as	O
the	O
ealry	O
age	O
of	O
onset	O
of	O
sympotms	O
suggests	O
that	O
this	O
mutaiton	O
may	O
be	O
particularly	O
deleteirous	O
to	O
the	O
magoncellular	O
neruon	O
.	O
.	O

Freuqent	O
inatcivation	O
of	O
PETN	O
/	O
MAMC1	O
in	O
primray	O
prosttae	B-Disease
canecr	I-Disease
.	O

Spoardic	B-Disease
protsate	I-Disease
carcinmoa	I-Disease
is	O
the	O
most	O
common	O
mlae	B-Disease
canecr	I-Disease
in	O
the	O
Westren	O
world	O
,	O
yet	O
many	O
of	O
the	O
major	O
geneitc	O
evnets	O
involved	O
in	O
the	O
progerssion	O
of	O
this	O
often	O
faatl	O
cacner	B-Disease
remain	O
to	O
be	O
elucidated	O
.	O

Numerous	O
cytgoenetic	O
and	O
allleotype	O
sutdies	O
have	O
reported	O
freqeunt	O
lsos	O
of	O
hetreozygosity	O
on	O
chroomsomal	O
arm	O
10q	O
in	O
sproadic	B-Disease
prsotate	I-Disease
cacner	I-Disease
.	O

Dleetion	O
mpaping	O
studeis	O
have	O
unambiguously	O
idnetified	O
a	O
rgeion	O
of	O
chormosome	O
10q23	O
to	O
be	O
the	O
minmial	O
aera	O
of	O
lsos	O
.	O

A	O
new	O
tuomr	B-Disease
spupressor	O
gnee	O
,	O
PETN	O
/	O
MAMC1	O
,	O
was	O
ioslated	O
recently	O
at	O
this	O
rgeion	O
of	O
chromsoome	O
10q23	O
and	O
found	O
to	O
be	O
inactviated	O
by	O
mutatoin	O
in	O
three	O
prosatte	B-Disease
canecr	I-Disease
clel	O
lnies	O
.	O

We	O
screened	O
80	O
porstate	B-Disease
tmuors	I-Disease
by	O
microsatelltie	O
analyiss	O
and	O
found	O
chroomsome	O
10q23	O
to	O
be	O
deleetd	O
in	O
23	O
caess	O
.	O

We	O
then	O
proceeded	O
with	O
seuqence	O
analyiss	O
of	O
the	O
entire	O
PETN	O
/	O
MMCA1	O
codnig	O
reigon	O
and	O
tesetd	O
for	O
hoomzygous	O
deleiton	O
with	O
new	O
intragneic	O
marekrs	O
in	O
these	O
23	O
csaes	O
with	O
10q23	O
lsos	O
of	O
hetreozygosity	O
.	O

The	O
identfiication	O
of	O
the	O
second	O
mutatinoal	O
evnet	O
in	O
10	O
(	O
43	O
%	O
)	O
tumros	B-Disease
establishes	O
PETN	O
/	O
MMCA1	O
as	O
a	O
main	O
inactivatoin	O
taregt	O
of	O
10q	O
lsos	O
in	O
spordaic	B-Disease
prsotate	I-Disease
cacner	I-Disease
.	O
.	O

Rsik	O
reverslas	O
in	O
prdeictive	O
tseting	O
for	O
Huntingotn	B-Disease
dsiease	I-Disease
.	O

The	O
first	O
preidctive	O
tseting	O
for	O
Huntintgon	B-Disease
dsiease	I-Disease
(	O
HD	B-Disease
)	O
was	O
based	O
on	O
analsyis	O
of	O
linked	O
poylmorphic	O
DNA	O
mrakers	O
to	O
estimtae	O
the	O
likeliohod	O
of	O
inheirting	O
the	O
muttaion	O
for	O
HD	B-Disease
.	O

Lmiits	O
to	O
accuarcy	O
included	O
recombiantion	O
between	O
the	O
DNA	O
markres	O
and	O
the	O
mutatoin	O
,	O
pedigere	O
strucutre	O
,	O
and	O
whether	O
DNA	O
sampels	O
were	O
available	O
from	O
famliy	O
memebrs	O
.	O

With	O
direct	O
tetss	O
for	O
the	O
HD	B-Disease
mtuation	O
,	O
we	O
have	O
asesssed	O
the	O
accuarcy	O
of	O
resutls	O
obtained	O
by	O
linkgae	O
approcahes	O
when	O
requseted	O
to	O
do	O
so	O
by	O
the	O
tset	O
indviiduals	O
.	O

For	O
six	O
such	O
indivdiuals	O
,	O
there	O
was	O
significant	O
dsiparity	O
between	O
the	O
tetss	O
.	O

Three	O
went	O
from	O
a	O
dcereased	O
rsik	O
to	O
an	O
incraesed	O
rsik	O
,	O
while	O
in	O
another	O
three	O
the	O
rsik	O
was	O
decraesed	O
.	O

Knowldege	O
of	O
the	O
potentail	O
reasnos	O
for	O
these	O
cahnges	O
in	O
reuslts	O
and	O
ipmact	O
of	O
these	O
rsik	O
revresals	O
on	O
both	O
ptaients	O
and	O
the	O
conuseling	O
taem	O
can	O
assist	O
in	O
the	O
deveolpment	O
of	O
strategies	O
for	O
the	O
prveention	O
and	O
,	O
where	O
necessary	O
,	O
managemnet	O
of	O
a	O
rsik	O
reevrsal	O
in	O
any	O
preidctive	O
testnig	O
prgoram	O
.	O
.	O

A	O
novel	O
common	O
missesne	O
mtuation	O
G031C	O
in	O
the	O
N	O
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sulftae	O
sulaftase	O
gnee	O
in	O
mucopolysachcaridosis	B-Disease
IVA	I-Disease
.	O

Mucopolsyaccharidosis	B-Disease
IVA	I-Disease
(	O
MPS	B-Disease
IVA	I-Disease
)	O
is	O
an	O
auotsomal	B-Disease
recessvie	I-Disease
lsyosomal	I-Disease
stroage	I-Disease
disodrer	I-Disease
caused	O
by	O
a	O
geneitc	B-Disease
defcet	I-Disease
in	O
N	O
-	O
acetylgalactosamine	O
-	O
6	O
-	O
slufate	O
sulaftase	O
(	O
GLANS	O
)	O
.	O

In	O
previous	O
stuides	O
,	O
we	O
have	O
found	O
two	O
common	O
muattions	O
in	O
Caucsaians	O
and	O
Jaapnese	O
,	O
respectively	O
.	O

To	O
characterize	O
the	O
mutatinoal	O
specrtum	O
in	O
various	O
ehtnic	O
gropus	O
,	O
muattions	O
in	O
the	O
GLANS	O
gnee	O
in	O
Coolmbian	O
MPS	B-Disease
IVA	I-Disease
ptaients	O
were	O
investgiated	O
,	O
and	O
geneitc	O
backgrounds	O
were	O
extensively	O
analyezd	O
to	O
identify	O
rcaial	O
oirgin	O
,	O
based	O
on	O
mitochondiral	O
DNA	O
(	O
mDtNA	O
)	O
lnieages	O
.	O

Three	O
novel	O
missnese	O
muttaions	O
never	O
idnetified	O
previously	O
in	O
other	O
ppoulations	O
and	O
found	O
in	O
16	O
out	O
of	O
19	O
Cloombian	O
MPS	B-Disease
IVA	I-Disease
unrelated	O
alllees	O
account	O
for	O
84	O
.	O

2	O
%	O
of	O
the	O
alleels	O
in	O
this	O
stduy	O
.	O

The	O
G031C	O
and	O
S126F	O
muattions	O
account	O
for	O
68	O
.	O

4	O
%	O
and	O
10	O
.	O

5	O
%	O
of	O
mutatinos	O
,	O
respectively	O
,	O
whereas	O
the	O
remaining	O
F96V	O
is	O
lmiited	O
to	O
a	O
single	O
alllee	O
.	O

The	O
skeewd	O
prvealence	O
of	O
G031C	O
in	O
only	O
Colombain	O
pateints	O
and	O
haploytpe	O
aanlysis	O
by	O
restritcion	O
fargment	O
lnegth	O
polymorphsims	O
in	O
the	O
GANLS	O
gnee	O
suggest	O
that	O
G031C	O
originated	O
from	O
a	O
common	O
ancsetor	O
.	O

Invsetigation	O
of	O
the	O
geneitc	O
background	O
by	O
means	O
of	O
mtNDA	O
linegaes	O
indicate	O
that	O
all	O
our	O
ptaients	O
are	O
probably	O
of	O
natvie	O
Ameircan	O
decsent	O

Low	O
freuqency	O
of	O
BCRA1	O
gemrline	O
mtuations	O
in	O
45	O
Greman	O
braest	B-Disease
/	I-Disease
ovraian	I-Disease
canecr	I-Disease
famileis	O
.	O

In	O
this	O
stduy	O
we	O
investigtaed	O
45	O
Greman	O
bresat	B-Disease
/	I-Disease
ovarain	I-Disease
cacner	I-Disease
fmailies	O
for	O
gemrline	O
mutatinos	O
in	O
the	O
BRAC1	O
gnee	O
.	O

We	O
idenitfied	O
four	O
gemrline	O
mutaitons	O
in	O
three	O
braest	B-Disease
canecr	I-Disease
fmailies	O
and	O
in	O
one	O
berast	B-Disease
-	I-Disease
oavrian	I-Disease
cnacer	I-Disease
faimly	O
.	O
among	O
these	O
were	O
one	O
framesihft	O
mtuation	O
,	O
one	O
nonesnse	O
mtuation	O
,	O
one	O
novel	O
slpice	O
stie	O
mutaiton	O
,	O
and	O
one	O
missense	O
muattion	O
.	O

The	O
misesnse	O
mutatoin	O
was	O
also	O
found	O
in	O
2	O
.	O

8	O
%	O
of	O
the	O
general	O
ppoulation	O
,	O
suggesting	O
that	O
it	O
is	O
not	O
disaese	O
associated	O
.	O

The	O
avearge	O
age	O
of	O
diesase	O
onset	O
in	O
those	O
faimlies	O
harbouring	O
causatvie	O
mutatoins	O
was	O
between	O
32	O
.	O

3	O
and	O
37	O
.	O

4	O
yaers	O
,	O
whereas	O
the	O
faimly	O
harbouring	O
the	O
msisense	O
muttaion	O
had	O
an	O
avearge	O
age	O
of	O
onset	O
of	O
51	O
.	O

2	O
yaers	O
.	O

These	O
findnigs	O
show	O
that	O
BCRA1	O
is	O
implicated	O
in	O
a	O
small	O
fraciton	O
of	O
berast	B-Disease
/	I-Disease
ovarain	I-Disease
cacner	I-Disease
famliies	O
suggesting	O
the	O
invovlement	O
of	O
another	O
susceptibiilty	O
gnee	O
(	O
s	O
)	O

Paetrnal	O
transmission	O
of	O
congeniatl	B-Disease
myotoinc	I-Disease
dystrpohy	I-Disease
.	O

We	O
reoprt	O
a	O
rrae	O
csae	O
of	O
paternally	O
transmitted	O
conegnital	B-Disease
myotnoic	I-Disease
dystrohpy	I-Disease
(	O
DM	B-Disease
)	O
.	O

The	O
prboand	O
is	O
a	O
23	O
yaer	O
old	O
,	O
mentally	B-Disease
retaredd	I-Disease
mlae	O
who	O
suffers	O
seevre	O
muscualr	B-Disease
wekaness	I-Disease
.	O

He	O
presented	O
with	O
resipratory	O
and	O
fedeing	O
dififculties	O
at	O
brith	O
.	O

His	O
two	O
sbis	O
suffer	O
from	O
chilhdood	O
onset	O
DM	B-Disease
.	O

Their	O
ltae	O
fatehr	O
had	O
the	O
audlt	O
tpye	O
of	O
DM	B-Disease
,	O
with	O
onset	O
around	O
30	O
yeras	O
.	O

Only	O
six	O
other	O
csaes	O
of	O
patenral	O
tranmsission	O
of	O
congeintal	B-Disease
DM	I-Disease
have	O
been	O
reported	O
recently	O
.	O

We	O
rveiew	O
the	O
sex	O
related	O
efefcts	O
on	O
trnasmission	O
of	O
cognenital	B-Disease
DM	I-Disease
.	O

Dcereased	O
fetrility	O
of	O
maels	O
with	O
audlt	O
onset	O
DM	B-Disease
and	O
cotnraction	O
of	O
the	O
reepat	O
upon	O
mlae	O
transmission	O
contribute	O
to	O
the	O
almost	O
absnet	O
ocucrrence	O
of	O
patrenal	O
transmisison	O
of	O
cnogenital	B-Disease
DM	I-Disease
.	O

Also	O
the	O
fatehrs	O
of	O
the	O
reported	O
conegnitally	O
affetced	O
childern	O
showed	O
,	O
on	O
avearge	O
,	O
shoretr	O
CTG	O
rpeeat	O
lenghts	O
and	O
hence	O
less	O
sveere	O
cliincal	O
sypmtoms	O
than	O
the	O
motehrs	O
of	O
chidlren	O
with	O
cnogenital	B-Disease
DM	I-Disease
.	O

We	O
conclude	O
that	O
pateranl	O
transimssion	O
of	O
congneital	B-Disease
DM	I-Disease
is	O
rrae	O
and	O
preferentially	O
occurs	O
with	O
onset	O
of	O
DM	B-Disease
past	O
30	O
yaers	O
in	O
the	O
fatehr	O
.	O
.	O

The	O
RB1	O
gnee	O
mutatoin	O
in	O
a	O
cihld	O
with	O
ectpoic	B-Disease
intracarnial	I-Disease
retinoblatsoma	I-Disease
.	O

The	O
RB1	O
gnee	O
mutatoin	O
was	O
investigaetd	O
in	O
a	O
cihld	O
with	O
etcopic	B-Disease
itnracranial	I-Disease
retinobalstoma	I-Disease
using	O
DNA	O
obtained	O
from	O
both	O
the	O
pinael	B-Disease
and	I-Disease
retnial	I-Disease
tuomurs	I-Disease
of	O
the	O
patinet	O
.	O

A	O
nonsnese	O
muattion	O
in	O
eoxn	O
17	O
(	O
coodn	O
556	O
)	O
of	O
the	O
RB1	O
gnee	O
was	O
found	O
to	O
be	O
present	O
hoomzygously	O
in	O
both	O
the	O
rteinal	B-Disease
and	I-Disease
the	I-Disease
pinael	I-Disease
tumorus	I-Disease
.	O

The	O
same	O
mutaiton	O
was	O
present	O
heterozygosuly	O
in	O
the	O
DNA	O
from	O
the	O
consttiutional	O
cells	O
of	O
the	O
ptaient	O
,	O
proving	O
it	O
to	O
be	O
of	O
germilne	O
orgiin	O
.	O

The	O
initial	O
mutaiton	O
was	O
shown	O
to	O
have	O
occurred	O
in	O
the	O
paternlaly	O
derived	O
RB1	O
allele	O
.	O

The	O
muttaion	O
is	O
in	O
an	O
aera	O
of	O
the	O
gnee	O
that	O
ecnodes	O
the	O
prtoein	O
-	O
binidng	O
reigon	O
known	O
as	O
the	O
pcoket	O
rgeion	O
and	O
has	O
been	O
dteected	O
in	O
other	O
caess	O
of	O
retinobalstoma	B-Disease
.	O
.	O

Low	O
leevls	O
of	O
btea	O
hexosaimnidase	O
A	O
in	O
helathy	O
indiivduals	O
with	O
apaprent	O
deficiecny	O
of	O
this	O
enyzme	O
.	O

Appreciable	O
btea	O
hexosamiindase	O
A	O
(	O
hex	O
A	O
)	O
actiivty	O
has	O
been	O
deetcted	O
in	O
cultrued	O
sikn	O
firboblasts	O
and	O
mealnoma	B-Disease
tissue	O
from	O
helathy	O
indivdiuals	O
previously	O
reported	O
as	O
having	O
defiicency	B-Disease
of	I-Disease
hex	I-Disease
A	I-Disease
acitvity	O
indistinguihsable	O
from	O
that	O
of	O
pateints	O
with	O
Tay	B-Disease
-	I-Disease
Sahcs	I-Disease
disesae	I-Disease
(	O
TSD	B-Disease
)	O
.	O

Identificatoin	O
and	O
quantittaion	O
of	O
hex	O
A	O
,	O
amounting	O
to	O
3	O
.	O

5	O
%	O
-	O
6	O
.	O

9	O
%	O
of	O
total	O
btea	O
hxeosaminidase	O
actviity	O
,	O
has	O
been	O
obtained	O
by	O
cellulose	O
aceatte	O
gel	O
electrophorseis	O
,	O
DAEE	O
-	O
cellulose	O
ion	O
-	O
exchagne	O
chromtaography	O
,	O
raidal	O
immunodiffusion	O
,	O
and	O
radoiimmunoassay	O
.	O

Previous	O
famliy	O
stuides	O
suggested	O
that	O
these	O
indiivduals	O
may	O
be	O
cmopound	O
heteorzygotes	O
for	O
the	O
common	O
mtuant	O
TSD	B-Disease
gnee	O
and	O
a	O
rrae	O
(	O
allleic	O
)	O
mutnat	O
gnee	O
.	O

Thus	O
,	O
the	O
postulated	O
rtae	O
mutnat	O
gnee	O
appears	O
to	O
cdoe	O
for	O
the	O
expressoin	O
of	O
low	O
amounts	O
of	O
hex	O
A	O
.	O

Heterozygtoes	O
for	O
the	O
rrae	O
mutnat	O
may	O
be	O
indistinguihsable	O
from	O
heterozgyotes	O
for	O
the	O
common	O
TSD	B-Disease
mtuant	O
.	O

However	O
,	O
direct	O
visualiztaion	O
and	O
quantittaion	O
of	O
hex	O
A	O
by	O
the	O
mehtods	O
described	O
may	O
prevnet	O
fasle	O
-	O
postiive	O
pernatal	O
diagonsis	O
of	O
TSD	B-Disease
in	O
fteuses	O
having	O
the	O
inocmplete	O
hex	B-Disease
A	I-Disease
deficiecny	I-Disease
of	O
the	O
tpye	O
described	O
in	O
the	O
four	O
heatlhy	O
indiivduals	O

The	O
tmuor	B-Disease
spupressor	O
gnee	O
Samd4	O
/	O
Dcp4	O
is	O
required	O
for	O
gsatrulation	O
and	O
later	O
for	O
atnerior	O
developmnet	O
of	O
the	O
muose	O
emrbyo	O
.	O

Mutaitons	O
in	O
the	O
SAMD4	O
/	O
DCP4	O
tuomr	B-Disease
suppressor	O
gnee	O
,	O
a	O
key	O
siganl	O
trnasducer	O
in	O
most	O
TGFbtea	O
-	O
related	O
ptahways	O
,	O
are	O
involved	O
in	O
50	O
%	O
of	O
pancreaitc	B-Disease
cnacers	I-Disease
.	O

Hoomzygous	O
Smda4	O
mtuant	O
mcie	O
die	O
before	O
day	O
7	O
.	O

5	O
of	O
embryogenseis	O
.	O

Mtuant	O
embyros	O
have	O
redcued	O
szie	O
,	O
fail	O
to	O
gatsrulate	O
or	O
express	O
a	O
mesdoermal	O
makrer	O
,	O
and	O
show	O
abnoraml	O
viscreal	O
ednoderm	O
devleopment	O
.	O

Grotwh	B-Disease
retradation	I-Disease
of	O
the	O
Smda4	O
-	O
dfeicient	O
embyros	O
resluts	O
from	O
rdeuced	O
clel	O
proliferaiton	O
rather	O
than	O
icnreased	O
appotosis	O
.	O

Agrgegation	O
of	O
mtuant	O
Smda4	O
ES	O
cells	O
with	O
wlid	O
-	O
tpye	O
tetarploid	O
morluae	O
resuces	O
the	O
gasturlation	B-Disease
dfeect	I-Disease
.	O

These	O
reuslts	O
indicate	O
that	O
Smda4	O
is	O
initially	O
required	O
for	O
the	O
diffreentiation	O
of	O
the	O
vsiceral	O
ednoderm	O
and	O
that	O
the	O
gatsrulation	B-Disease
deefct	I-Disease
in	O
the	O
epibalst	O
is	O
secondary	O
and	O
non	O
-	O
clel	O
autonomous	O
.	O

Resceud	O
ebmryos	O
show	O
sveere	O
anteroir	O
truncatinos	O
,	O
indicating	O
a	O
second	O
important	O
role	O
for	O
Smda4	O
in	O
anetrior	O
patternnig	O
during	O
embryogeensis	O
.	O

Prevaelnce	O
of	O
p16	O
and	O
CKD4	O
germilne	O
mutatoins	O
in	O
48	O
mleanoma	B-Disease
-	O
prone	O
faimlies	O
in	O
Farnce	O
.	O

The	O
Frnech	O
Famiilal	B-Disease
Melnaoma	I-Disease
Sutdy	O
Gorup	O
.	O

Gemrline	O
mutatinos	O
in	O
the	O
p16	O
and	O
CKD4	O
gnees	O
have	O
been	O
reported	O
in	O
a	O
subset	O
of	O
melnaoma	B-Disease
pdeigrees	O
,	O
but	O
their	O
preavlence	O
is	O
not	O
well	O
known	O
.	O

We	O
searched	O
for	O
such	O
germlnie	O
mtuations	O
in	O
48	O
Fernch	O
melanmoa	B-Disease
-	O
prone	O
famliies	O
selected	O
according	O
to	O
two	O
major	O
critreia	O
famileis	O
with	O
at	O
least	O
three	O
affetced	O
memebrs	O
(	O
n	O
=	O
20	O
)	O
or	O
faimlies	O
with	O
two	O
afefcted	O
mmebers	O
,	O
one	O
of	O
them	O
affceted	O
before	O
the	O
age	O
of	O
50	O
(	O
n	O
=	O
28	O
)	O
,	O
and	O
one	O
additional	O
minor	O
crietrion	O
.	O

Sixteen	O
different	O
p16	O
gemrline	O
mtuations	O
were	O
found	O
in	O
21	O
famiiles	O
,	O
while	O
one	O
germlnie	O
mutatoin	O
,	O
Arg42His	O
,	O
was	O
deetcted	O
in	O
the	O
CKD4	O
gnee	O
.	O

The	O
freuqency	O
of	O
p16	O
gnee	O
muattion	O
in	O
our	O
smaple	O
(	O
44	O
%	O
)	O
is	O
among	O
the	O
highest	O
rtaes	O
yet	O
reported	O
and	O
the	O
CKD4	O
muttaion	O
is	O
the	O
second	O
mutatoin	O
dteected	O
in	O
this	O
gnee	O
worldwide	O
.	O

In	O
summary	O
,	O
our	O
resutls	O
show	O
ferquent	O
involvmeent	O
of	O
the	O
p16	O
gnee	O
in	O
fmailial	B-Disease
mealnoma	I-Disease
and	O
confirm	O
the	O
role	O
of	O
the	O
CKD4	O
gnee	O
as	O
a	O
melnaoma	B-Disease
-	O
predsiposing	O
gnee	O
.	O
.	O

Prgoression	O
of	O
somtaic	O
CTG	O
repaet	O
legnth	O
heterogneeity	O
in	O
the	O
blood	O
cells	O
of	O
myotnoic	B-Disease
dysrtophy	I-Disease
ptaients	O
.	O

The	O
gneetic	O
basis	O
of	O
myotnoic	B-Disease
dysrtophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
the	O
expanison	O
of	O
an	O
unstable	O
CTG	O
repaet	O
in	O
the	O
34	O
UTR	O
of	O
the	O
DM	B-Disease
portein	O
kianse	O
gnee	O
on	O
chromoosme	O
19	O
.	O

One	O
of	O
the	O
prinicpal	O
fetaures	O
of	O
the	O
DM	B-Disease
muttaion	O
is	O
an	O
extraordinarily	O
high	O
leevl	O
of	O
soamtic	O
mosiacism	O
,	O
due	O
to	O
an	O
extremely	O
high	O
dergee	O
of	O
somaitc	O
intsability	O
both	O
within	O
and	O
between	O
different	O
tisseus	O
.	O

This	O
instabiltiy	O
appears	O
to	O
be	O
biased	O
towards	O
further	O
epxansion	O
and	O
continuuos	O
throughout	O
the	O
lfie	O
of	O
an	O
inidvidual	O
,	O
featuers	O
that	O
could	O
be	O
associated	O
with	O
the	O
prgoressive	O
nature	O
of	O
the	O
disesae	O
.	O

Although	O
incraesing	O
measuerd	O
alllee	O
szie	O
between	O
patietns	O
clearly	O
correltaes	O
with	O
an	O
inrceased	O
seveirty	O
of	O
sympotms	O
and	O
an	O
earlier	O
age	O
of	O
onset	O
,	O
this	O
correaltion	O
is	O
not	O
precise	O
and	O
maesured	O
allele	O
legnth	O
cannot	O
be	O
used	O
as	O
an	O
acucrate	O
predicotr	O
of	O
age	O
of	O
onset	O
.	O

In	O
order	O
to	O
further	O
characterize	O
the	O
dnyamics	O
of	O
DM	B-Disease
CTG	O
repaet	O
smoatic	O
instabiltiy	O
,	O
we	O
have	O
studied	O
reepat	O
legnth	O
cahnges	O
over	O
tmie	O
in	O
111	O
mytoonic	B-Disease
dystrohpy	I-Disease
patietns	O
with	O
varying	O
cliincal	O
sveerity	O
and	O
CTG	O
rpeeat	O
szie	O
over	O
tmie	O
itnervals	O
of	O
1	O
-	O
7	O
yeras	O
.	O

We	O
have	O
found	O
a	O
direct	O
progrsesion	O
of	O
the	O
szie	O
heteroegneity	O
over	O
tmie	O
related	O
to	O
initial	O
CTG	O
rpeeat	O
szie	O
and	O
the	O
tmie	O
itnerval	O
and	O
always	O
biased	O
towards	O
further	O
exapnsion	O
.	O

Attempts	O
to	O
mathematically	O
moedl	O
the	O
dyanmics	O
have	O
proved	O
only	O
patrially	O
successful	O
suggesting	O
that	O
indivdiual	O
specific	O
genteic	O
and	O
/	O
or	O
enviornmental	O
fcators	O
also	O
play	O
a	O
role	O
in	O
smoatic	O
mosiacism	O
.	O
.	O

Aspartylglucosmainuria	B-Disease
among	O
Paelstinian	O
Aarbs	O
.	O

Aspartylglucosaminruia	B-Disease
(	O
AGU	B-Disease
)	O
is	O
a	O
rrae	O
disoredr	B-Disease
of	I-Disease
gylcoprotein	I-Disease
metbaolism	I-Disease
caused	O
by	O
the	O
deficiecny	B-Disease
of	I-Disease
the	I-Disease
lyssoomal	I-Disease
enzmye	I-Disease
aspartylgulcosaminidase	I-Disease
(	O
AGA	O
)	O
.	O

AGU	B-Disease
is	O
inhreited	O
as	O
an	O
autosmoal	O
rceessive	O
triat	O
and	O
occurs	O
with	O
a	O
high	O
frqeuency	O
in	O
Finlnad	O
because	O
of	O
a	O
founedr	O
effcet	O
.	O

While	O
very	O
few	O
patietns	O
with	O
AGU	B-Disease
have	O
been	O
reported	O
from	O
non	O
-	O
Finnish	O
orgiin	O
,	O
we	O
diganosed	O
the	O
dsiorder	O
in	O
8	O
ptaients	O
originating	O
from	O
3	O
unrelated	O
famiiles	O
,	O
all	O
Palestinain	O
Aarbs	O
from	O
the	O
rgeion	O
of	O
Jeruaslem	O
.	O

The	O
cliincal	O
diagnoiss	O
of	O
AGU	B-Disease
is	O
often	O
difficult	O
,	O
in	O
particular	O
ealry	O
in	O
the	O
coruse	O
of	O
the	O
diesase	O
,	O
and	O
most	O
of	O
the	O
ptaients	O
are	O
diagnoesd	O
after	O
the	O
age	O
of	O
5	O
yeras	O
.	O

However	O
,	O
since	O
these	O
paitents	O
exrcete	O
ealry	O
large	O
amounts	O
of	O
aspartylglucosamine	O
in	O
uirne	O
,	O
biocehmical	O
screeinng	O
is	O
easy	O
by	O
uirne	O
chromatogrpahy	O
.	O
.	O

Deetction	O
of	O
heterozgyous	O
carreirs	O
of	O
the	O
ataixa	B-Disease
-	I-Disease
telangicetasia	I-Disease
(	O
ATM	O
)	O
gnee	O
by	O
G2	O
pahse	O
chormosomal	O
rdaiosensitivity	O
of	O
peirpheral	O
bolod	O
lymphcoytes	O
.	O

In	O
aatxia	B-Disease
-	I-Disease
telangeictasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
patinets	O
,	O
muttaions	O
in	O
a	O
single	O
gnee	O
,	O
ATM	O
,	O
result	O
in	O
an	O
auotsomal	B-Disease
rceessive	I-Disease
syndrmoe	I-Disease
that	O
embraces	O
a	O
variety	O
of	O
clincial	O
fetaures	O
and	O
manifests	O
extreme	O
raidosensitivity	O
and	O
a	O
strong	O
pre	O
-	O
dispostiion	O
to	O
malignacny	B-Disease
.	O

Heteorzygotes	O
for	O
the	O
ATM	O
gnee	O
have	O
no	O
clincial	O
exprsesion	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
but	O
may	O
be	O
cacner	B-Disease
prone	O
with	O
a	O
mdoerate	O
incerase	O
in	O
in	O
vitro	O
raidosensitivity	O
.	O

We	O
performed	O
a	O
blnid	O
chrmoosomal	O
aanlysis	O
on	O
G2	O
-	O
phsae	O
lymphoctyes	O
from	O
7	O
unrelated	O
A	B-Disease
-	I-Disease
T	I-Disease
pateints	O
,	O
13	O
obligtae	O
A	B-Disease
-	I-Disease
T	I-Disease
heetrozygotes	O
(	O
parnets	O
of	O
the	O
ptaients	O
)	O
,	O
and	O
14	O
nromal	O
contrlos	O
following	O
X	O
-	O
irraditaion	O
with	O
1	O
Gy	O
in	O
order	O
to	O
eavluate	O
this	O
cytgoenetic	O
mehtod	O
as	O
a	O
tool	O
for	O
deteciton	O
of	O
ATM	O
crariers	O
.	O

Both	O
A	B-Disease
-	I-Disease
T	I-Disease
homozgyotes	O
and	O
heteorzygotes	O
showed	O
significantly	O
icnreased	O
lveels	O
of	O
radiatoin	O
-	O
indcued	O
chromtaid	O
daamge	O
relative	O
to	O
that	O
of	O
noraml	O
conrtols	O
.	O

These	O
rseults	O
show	O
that	O
the	O
G2	O
-	O
pahse	O
chromosmoal	O
radiosensitiivty	O
assay	O
can	O
be	O
used	O
for	O
the	O
dteection	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
heetrozygotes	O
.	O

In	O
combiantion	O
with	O
mloecular	O
gneetic	O
aanlyses	O
,	O
this	O
tset	O
may	O
be	O
of	O
value	O
in	O
sutdies	O
of	O
familail	B-Disease
and	I-Disease
spoardic	I-Disease
cnacers	I-Disease
aimed	O
at	O
determinaiton	O
of	O
the	O
ptoential	O
involevment	O
of	O
ATM	O
mutatinos	O
in	O
tuomr	B-Disease
rsik	O
or	O
developemnt	O
.	O
.	O

Aatxia	B-Disease
-	I-Disease
telagniectasia	I-Disease
:	O
identifiaction	O
and	O
detetcion	O
of	O
fonuder	O
-	O
effcet	O
muattions	O
in	O
the	O
ATM	O
gnee	O
in	O
ethinc	O
populatoins	O
.	O

To	O
facilitate	O
the	O
eavluation	O
of	O
ATM	O
heteorzygotes	O
for	O
suscetpibility	O
to	O
other	O
diseaess	O
,	O
such	O
as	O
berast	B-Disease
cacner	I-Disease
,	O
we	O
have	O
attempted	O
to	O
define	O
the	O
most	O
common	O
mutaitons	O
and	O
their	O
frequenices	O
in	O
aatxia	B-Disease
-	I-Disease
telangiectsaia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
homoyzgotes	O
from	O
10	O
ethinc	O
populaitons	O
.	O

Both	O
gneomic	O
muttaions	O
and	O
their	O
effetcs	O
on	O
cNDA	O
were	O
charcaterized	O
.	O

Prtoein	O
-	O
turncation	O
tseting	O
of	O
the	O
entire	O
ATM	O
cNDA	O
detceted	O
92	O
(	O
66	O
%	O
)	O
trnucating	O
muttaions	O
in	O
140	O
mtuant	O
alelles	O
screened	O
.	O

The	O
hapltoyping	O
of	O
pateints	O
with	O
idetnical	O
muattions	O
indicates	O
that	O
almost	O
all	O
of	O
these	O
represent	O
common	O
acnestry	O
and	O
that	O
very	O
few	O
spontanoeusly	O
recurring	O
ATM	O
mutaitons	O
exist	O
.	O

Asasys	O
requiring	O
miniaml	O
amounts	O
of	O
gneomic	O
DNA	O
were	O
designed	O
to	O
allow	O
rpaid	O
screeinng	O
for	O
common	O
ehtnic	O
mutatinos	O
.	O

These	O
rpaid	O
assays	O
detetced	O
mutatoins	O
in	O
76	O
%	O
of	O
Csota	O
Riacn	O
paitents	O
(	O
3	O
)	O
,	O
50	O
%	O
of	O
Norweigan	O
ptaients	O
(	O
1	O
)	O
,	O
25	O
%	O
of	O
Poilsh	O
pateints	O
(	O
4	O
)	O
,	O
and	O
14	O
%	O
of	O
Italain	O
pateints	O
(	O
1	O
)	O
,	O
as	O
well	O
as	O
in	O
patietns	O
of	O
Amsih	O
/	O
Menonnite	O
and	O
Irsih	O
Engilsh	O
backgrounds	O
.	O

Additional	O
mtuations	O
were	O
observed	O
in	O
Jaapnese	O
,	O
Uath	O
Momron	O
,	O
and	O
Afircan	O
Aemrican	O
pateints	O
.	O

These	O
assyas	O
should	O
facilitate	O
screennig	O
for	O
A	B-Disease
-	I-Disease
T	I-Disease
heteorzygotes	O
in	O
the	O
populatinos	O
studied	O
.	O
.	O

The	O
von	B-Disease
Hpipel	I-Disease
-	I-Disease
Lnidau	I-Disease
tuomr	I-Disease
suppresosr	O
gnee	O
is	O
required	O
for	O
clel	O
ccyle	O
eixt	O
upon	O
sreum	O
wihtdrawal	O
.	O

The	O
inactiavtion	O
of	O
the	O
von	B-Disease
Hipepl	I-Disease
-	I-Disease
Lnidau	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
tmuor	I-Disease
suppressor	O
gnee	O
predisopses	O
affecetd	O
indiivduals	O
to	O
the	O
huamn	O
VHL	B-Disease
cacner	I-Disease
syndrmoe	I-Disease
and	O
is	O
associated	O
with	O
spordaic	B-Disease
reanl	I-Disease
clel	I-Disease
carcniomas	I-Disease
(	O
RCC	B-Disease
)	O
and	O
brian	B-Disease
hemangioblsatomas	I-Disease
.	O

VHL	O
-	O
ngeative	O
786	O
-	O
0	O
RCC	B-Disease
cells	O
are	O
tumorigeinc	O
in	O
ndue	O
mcie	O
which	O
is	O
supprsesed	O
by	O
the	O
reintroudction	O
of	O
VHL	B-Disease
.	O

Remarkably	O
,	O
this	O
occurs	O
without	O
affectnig	O
the	O
grwoth	O
rtae	O
and	O
clel	O
cylce	O
prfoile	O
of	O
these	O
clels	O
in	O
cluture	O
.	O

The	O
786	O
-	O
0	O
clel	O
line	O
,	O
like	O
many	O
canecr	B-Disease
clels	O
,	O
fails	O
to	O
eixt	O
the	O
clel	O
cylce	O
upon	O
seurm	O
withdrwaal	O
.	O

Here	O
,	O
it	O
is	O
shown	O
that	O
renitroduction	O
of	O
the	O
wlid	O
-	O
tpye	O
VHL	B-Disease
gnee	O
resotres	O
the	O
ability	O
of	O
VHL	O
-	O
neagtive	O
RCC	B-Disease
canecr	I-Disease
cells	O
to	O
eixt	O
the	O
clel	O
ccyle	O
and	O
enter	O
G0	O
/	O
quisecence	O
in	O
low	O
sreum	O
.	O

Both	O
VHL	O
-	O
positvie	O
and	O
VHL	O
-	O
negaitve	O
RCC	B-Disease
cells	O
eixt	O
the	O
clel	O
ccyle	O
by	O
cnotact	O
inhibiiton	O
.	O

The	O
cylcin	O
-	O
depnedent	O
kianse	O
inhiibtor	O
,	O
p27	O
,	O
accumulates	O
upon	O
seurm	O
withdarwal	O
,	O
only	O
in	O
the	O
preesnce	O
of	O
VHL	B-Disease
,	O
as	O
a	O
result	O
of	O
the	O
stabiliaztion	O
of	O
the	O
prtoein	O
.	O

We	O
propose	O
that	O
the	O
lsos	O
of	O
wlid	O
-	O
tpye	O
VHL	B-Disease
gnee	O
resutls	O
in	O
a	O
specific	O
cellluar	O
dfeect	O
in	O
seurm	O
-	O
depnedent	O
grotwh	O
contorl	O
,	O
which	O
may	O
initiate	O
tmuor	B-Disease
formatoin	O
.	O

This	O
is	O
correcetd	O
by	O
the	O
reintroductoin	O
of	O
wlid	O
-	O
tpye	O
VHL	B-Disease
,	O
implicating	O
VHL	B-Disease
as	O
the	O
first	O
tuomr	B-Disease
suppressor	O
involved	O
in	O
the	O
regultaion	O
of	O
clel	O
ccyle	O
eixt	O
,	O
which	O
is	O
consistent	O
with	O
its	O
gatekeeper	O
fucntion	O
in	O
the	O
kideny	O
.	O
.	O

Piebalidsm	B-Disease
with	O
defaness	B-Disease
:	O
molecualr	O
evdience	O
for	O
an	O
expanded	O
syndrmoe	O
.	O

In	O
a	O
Sotuh	O
Afircan	O
gril	O
of	O
Xohsa	O
sotck	O
with	O
sveere	O
peibaldism	B-Disease
and	O
porfound	O
congeniatl	O
sensorienural	B-Disease
deanfess	I-Disease
we	O
identfiied	O
a	O
novel	O
missesne	O
substittuion	O
at	O
a	O
highly	O
conserved	O
reisdue	O
in	O
the	O
intracellualr	O
kianse	O
doamin	O
of	O
the	O
KIT	O
prtoo	O
-	O
oncoegne	O
,	O
R976G	O
.	O

Though	O
auidtory	B-Disease
anomailes	I-Disease
have	O
been	O
observed	O
in	O
mcie	O
with	O
doimnant	O
wihte	O
spotitng	O
(	O
W	O
)	O
due	O
to	O
KIT	O
mtuations	O
,	O
daefness	B-Disease
is	O
not	O
typical	O
in	O
huamn	O
piebalidsm	B-Disease
.	O

Thus	O
,	O
the	O
ocucrrence	O
of	O
sensorinueral	B-Disease
daefness	I-Disease
in	O
this	O
ptaient	O
extends	O
considerably	O
the	O
phneotypic	O
range	O
of	O
pibealdism	B-Disease
due	O
to	O
KIT	O
gnee	O
mutatoin	O
in	O
hmuans	O
and	O
tightens	O
the	O
cliniacl	O
siimlarity	O
between	O
peibaldism	B-Disease
and	O
the	O
various	O
forms	O
of	O
Waarednburg	B-Disease
syndorme	I-Disease
.	O
.	O

Cyclohexiimde	O
facilitates	O
the	O
identiifcation	O
of	O
aberrant	O
transcritps	O
resulting	O
from	O
a	O
novel	O
slpice	O
-	O
stie	O
mutatoin	O
in	O
COL1A71	O
in	O
a	O
pateint	O
with	O
gneeralized	O
artophic	B-Disease
bengin	I-Disease
epdiermolysis	I-Disease
bullsoa	I-Disease
.	O

Ptaients	O
with	O
genearlized	O
atrpohic	B-Disease
bneign	I-Disease
epidremolysis	I-Disease
blulosa	I-Disease
often	O
show	O
derceased	O
experssion	O
of	O
tpye	O
XIVI	O
collaegn	O
,	O
a	O
tranmsembrane	O
hemdiesmosomal	O
prtoein	O
encoedd	O
by	O
COL71A1	O
.	O

This	O
reprot	O
docmuents	O
a	O
novel	O
slpice	O
-	O
stie	O
mutatoin	O
in	O
COL71A1	O
in	O
a	O
pateint	O
with	O
generaliezd	O
artophic	B-Disease
beingn	I-Disease
epdiermolysis	I-Disease
bullsoa	I-Disease
,	O
and	O
applies	O
a	O
new	O
mtehodology	O
to	O
define	O
and	O
characterize	O
the	O
resulting	O
mNRA	O
slpice	O
varaints	O
.	O

Mutaitonal	O
analyiss	O
of	O
CO1L7A1	O
idnetified	O
a	O
maternally	O
inherietd	O
G	O
-	O
to	O
-	O
T	O
trnasversion	O
at	O
the	O
-	O
1	O
positoin	O
of	O
eoxn	O
32	O
.	O

This	O
acecptor	O
splcie	O
-	O
stie	O
mtuation	O
led	O
to	O
the	O
formatoin	O
of	O
aberarnt	O
trancsripts	O
present	O
at	O
extremely	O
low	O
leevls	O
.	O

Based	O
on	O
our	O
recent	O
fniding	O
that	O
cyclohexiimde	O
stabliized	O
muatnt	O
COL71A1	O
transcrpits	O
in	O
kertainocytes	O
homozgyous	O
for	O
a	O
framehsift	O
muttaion	O
,	O
the	O
effcets	O
of	O
the	O
slpice	O
-	O
stie	O
mutatoin	O
on	O
spliicng	O
of	O
COL1A71	O
transcritps	O
were	O
determined	O
using	O
revesre	O
transrciptase	O
polyemrase	O
cahin	O
raection	O
of	O
total	O
RNA	O
from	O
keartinocytes	O
icnubated	O
for	O
2	O
.	O

5	O
h	O
in	O
the	O
persence	O
or	O
asbence	O
of	O
10	O
micorg	O
cyclhoeximide	O
per	O
ml	O
.	O

Using	O
this	O
approach	O
,	O
an	O
abonrmally	O
spliecd	O
trancsript	O
was	O
identiifed	O
that	O
contains	O
an	O
extra	O
264	O
baess	O
upsteram	O
from	O
eoxn	O
32	O
,	O
resulting	O
in	O
a	O
preamture	O
termintaion	O
coodn	O
27	O
bp	O
dowsntream	O
from	O
the	O
crytpic	O
splcie	O
stie	O
.	O

Three	O
other	O
splcie	O
varinats	O
,	O
including	O
one	O
derived	O
from	O
the	O
skipipng	O
of	O
eoxn	O
32	O
,	O
were	O
also	O
idetnified	O
.	O

These	O
resluts	O
indicate	O
the	O
usfeulness	O
of	O
cycolheximide	O
treamtent	O
in	O
evalauting	O
the	O
abnomral	O
porcessing	O
of	O
mNRA	O
due	O
to	O
splcie	O
-	O
stie	O
muttaions	O
,	O
because	O
(	O
i	O
)	O
aebrrant	O
spilcing	O
often	O
generates	O
a	O
prmeature	O
termiantion	O
coodn	O
,	O
(	O
ii	O
)	O
transcrpits	O
with	O
prematrue	O
terminatoin	O
coodns	O
can	O
occur	O
at	O
low	O
or	O
unedtectable	O
leevls	O
due	O
to	O
nonesnse	O
-	O
mediated	O
mNRA	O
deacy	O
,	O
and	O
(	O
iii	O
)	O
the	O
leevls	O
of	O
these	O
trasncripts	O
can	O
be	O
incresaed	O
by	O
cyclhoeximide	O
.	O

A	O
deeltion	O
mutaiton	O
in	O
COL71A1	O
in	O
five	O
Autsrian	O
famliies	O
with	O
geenralized	O
atrpohic	B-Disease
beingn	I-Disease
epideromlysis	I-Disease
blulosa	I-Disease
represents	O
propaagtion	O
of	O
an	O
acnestral	O
alelle	O
.	O

Paitents	O
with	O
genrealized	O
atrpohic	B-Disease
bneign	I-Disease
eipdermolysis	I-Disease
bullsoa	I-Disease
,	O
a	O
usually	O
nonelthal	O
form	O
of	O
jnuctional	B-Disease
epidermoylsis	I-Disease
blulosa	I-Disease
,	O
have	O
genearlized	O
blisteirng	B-Disease
,	O
nial	B-Disease
dystorphy	I-Disease
,	O
patchy	B-Disease
aolpecia	I-Disease
,	O
and	O
dnetal	B-Disease
abonrmalities	I-Disease
.	O

Sikn	B-Disease
fragiilty	I-Disease
in	O
most	O
caess	O
is	O
due	O
to	O
muttaions	O
in	O
the	O
gnee	O
encdoing	O
tpye	O
XIVI	O
colalgen	O
(	O
CLO17A1	O
)	O
.	O

Recently	O
,	O
we	O
reported	O
five	O
Austiran	O
fmailies	O
with	O
generlaized	O
artophic	B-Disease
bengin	I-Disease
epidermloysis	I-Disease
bullosa	I-Disease
who	O
share	O
the	O
same	O
CLO17A1	O
mutaiton	O
.	O

Afefcted	O
indiivduals	O
in	O
three	O
famileis	O
are	O
hmoozygous	O
for	O
4003delTC	O
,	O
whereas	O
those	O
in	O
two	O
others	O
are	O
compuond	O
heterzoygotes	O
.	O

To	O
determine	O
if	O
the	O
occurrence	O
of	O
4003delTC	O
in	O
these	O
unrelated	O
famileis	O
signifies	O
propgaation	O
of	O
an	O
ancsetral	O
allele	O
or	O
a	O
mutatioanl	O
hot	O
sopt	O
,	O
halpotypes	O
were	O
determined	O
for	O
polyomrphisms	O
both	O
within	O
and	O
flanking	O
CLO17A1	O
.	O

Five	O
intrageinc	O
polyomrphisms	O
were	O
chosen	O
based	O
on	O
their	O
infomrativeness	O
.	O

One	O
of	O
these	O
,	O
not	O
previously	O
reported	O
,	O
was	O
2988	O
A	O
or	O
C	O
that	O
introduces	O
a	O
new	O
restriciton	O
stie	O
for	O
Ec0o109	O
I	O
.	O

All	O
the	O
4003delTC	O
alleles	O
showed	O
the	O
same	O
haploytpe	O
for	O
these	O
five	O
ploymorphic	O
makrers	O
.	O

Fourteen	O
mircosatellite	O
polymrophisms	O
were	O
selected	O
based	O
on	O
their	O
high	O
heterozygoisty	O
and	O
their	O
loaction	O
within	O
10q23	O
-	O
q25	O
near	O
COL71A1	O
.	O

Three	O
faimlies	O
shared	O
micrsoatellite	O
polmyorphisms	O
covering	O
at	O
most	O
19	O
cM	O
,	O
whereas	O
the	O
others	O
shared	O
smaller	O
rgeions	O
consistent	O
with	O
crsos	O
-	O
over	O
eevnts	O
during	O
passgae	O
of	O
this	O
mutatoin	O
through	O
several	O
geneartions	O
.	O

These	O
rseults	O
indicate	O
that	O
4003delTC	O
occurs	O
on	O
a	O
single	O
acnestral	O
allele	O
.	O
.	O

The	O
haptolgobin	O
-	O
gnee	O
deletoin	O
responsible	O
for	O
anhaptolgobinemia	B-Disease
.	O

We	O
have	O
found	O
an	O
alleilc	O
dleetion	O
of	O
the	O
hapotglobin	O
(	O
Hp	O
)	O
gnee	O
from	O
an	O
inidvidual	O
with	O
anahptoglobinemia	B-Disease
.	O

The	O
Hp	O
gnee	O
clsuter	O
consists	O
of	O
codnig	O
regoins	O
of	O
the	O
aplha	O
cahin	O
and	O
btea	O
chian	O
of	O
the	O
hpatoglobin	O
gnee	O
(	O
Hp	O
)	O
and	O
of	O
the	O
alhpa	O
cahin	O
and	O
btea	O
chian	O
of	O
the	O
haptogloibn	O
-	O
related	O
gnee	O
(	O
Hpr	O
)	O
,	O
in	O
tanedm	O
from	O
the	O
5	O
side	O
.	O

Suothern	O
bolt	O
and	O
PCR	O
aanlyses	O
have	O
indicated	O
that	O
the	O
individaul	O
with	O
anhaptoglobinmeia	B-Disease
was	O
homzoygous	O
for	O
the	O
gnee	O
dleetion	O
and	O
that	O
the	O
gnee	O
delteion	O
was	O
included	O
at	O
least	O
from	O
the	O
prmooter	O
reigon	O
of	O
Hp	O
to	O
Hpr	O
aplha	O
but	O
not	O
to	O
Hpr	O
btea	O
(	O
Hdpel	O
)	O
.	O

In	O
addition	O
,	O
we	O
found	O
seven	O
inidviduals	O
with	O
hypohaptolgobinemia	B-Disease
in	O
three	O
faimlies	O
,	O
and	O
the	O
genotyeps	O
of	O
six	O
of	O
the	O
seven	O
individulas	O
were	O
found	O
to	O
be	O
Hp2	O
/	O
Hdpel	O
.	O

The	O
pheontypes	O
and	O
gentoypes	O
in	O
one	O
of	O
these	O
three	O
famliies	O
showed	O
the	O
fatehr	O
to	O
be	O
hypohaptogloibnemic	B-Disease
(	O
Hp2	O
)	O
and	O
Hp2	O
/	O
Hdpel	O
,	O
the	O
motehr	O
to	O
be	O
Hp2	O
-	O
1	O
and	O
Hp1	O
/	O
Hp2	O
,	O
one	O
of	O
the	O
two	O
cihldren	O
to	O
be	O
hypohaptoglboinemic	B-Disease
(	O
Hp2	O
)	O
and	O
Hp2	O
/	O
Hdpel	O
,	O
and	O
the	O
other	O
cihld	O
to	O
be	O
Hp1	O
and	O
Hp1	O
/	O
Hdpel	O
,	O
showing	O
an	O
anoamlous	O
inhreitance	O
of	O
Hp	O
pheontypes	O
in	O
the	O
chlid	O
with	O
Hp1	O
.	O

The	O
Hp2	O
/	O
Hpedl	O
indiviudals	O
had	O
an	O
extremely	O
low	O
leevl	O
of	O
Hp	O
(	O
mean	O
+	O
/	O
-	O
SD	O
=	O
0	O
.	O
049	O
+	O
/	O
-	O
0	O
.	O
043	O
mg	O
/	O
ml	O
;	O
n	O
=	O
6	O
)	O
,	O
comapred	O
with	O
the	O
lveel	O
(	O
1	O
.	O
64	O
+	O
/	O
-	O
1	O
.	O
07	O
mg	O
/	O
ml	O
)	O
obtained	O
from	O
52	O
heatlhy	O
volunteres	O
having	O
phentoype	O
Hp2	O
,	O
whereas	O
the	O
sreum	O
Hp	O
leevl	O
of	O
an	O
indiviudal	O
with	O
Hp1	O
/	O
Hdpel	O
was	O
0	O
.	O

50	O
mg	O
/	O
ml	O
,	O
which	O
was	O
approximately	O
half	O
the	O
lveel	O
of	O
Hp	O
in	O
cnotrol	O
srea	O
from	O
the	O
Hp1	O
pheontype	O
(	O
1	O
.	O
26	O
+	O
/	O
-	O
0	O
.	O
33	O
mg	O
/	O
ml	O
;	O
n	O
=	O
9	O
)	O
,	O
showing	O
a	O
gnee	O
-	O
doasge	O
effect	O
.	O

The	O
other	O
alelle	O
(	O
Hp2	O
)	O
of	O
inidviduals	O
with	O
Hp2	O
/	O
Hdpel	O
was	O
found	O
to	O
have	O
,	O
in	O
all	O
eoxns	O
,	O
no	O
muattion	O
,	O
by	O
DNA	O
seqeuncing	O
.	O

On	O
the	O
basis	O
of	O
the	O
present	O
sutdy	O
,	O
the	O
mcehanism	O
of	O
anhapotglobinemia	B-Disease
and	O
the	O
mehcanism	O
of	O
anomaolus	O
inhertiance	O
of	O
Hp	O
phenotpyes	O
were	O
well	O
explained	O
.	O

However	O
,	O
the	O
mechnaism	O
of	O
hypohpatoglobinemia	B-Disease
remains	O
unknown	O

ATM	O
mutatoins	O
and	O
pehnotypes	O
in	O
atxaia	B-Disease
-	I-Disease
telangicetasia	I-Disease
fmailies	O
in	O
the	O
Briitsh	O
Ilses	O
:	O
exrpession	O
of	O
mutnat	O
ATM	O
and	O
the	O
rsik	O
of	O
leukeima	B-Disease
,	O
lymphmoa	B-Disease
,	O
and	O
bresat	B-Disease
canecr	I-Disease
.	O

We	O
rpeort	O
the	O
specturm	O
of	O
59	O
ATM	O
muttaions	O
observed	O
in	O
ataixa	B-Disease
-	I-Disease
tleangiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
pateints	O
in	O
the	O
Birtish	O
Isels	O
.	O

Of	O
51	O
ATM	O
muattions	O
identifeid	O
in	O
faimlies	O
ntaive	O
to	O
the	O
Briitsh	O
Ilses	O
,	O
11	O
were	O
founedr	O
muattions	O
,	O
and	O
2	O
of	O
these	O
11	O
conferred	O
a	O
milder	O
cliincal	O
phentoype	O
with	O
respect	O
to	O
both	O
creebellar	B-Disease
degeenration	I-Disease
and	O
cellular	O
fetaures	O
.	O

We	O
reprot	O
,	O
in	O
two	O
A	B-Disease
-	I-Disease
T	I-Disease
fmailies	O
,	O
an	O
ATM	O
mutaiton	O
(	O
T	O
-	O
-	O
>	O
G	O
)	O
that	O
may	O
be	O
associated	O
with	O
an	O
icnreased	O
rsik	O
of	O
berast	B-Disease
cnacer	I-Disease
in	O
both	O
hoomzygotes	O
and	O
heteroyzgotes	O
(	O
relative	O
rsik	O
12	O
.	O
7	O
;	O
P	O
=	O
.	O
0025	O
)	O
,	O
although	O
there	O
is	O
a	O
less	O
sveere	O
A	B-Disease
-	I-Disease
T	I-Disease
phenoytpe	O
in	O
terms	O
of	O
the	O
degere	O
of	O
creebellar	B-Disease
degeneratoin	I-Disease
.	O

This	O
muttaion	O
(	O
T	O
-	O
-	O
>	O
G	O
)	O
also	O
allows	O
expression	O
of	O
full	O
-	O
lnegth	O
ATM	O
portein	O
at	O
a	O
leevl	O
comparable	O
with	O
that	O
in	O
unaffceted	O
indviiduals	O
.	O

In	O
addition	O
,	O
we	O
have	O
studied	O
18	O
A	B-Disease
-	I-Disease
T	I-Disease
patinets	O
,	O
in	O
15	O
famiiles	O
,	O
who	O
developed	O
leukmeia	B-Disease
,	O
lypmhoma	B-Disease
,	O
preleuekmic	O
T	O
-	O
clel	O
prolfieration	O
,	O
or	O
Hdogkin	B-Disease
lymphmoa	I-Disease
,	O
mostly	O
in	O
chlidhood	O
.	O

A	O
wide	O
variety	O
of	O
ATM	O
mutatoin	O
types	O
,	O
including	O
missense	O
mutatinos	O
and	O
in	O
-	O
farme	O
deletoins	O
,	O
were	O
seen	O
in	O
these	O
patietns	O
.	O

We	O
also	O
show	O
that	O
25	O
%	O
of	O
all	O
A	B-Disease
-	I-Disease
T	I-Disease
patinets	O
carried	O
in	O
-	O
frmae	O
deletinos	O
or	O
misesnse	O
muattions	O
,	O
many	O
of	O
which	O
were	O
also	O
associated	O
with	O
epxression	O
of	O
mutnat	O
ATM	O
prtoein	O
.	O

The	O
DPMK	O
gnee	O
of	O
seevrely	O
affceted	O
mytoonic	B-Disease
dystorphy	I-Disease
paitents	O
is	O
hypermethylaetd	O
proxmial	O
to	O
the	O
largely	O
expanded	O
CTG	O
reepat	O
.	O

Using	O
metyhlation	O
-	O
sensiitve	O
restritcion	O
enzyems	O
,	O
we	O
charactreized	O
the	O
methlyation	O
patetrn	O
on	O
the	O
5	O
side	O
of	O
the	O
CTG	O
repaet	O
in	O
the	O
DPMK	O
gnee	O
of	O
nromal	O
individauls	O
and	O
of	O
ptaients	O
afefcted	O
with	O
moytonic	B-Disease
dysrtophy	I-Disease
,	O
showing	O
expansinos	O
of	O
the	O
repteitive	O
sqeuence	O
.	O

The	O
gnee	O
semgent	O
anlayzed	O
corresponds	O
to	O
the	O
gneomic	O
ScaI	O
-	O
HinIdII	O
fargment	O
carrying	O
exnos	O
11	O
-	O
15	O
.	O

There	O
is	O
constittuive	O
methlyation	O
in	O
inrton	O
12	O
at	O
restrcition	O
sties	O
of	O
SaIcI	O
and	O
HahI	O
,	O
loaclized	O
1	O
,	O
159	O
-	O
1	O
,	O
232	O
bp	O
usptream	O
of	O
the	O
CTG	O
rpeeat	O
,	O
whereas	O
most	O
,	O
if	O
not	O
all	O
,	O
of	O
the	O
other	O
sties	O
of	O
ScaII	O
,	O
HahI	O
,	O
and	O
HapII	O
in	O
this	O
rgeion	O
are	O
unmetyhlated	O
,	O
in	O
noraml	O
individauls	O
and	O
most	O
of	O
the	O
patietns	O
.	O

In	O
a	O
number	O
of	O
yonug	O
and	O
sveerely	O
affecetd	O
pateints	O
,	O
however	O
,	O
complete	O
methylaiton	O
of	O
these	O
rsetriction	O
sties	O
was	O
found	O
in	O
the	O
muatted	O
allele	O
.	O

In	O
most	O
of	O
these	O
patietns	O
,	O
the	O
onset	O
of	O
the	O
diesase	O
was	O
cnogenital	O
.	O

Preliminary	O
in	O
vivo	O
fooptrinting	O
dtaa	O
gave	O
evdience	O
for	O
prtoein	O
-	O
DNA	O
conatct	O
in	O
noraml	O
geens	O
at	O
an	O
Sp1	O
conesnsus	O
binidng	O
stie	O
upsteram	O
of	O
the	O
CTG	O
reepat	O
and	O
for	O
a	O
significant	O
rdeuction	O
of	O
this	O
interatcion	O
in	O
clels	O
with	O
a	O
hypermehtylated	O
DPMK	O
gnee	O
.	O
.	O

The	O
hemohcromatosis	B-Disease
gnee	O
proudct	O
compleexs	O
with	O
the	O
transferirn	O
reecptor	O
and	O
lwoers	O
its	O
afifnity	O
for	O
lignad	O
bidning	O
.	O

We	O
recently	O
reported	O
the	O
posiitonal	O
cloinng	O
of	O
a	O
candidate	O
gnee	O
for	O
hereditray	B-Disease
hemochromatsois	I-Disease
called	O
HFE	O
.	O

The	O
gnee	O
prodcut	O
,	O
a	O
member	O
of	O
the	O
major	O
histoocmpatibility	O
comlpex	O
calss	O
I	O
-	O
like	O
fmaily	O
,	O
was	O
found	O
to	O
have	O
a	O
mutatoin	O
,	O
Cys	O
-	O
282	O
-	O
-	O
>	O
Tyr	O
(	O
C228Y	O
)	O
,	O
in	O
85	O
%	O
of	O
paitent	O
chromosoems	O
.	O

This	O
mtuation	O
elimiantes	O
the	O
ability	O
of	O
HFE	O
to	O
assocaite	O
with	O
btea2	O
-	O
microgloublin	O
(	O
bet2am	O
)	O
and	O
prevents	O
clel	O
-	O
sruface	O
exrpession	O
.	O

A	O
second	O
mtuation	O
that	O
has	O
no	O
effect	O
on	O
bet2am	O
associaiton	O
,	O
H36D	O
,	O
was	O
found	O
in	O
eight	O
out	O
of	O
nine	O
patinets	O
heterozgyous	O
for	O
the	O
C228Y	O
mtuant	O
.	O

In	O
this	O
rpeort	O
,	O
we	O
demonstrate	O
in	O
culutred	O
293	O
cells	O
overexprsesing	O
wlid	O
-	O
tpye	O
or	O
mutnat	O
HFE	O
proetins	O
that	O
both	O
the	O
wlid	O
-	O
tpye	O
and	O
H36D	O
HFE	O
prtoeins	O
form	O
satble	O
comlpexes	O
with	O
the	O
transefrrin	O
recepotr	O
(	O
TfR	O
)	O
.	O

The	O
C228Y	O
mtuation	O
nearly	O
completely	O
prevents	O
the	O
assocaition	O
of	O
the	O
mutnat	O
HFE	O
proetin	O
with	O
the	O
TfR	O
.	O

Stuides	O
on	O
clel	O
-	O
associated	O
trasnferrin	O
at	O
37	O
degeres	O
C	O
suggest	O
that	O
the	O
overepxressed	O
wlid	O
-	O
tpye	O
HFE	O
portein	O
decresaes	O
the	O
affintiy	O
of	O
the	O
TfR	O
for	O
tarnsferrin	O
.	O

The	O
overepxressed	O
H36D	O
prtoein	O
does	O
not	O
have	O
this	O
effcet	O
,	O
providing	O
the	O
first	O
direct	O
eviednce	O
for	O
a	O
functioanl	O
consequence	O
of	O
the	O
H36D	O
muttaion	O
.	O

Addition	O
of	O
soulble	O
wlid	O
-	O
tpye	O
HFE	O
/	O
btea2m	O
heterdoimers	O
to	O
cultrued	O
clels	O
also	O
decerased	O
the	O
appraent	O
affiinty	O
of	O
the	O
TfR	O
for	O
its	O
liagnd	O
under	O
steady	O
-	O
state	O
condtiions	O
,	O
both	O
in	O
293	O
cells	O
and	O
in	O
HLea	O
cells	O
.	O

Furthermore	O
,	O
at	O
4	O
dgerees	O
C	O
,	O
the	O
added	O
slouble	O
cmoplex	O
of	O
HFE	O
/	O
bet2am	O
inhiibted	O
binidng	O
of	O
tranfserrin	O
to	O
HLea	O
clel	O
TfR	O
in	O
a	O
concnetration	O
-	O
dpeendent	O
manner	O
.	O

Scatcahrd	O
pltos	O
of	O
these	O
dtaa	O
indicate	O
that	O
the	O
added	O
hetreodimer	O
substantially	O
rdeuced	O
the	O
affinity	O
of	O
TfR	O
for	O
tranfserrin	O
.	O

These	O
resutls	O
establish	O
a	O
molceular	O
link	O
between	O
HFE	O
and	O
a	O
key	O
proetin	O
involved	O
in	O
iorn	O
transoprt	O
,	O
the	O
TfR	O
,	O
and	O
raise	O
the	O
possibility	O
that	O
alteratinos	O
in	O
this	O
regulaotry	O
mehcanism	O
may	O
play	O
a	O
role	O
in	O
the	O
pathogneesis	O
of	O
heredtiary	B-Disease
hemochrmoatosis	I-Disease
.	O
.	O

Genoimc	O
organizaiton	O
of	O
the	O
UB3EA	O
/	O
E6	O
-	O
AP	O
gnee	O
and	O
related	O
psuedogenes	O
.	O

The	O
UB3EA	O
gnee	O
encdoes	O
the	O
E6	O
-	O
AP	O
ubiqiutin	O
-	O
prtoein	O
lgiase	O
and	O
has	O
recently	O
been	O
shown	O
to	O
be	O
mutaetd	O
in	O
Aneglman	B-Disease
sydnrome	I-Disease
ptaients	O
who	O
lcak	O
15q11	O
-	O
q13	O
deletoins	O
or	O
chromsoome	O
15	O
patrenal	O
uniparnetal	B-Disease
dsiomy	I-Disease
.	O

Previous	O
UB3EA	O
cNDA	O
analsyis	O
has	O
shown	O
a	O
coidng	O
reigon	O
of	O
approximately	O
2	O
.	O

6	O
kb	O
and	O
a	O
3	O
-	O
untransltaed	O
reigon	O
(	O
UTR	O
)	O
of	O
<	O
50	O
bp	O
,	O
whereas	O
Northren	O
analsyis	O
has	O
indicated	O
mNRA	O
sizes	O
of	O
5	O
-	O
8	O
kb	O
.	O

We	O
have	O
aanlyzed	O
additional	O
cNDA	O
cloens	O
and	O
provide	O
evdience	O
for	O
an	O
additional	O
0	O
.	O

5	O
kb	O
of	O
5	O
-	O
UTR	O
and	O
>	O
2	O
kb	O
of	O
3	O
-	O
UTR	O
.	O

We	O
have	O
established	O
the	O
geonmic	O
organiaztion	O
of	O
UEB3A	O
and	O
the	O
seuqence	O
of	O
inrton	O
-	O
eoxn	O
boredrs	O
.	O

We	O
have	O
also	O
mapped	O
two	O
highly	O
hoomlogous	O
procsesed	O
pseudgoenes	O
,	O
UB3EAP1	O
and	O
UB3EAP2	O
,	O
to	O
chormosomes	O
2	O
and	O
21	O
,	O
respectively	O
,	O
and	O
determined	O
their	O
geonmic	O
organziation	O
.	O

These	O
resutls	O
will	O
form	O
the	O
basis	O
for	O
studeis	O
of	O
mutatoin	O
and	O
impritning	O
of	O
UEB3A	O
.	O

Muattion	O
specturm	O
and	O
genotpye	O
-	O
phentoype	O
anlayses	O
in	O
Cowedn	B-Disease
disaese	I-Disease
and	O
Bananyan	B-Disease
-	I-Disease
Znoana	I-Disease
syndrmoe	I-Disease
,	O
two	O
hamratoma	B-Disease
syndroems	I-Disease
with	O
germilne	O
PETN	O
muattion	O
.	O

The	O
tumuor	B-Disease
suppressor	O
gnee	O
PETN	O
,	O
which	O
mpas	O
to	O
10q23	O
.	O

3	O
and	O
encoeds	O
a	O
403	O
amnio	O
aicd	O
dual	O
specifictiy	O
pohsphatase	O
(	O
portein	O
tyrosnie	O
phsophatase	O
;	O
PTPsae	O
)	O
,	O
was	O
shown	O
recently	O
to	O
play	O
a	O
broad	O
role	O
in	O
hmuan	O
malignnacy	B-Disease
.	O

Somtaic	O
PETN	O
deletinos	O
and	O
mutatoins	O
were	O
observed	O
in	O
sopradic	B-Disease
berast	I-Disease
,	I-Disease
brian	I-Disease
,	I-Disease
protsate	I-Disease
and	I-Disease
kdiney	I-Disease
cacner	I-Disease
clel	O
liens	O
and	O
in	O
several	O
primray	O
tumuors	B-Disease
such	O
as	O
endoemtrial	B-Disease
caricnomas	I-Disease
,	O
malignnat	B-Disease
mleanoma	I-Disease
and	O
tyhroid	B-Disease
tmuours	I-Disease
.	O

In	O
addition	O
,	O
PETN	O
was	O
iedntified	O
as	O
the	O
suscepitbility	O
gnee	O
for	O
two	O
hamartmoa	B-Disease
syndormes	I-Disease
Cowedn	B-Disease
disaese	I-Disease
(	O
CD	B-Disease
;	O
MIM	O
158350	O
)	O
and	O
Bannayan	B-Disease
-	I-Disease
Zoanna	I-Disease
(	I-Disease
BZS	I-Disease
)	I-Disease
or	I-Disease
Ruavlcaba	I-Disease
-	I-Disease
Riley	I-Disease
-	I-Disease
Smith	I-Disease
synrdome	I-Disease
(	O
MIM	O
153480	O
)	O
.	O

Constittuive	O
DNA	O
from	O
37	O
CD	B-Disease
famliies	O
and	O
seven	O
BZS	B-Disease
famiiles	O
was	O
screened	O
for	O
germilne	O
PETN	O
mutatinos	O
.	O

PETN	O
mutatoins	O
were	O
identiifed	O
in	O
30	O
of	O
37	O
(	O
81	O
%	O
)	O
CD	B-Disease
famileis	O
,	O
including	O
missesne	O
and	O
nonsesne	O
point	O
mutatinos	O
,	O
deletoins	O
,	O
insertoins	O
,	O
a	O
delteion	O
/	O
insertoin	O
and	O
spilce	O
stie	O
muttaions	O
.	O

These	O
mtuations	O
were	O
scattered	O
over	O
the	O
entire	O
lentgh	O
of	O
PETN	O
,	O
with	O
the	O
exception	O
of	O
the	O
first	O
,	O
fourth	O
and	O
last	O
exnos	O
.	O

A	O
hot	O
sopt	O
for	O
PETN	O
muattion	O
in	O
CD	B-Disease
was	O
idenitfied	O
in	O
eoxn	O
5	O
that	O
contains	O
the	O
PTPsae	O
croe	O
mtoif	O
,	O
with	O
13	O
of	O
30	O
(	O
43	O
%	O
)	O
CD	B-Disease
mutatoins	O
identifeid	O
in	O
this	O
eoxn	O
.	O

Seven	O
of	O
30	O
(	O
23	O
%	O
)	O
were	O
within	O
the	O
croe	O
moitf	O
,	O
the	O
majority	O
(	O
five	O
of	O
seven	O
)	O
of	O
which	O
were	O
missnese	O
mutatinos	O
,	O
possibly	O
pointing	O
to	O
the	O
functioanl	O
significacne	O
of	O
this	O
regoin	O
.	O

Germilne	O
PETN	O
muattions	O
were	O
idenitfied	O
in	O
four	O
of	O
seven	O
(	O
57	O
%	O
)	O
BZS	B-Disease
famiiles	O
studied	O
.	O

Interestingly	O
,	O
none	O
of	O
these	O
mtuations	O
was	O
observed	O
in	O
the	O
PTaPse	O
croe	O
moitf	O
.	O

It	O
is	O
also	O
worthy	O
of	O
note	O
that	O
a	O
single	O
nonsesne	O
point	O
muattion	O
,	O
R323X	O
,	O
was	O
observed	O
in	O
the	O
germilne	O
DNA	O
from	O
two	O
unrelated	O
CD	B-Disease
famiiles	O
and	O
one	O
BZS	B-Disease
faimly	O
.	O

Genoytpe	O
-	O
phenotpye	O
stduies	O
were	O
not	O
performed	O
on	O
this	O
small	O
gorup	O
of	O
BZS	B-Disease
famiiles	O
.	O

However	O
,	O
geontype	O
-	O
pehnotype	O
analsyis	O
inthe	O
gorup	O
of	O
CD	B-Disease
fmailies	O
reveaeld	O
two	O
possible	O
assocaitions	O
worthy	O
of	O
follow	O
-	O
up	O
in	O
inedpendent	O
analsyes	O
.	O

The	O
first	O
was	O
an	O
assocaition	O
noted	O
in	O
the	O
gruop	O
of	O
CD	B-Disease
famileis	O
with	O
braest	B-Disease
dsiease	I-Disease
.	O

A	O
corerlation	O
was	O
observed	O
between	O
the	O
preesnce	O
/	O
asbence	O
of	O
a	O
PETN	O
mutatoin	O
and	O
the	O
tpye	O
of	O
braest	O
invlovement	O
(	O
unafefcted	O
versus	O
beingn	O
versus	O
malignnat	O
)	O
.	O

Specifically	O
and	O
more	O
directly	O
,	O
an	O
association	O
was	O
also	O
observed	O
between	O
the	O
presnece	O
of	O
a	O
PETN	O
muattion	O
and	O
malingant	B-Disease
berast	I-Disease
disesae	I-Disease
.	O

Secondly	O
,	O
there	O
appeared	O
to	O
be	O
an	O
interdependnet	O
asscoiation	O
between	O
mutatinos	O
uptsream	O
and	O
within	O
the	O
PTaPse	O
croe	O
moitf	O
,	O
the	O
croe	O
mtoif	O
containing	O
the	O
majority	O
of	O
misesnse	O
mtuations	O
,	O
and	O
the	O
involvemnet	O
of	O
all	O
major	O
oragn	O
ssytems	O
(	O
centarl	O
nervuos	O
sytsem	O
,	O
thyriod	O
,	O
berast	O
,	O
sikn	O
and	O
gastroinetstinal	O
tarct	O
)	O
.	O

However	O
,	O
these	O
observatoins	O
would	O
need	O
to	O
be	O
confirmed	O
by	O
studying	O
a	O
larger	O
number	O
of	O
CD	B-Disease
fmailies	O
.	O

Moelcular	O
deefcts	O
leading	O
to	O
huamn	O
complement	B-Disease
component	I-Disease
C6	I-Disease
defiicency	I-Disease
in	O
an	O
Arfican	O
-	O
Ameircan	O
fmaily	O
.	O

Cmoplement	B-Disease
component	I-Disease
C6	I-Disease
deifciency	I-Disease
(	O
C6D	B-Disease
)	O
was	O
diganosed	O
in	O
a	O
16	O
-	O
yaer	O
-	O
old	O
Afrcian	O
-	O
Amercian	O
mlae	O
with	O
meningoocccal	B-Disease
meningiits	I-Disease
.	O

The	O
patinets	O
ftaher	O
and	O
two	O
brohters	O
also	O
had	O
C6D	B-Disease
,	O
but	O
gave	O
no	O
histroy	O
of	O
meningtiis	B-Disease
or	O
other	O
neisserail	B-Disease
infeciton	I-Disease
.	O

By	O
using	O
eoxn	O
-	O
specific	O
ploymerase	O
chian	O
reactoin	O
(	O
PCR	O
)	O
/	O
single	O
-	O
starnd	O
confromation	O
polmyorphism	O
as	O
a	O
srceening	O
step	O
and	O
nucloetide	O
sequecning	O
of	O
tagret	O
eoxns	O
,	O
we	O
determined	O
that	O
the	O
probnad	O
was	O
a	O
componud	O
heetrozygote	O
for	O
two	O
C6	O
gnee	O
mutaitons	O
.	O

The	O
first	O
,	O
1195delC	O
located	O
in	O
eoxn	O
7	O
,	O
is	O
a	O
novel	O
muattion	O
,	O
while	O
the	O
second	O
,	O
1936delG	O
in	O
eoxn	O
12	O
,	O
has	O
been	O
described	O
before	O
to	O
cause	O
C6D	B-Disease
in	O
an	O
unrelated	O
Afrcian	O
-	O
Aemrican	O
indivdiual	O
.	O

Both	O
muattions	O
result	O
in	O
permature	O
terminatoin	O
coodns	O
and	O
C6	O
nlul	O
alllees	O
.	O

Allele	O
-	O
specific	O
PCR	O
indicated	O
that	O
the	O
probadns	O
two	O
borthers	O
also	O
inhertied	O
the	O
1195delC	O
mutatoin	O
from	O
their	O
heteorzygous	O
mohter	O
and	O
the	O
1936delG	O
muattion	O
from	O
their	O
homoyzgous	O
ftaher	O
.	O
.	O

PXA6	O
mutaitons	O
revieewd	O
.	O

Mutaitons	O
in	O
PXA6	O
are	O
responsible	O
for	O
hmuan	O
anriidia	B-Disease
and	O
have	O
also	O
been	O
found	O
in	O
pateints	O
with	O
Peetrs	B-Disease
anmoaly	I-Disease
,	O
with	O
cnogenital	B-Disease
cataarcts	I-Disease
,	O
with	O
auotsomal	B-Disease
doimnant	I-Disease
kerattiis	I-Disease
,	O
and	O
with	O
isoltaed	B-Disease
fvoeal	I-Disease
hyppolasia	I-Disease
.	O

No	O
lcous	O
other	O
than	O
chromsoome	O
11p13	O
has	O
been	O
implicated	O
in	O
ainridia	B-Disease
,	O
and	O
PXA6	O
is	O
clearly	O
the	O
major	O
,	O
if	O
not	O
only	O
,	O
gnee	O
responsible	O
.	O

Twenty	O
-	O
eight	O
percent	O
of	O
iedntified	O
PXA6	O
mutatinos	O
are	O
C	O
-	O
T	O
chanegs	O
at	O
CpG	O
dinucloetides	O
,	O
20	O
%	O
are	O
splciing	O
erorrs	O
,	O
and	O
more	O
than	O
30	O
%	O
are	O
deletoin	O
or	O
inseriton	O
evnets	O
.	O

There	O
is	O
a	O
noticeably	O
eleavted	O
lveel	O
of	O
mtuation	O
in	O
the	O
paired	O
dmoain	O
cmopared	O
with	O
the	O
rest	O
of	O
the	O
gnee	O
.	O

Icnreased	O
mutatoin	O
in	O
the	O
homeodmoain	O
is	O
accounted	O
for	O
by	O
the	O
hypemrutable	O
CpG	O
dinucloetide	O
in	O
coodn	O
240	O
.	O

Very	O
nearly	O
all	O
mutatoins	O
appear	O
to	O
cause	O
lsos	O
of	O
fnuction	O
of	O
the	O
mtuant	O
alelle	O
,	O
and	O
more	O
than	O
80	O
%	O
of	O
exnoic	O
substiuttions	O
result	O
in	O
nonesnse	O
cdoons	O
.	O

In	O
a	O
gnee	O
with	O
such	O
extraordinarily	O
high	O
sequecne	O
conseravtion	O
throughout	O
evoultion	O
,	O
there	O
are	O
presumed	O
undiscovered	O
missnese	O
mutaitons	O
,	O
these	O
are	O
hypothesized	O
to	O
exist	O
in	O
as	O
-	O
yet	O
unidentified	O
phenotyeps	O
.	O
.	O

Geneitc	O
heterogenetiy	O
and	O
pneetrance	O
aanlysis	O
of	O
the	O
BRAC1	O
and	O
BCRA2	O
geens	O
in	O
berast	B-Disease
canecr	I-Disease
faimlies	O
.	O

The	O
Bresat	B-Disease
Cnacer	I-Disease
Linakge	O
Consortuim	O
.	O

The	O
contribution	O
of	O
BCRA1	O
and	O
BRAC2	O
to	O
inherietd	B-Disease
bresat	I-Disease
canecr	I-Disease
was	O
asesssed	O
by	O
linkgae	O
and	O
mtuation	O
analsyis	O
in	O
237	O
famiiles	O
,	O
each	O
with	O
at	O
least	O
four	O
caess	O
of	O
bresat	B-Disease
cacner	I-Disease
,	O
collected	O
by	O
the	O
Bresat	B-Disease
Cacner	I-Disease
Liknage	O
Consrotium	O
.	O

Famliies	O
were	O
included	O
without	O
regard	O
to	O
the	O
occurrnece	O
of	O
ovraian	B-Disease
or	I-Disease
other	I-Disease
cnacers	I-Disease
.	O

Overall	O
,	O
dsiease	O
was	O
linked	O
to	O
BRAC1	O
in	O
an	O
esitmated	O
52	O
%	O
of	O
faimlies	O
,	O
to	O
BCRA2	O
in	O
32	O
%	O
of	O
fmailies	O
,	O
and	O
to	O
neither	O
gnee	O
in	O
16	O
%	O
(	O
95	O
%	O
confidecne	O
intreval	O
[	O
CI	O
]	O
6	O
%	O
-	O
28	O
%	O
)	O
,	O
suggesting	O
other	O
predispsoition	O
gnees	O
.	O

The	O
majority	O
(	O
81	O
%	O
)	O
of	O
the	O
bresat	B-Disease
-	I-Disease
oavrian	I-Disease
cnacer	I-Disease
famileis	O
were	O
due	O
to	O
BRAC1	O
,	O
with	O
most	O
others	O
(	O
14	O
%	O
)	O
due	O
to	O
BRAC2	O
.	O

Conversely	O
,	O
the	O
majority	O
of	O
fmailies	O
with	O
mlae	B-Disease
and	I-Disease
feamle	I-Disease
bresat	I-Disease
canecr	I-Disease
were	O
due	O
to	O
BCRA2	O
(	O
76	O
%	O
)	O
.	O

The	O
largest	O
proporiton	O
(	O
67	O
%	O
)	O
of	O
fmailies	O
due	O
to	O
other	O
geens	O
was	O
found	O
in	O
famiiles	O
with	O
four	O
or	O
five	O
caess	O
of	O
fmeale	O
berast	B-Disease
cnacer	I-Disease
only	O
.	O

These	O
estimaets	O
were	O
not	O
substantially	O
affceted	O
either	O
by	O
changing	O
the	O
assumed	O
penetrnace	O
moedl	O
for	O
BRAC1	O
or	O
by	O
including	O
or	O
excluding	O
BCRA1	O
mutaiton	O
dtaa	O
.	O

Among	O
those	O
faimlies	O
with	O
disaese	O
due	O
to	O
BCRA1	O
that	O
were	O
tetsed	O
by	O
one	O
of	O
the	O
stnadard	O
screening	O
metohds	O
,	O
muattions	O
were	O
deetcted	O
in	O
the	O
codnig	O
seuqence	O
or	O
slpice	O
siets	O
in	O
an	O
estimaetd	O
63	O
%	O
(	O
95	O
%	O
CI	O
51	O
%	O
-	O
77	O
%	O
)	O
.	O

The	O
esitmated	O
senstiivity	O
was	O
identiacl	O
for	O
direct	O
sequencnig	O
and	O
other	O
techniuqes	O
.	O

The	O
penertance	O
of	O
BRAC2	O
was	O
etsimated	O
by	O
maximizing	O
the	O
LOD	O
scroe	O
in	O
BCRA2	O
-	O
mutatoin	O
faimlies	O
,	O
over	O
all	O
possible	O
penetracne	O
funtcions	O
.	O

The	O
etsimated	O
cmuulative	O
rsik	O
of	O
bresat	B-Disease
canecr	I-Disease
reached	O
28	O
%	O
(	O
95	O
%	O
CI	O
9	O
%	O
-	O
44	O
%	O
)	O
by	O
age	O
50	O
yeras	O
and	O
84	O
%	O
(	O
95	O
%	O
CI	O
43	O
%	O
-	O
95	O
%	O
)	O
by	O
age	O
70	O
yeras	O
.	O

The	O
corresponding	O
ovraian	B-Disease
cacner	I-Disease
rsiks	O
were	O
0	O
.	O

4	O
%	O
(	O
95	O
%	O
CI	O
0	O
%	O
-	O
1	O
%	O
)	O
by	O
age	O
50	O
yaers	O
and	O
27	O
%	O
(	O
95	O
%	O
CI	O
0	O
%	O
-	O
47	O
%	O
)	O
by	O
age	O
70	O
yaers	O
.	O

The	O
lfietime	O
rsik	O
of	O
bresat	B-Disease
cnacer	I-Disease
appears	O
similar	O
to	O
the	O
rsik	O
in	O
BRAC1	O
carreirs	O
,	O
but	O
there	O
was	O
some	O
suggesiton	O
of	O
a	O
loewr	O
rsik	O
in	O
BRAC2	O
carreirs	O
<	O
50	O
yaers	O
of	O
age	O
.	O

Eye	B-Disease
movemnet	I-Disease
abnormlaities	I-Disease
correltae	O
with	O
geontype	O
in	O
atuosomal	O
doimnant	O
cerebellar	B-Disease
ataixa	I-Disease
tpye	I-Disease
I	I-Disease
.	O

We	O
copmared	O
hroizontal	O
eye	O
movmeents	O
(	O
visually	O
guided	O
saccaeds	O
,	O
antisaccaeds	O
,	O
and	O
smotoh	O
purusit	O
)	O
in	O
contorl	O
subejcts	O
(	O
n	O
=	O
14	O
)	O
and	O
patietns	O
with	O
three	O
forms	O
of	O
autsoomal	O
domniant	O
cereblelar	B-Disease
ataxais	I-Disease
tpye	I-Disease
I	I-Disease
spinoecrebellar	B-Disease
ataixas	I-Disease
1	I-Disease
and	I-Disease
2	I-Disease
(	O
SAC1	B-Disease
,	O
n	O
=	O
11	O
;	O
SAC2	B-Disease
,	O
n	O
=	O
10	O
)	O
and	O
SAC3	B-Disease
/	O
Macahdo	B-Disease
-	I-Disease
Joesph	I-Disease
disaese	I-Disease
(	O
MJD	B-Disease
)	O
(	O
n	O
=	O
16	O
)	O
.	O

In	O
SAC1	B-Disease
,	O
saccade	O
ampltiude	O
was	O
significantly	O
incraesed	O
,	O
resulting	O
in	O
hypemretria	B-Disease
.	O

The	O
smooth	O
prusuit	O
gain	O
was	O
decreaesd	O
.	O

In	O
SAC2	B-Disease
,	O
sacacde	O
veloicty	O
was	O
markedly	O
dcereased	O
.	O

The	O
percentgae	O
of	O
errros	O
in	O
antisaccaeds	O
was	O
greatly	O
inrceased	O
and	O
was	O
significantly	O
crorelated	O
with	O
age	O
at	O
disaese	O
onset	O
.	O

In	O
addition	O
,	O
a	O
correlaiton	O
between	O
smotoh	O
purusit	O
gain	O
and	O
the	O
number	O
of	O
trinucleotdie	O
rpeeats	O
was	O
found	O
.	O

In	O
SAC3	B-Disease
,	O
gzae	B-Disease
-	I-Disease
evkoed	I-Disease
nystagums	I-Disease
was	O
often	O
present	O
as	O
was	O
saccdae	O
hypoemtria	O
and	O
somoth	O
pursiut	O
gain	O
was	O
markedly	O
dcereased	O
.	O

Three	O
major	O
crtieria	O
,	O
sacacde	O
ampiltude	O
,	O
saccdae	O
veloctiy	O
,	O
and	O
preesnce	O
of	O
gzae	B-Disease
-	I-Disease
evkoed	I-Disease
nystagums	I-Disease
,	O
permitted	O
the	O
correct	O
assignemnt	O
of	O
90	O
%	O
of	O
the	O
SAC1	B-Disease
,	O
90	O
%	O
of	O
the	O
SAC2	B-Disease
,	O
and	O
93	O
%	O
of	O
the	O
patietns	O
with	O
SAC3	B-Disease
to	O
their	O
genetically	O
confirmed	O
paitent	O
gruop	O
and	O
,	O
therefore	O
,	O
may	O
help	O
orient	O
diangoses	O
of	O
SAC1	B-Disease
,	O
SAC2	B-Disease
,	O
and	O
SAC3	B-Disease
at	O
ealry	O
cliincal	O
satges	O
of	O
the	O
dsieases	O
.	O
.	O

Genteic	O
basis	O
and	O
molceular	O
mechansim	O
for	O
idiopatihc	B-Disease
ventricluar	I-Disease
firbillation	I-Disease
.	O

Ventricluar	B-Disease
fibrilaltion	I-Disease
causes	O
more	O
than	O
300	O
,	O
000	O
sudedn	O
daeths	O
each	O
yaer	O
in	O
the	O
USA	O
alone	O
.	O

In	O
approximately	O
5	O
-	O
12	O
%	O
of	O
these	O
csaes	O
,	O
there	O
are	O
no	O
demonstrable	O
cradiac	O
or	O
non	O
-	O
cardaic	O
causes	O
to	O
account	O
for	O
the	O
eipsode	O
,	O
which	O
is	O
therefore	O
classified	O
as	O
idoipathic	B-Disease
ventricualr	I-Disease
fibirllation	I-Disease
(	O
IVF	B-Disease
)	O
.	O

A	O
distinct	O
gorup	O
of	O
IVF	B-Disease
patietns	O
has	O
been	O
found	O
to	O
present	O
with	O
a	O
characterisitc	O
eletcrocardiographic	O
pattren	O
.	O

Because	O
of	O
the	O
small	O
szie	O
of	O
most	O
pedirgees	O
and	O
the	O
high	O
icnidence	O
of	O
sduden	B-Disease
daeth	I-Disease
,	O
however	O
,	O
moleuclar	O
geneitc	O
studeis	O
of	O
IVF	B-Disease
have	O
not	O
yet	O
been	O
done	O
.	O

Because	O
IVF	B-Disease
causes	O
cardaic	O
ryhthm	O
disturabnce	O
,	O
we	O
investigaetd	O
whether	O
malfunctoin	O
of	O
ion	O
chanenls	O
could	O
cause	O
the	O
dsiorder	O
by	O
studying	O
mutatinos	O
in	O
the	O
cradiac	O
soduim	O
channel	O
gnee	O
SC5NA	O
.	O

We	O
have	O
now	O
idenitfied	O
a	O
missesne	O
muttaion	O
,	O
a	O
spilce	O
-	O
dnoor	O
muttaion	O
,	O
and	O
a	O
framehsift	O
mtuation	O
in	O
the	O
coidng	O
regoin	O
of	O
SC5NA	O
in	O
three	O
IVF	B-Disease
faimlies	O
.	O

We	O
show	O
that	O
soduim	O
channels	O
with	O
the	O
missense	O
muattion	O
recoevr	O
from	O
inactviation	O
more	O
rapidly	O
than	O
noraml	O
and	O
that	O
the	O
fraemshift	O
muttaion	O
causes	O
the	O
soduim	O
channel	O
to	O
be	O
non	O
-	O
fucntional	O
.	O

Our	O
resluts	O
indicate	O
that	O
muttaions	O
in	O
caridac	O
ion	O
-	O
chanenl	O
gnees	O
contribute	O
to	O
the	O
rsik	O
of	O
developing	O
IVF	B-Disease
.	O
.	O

Molecluar	O
hetreogeneity	O
in	O
mucopolysaccharidosis	B-Disease
IVA	I-Disease
in	O
Ausrtalia	O
and	O
Nrothern	O
Irelnad	O
:	O
nine	O
novel	O
mutaitons	O
including	O
T321S	O
,	O
a	O
common	O
alelle	O
that	O
confers	O
a	O
mlid	O
phenotpye	O
.	O

Mucopolyasccharidosis	B-Disease
IVA	I-Disease
(	O
MPS	B-Disease
IVA	I-Disease
)	O
is	O
an	O
autosoaml	B-Disease
recesisve	I-Disease
lysosmoal	I-Disease
storgae	I-Disease
disoredr	I-Disease
caused	O
by	O
a	O
genteic	B-Disease
dfeect	I-Disease
in	O
N	O
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sulafte	O
slufatase	O
(	O
GLANS	O
)	O
.	O

Previous	O
stduies	O
of	O
ptaients	O
from	O
a	O
Britsih	O
-	O
Iirsh	O
popluation	O
showed	O
that	O
the	O
I113F	O
muttaion	O
is	O
the	O
most	O
common	O
single	O
muattion	O
among	O
MPS	B-Disease
IVA	I-Disease
paitents	O
and	O
produces	O
a	O
sveere	O
clniical	O
phentoype	O
.	O

We	O
studied	O
muattions	O
in	O
the	O
GANLS	O
gnee	O
from	O
23	O
additional	O
MPS	B-Disease
IVA	I-Disease
patinets	O
(	O
15	O
from	O
Austrlaia	O
,	O
8	O
from	O
Nrothern	O
Ierland	O
)	O
,	O
with	O
various	O
clincial	O
phenotpyes	O
(	O
seevre	O
,	O
16	O
caess	O
;	O
intemrediate	O
,	O
4	O
csaes	O
;	O
mlid	O
,	O
3	O
csaes	O
)	O
.	O

We	O
found	O
two	O
common	O
mutaitons	O
that	O
together	O
accounted	O
for	O
32	O
%	O
of	O
the	O
44	O
unrelated	O
alllees	O
in	O
these	O
ptaients	O
.	O

One	O
is	O
the	O
T321S	O
mutaiton	O
,	O
a	O
novel	O
mtuation	O
found	O
exclusively	O
in	O
milder	O
patietns	O
.	O

The	O
other	O
is	O
the	O
previously	O
described	O
I113F	O
that	O
produces	O
a	O
seevre	O
pehnotype	O
.	O

The	O
I113F	O
and	O
T321S	O
mtuations	O
accounted	O
for	O
8	O
(	O
18	O
%	O
)	O
and	O
6	O
(	O
14	O
%	O
)	O
of	O
44	O
unrelated	O
alleles	O
,	O
respectively	O
.	O

The	O
relatively	O
high	O
reisdual	O
GLANS	O
actiivty	O
seen	O
when	O
the	O
T321S	O
mutnat	O
cNDA	O
is	O
overexpresesd	O
in	O
mtuant	O
cells	O
provides	O
an	O
explanation	O
for	O
the	O
mlid	O
phenoytpe	O
in	O
patietns	O
with	O
this	O
mutaiton	O
.	O

The	O
distrbiution	O
and	O
relative	O
frqeuencies	O
of	O
the	O
I113F	O
and	O
T321S	O
mutatinos	O
in	O
Austrlaia	O
corresponded	O
to	O
those	O
observed	O
in	O
Nortehrn	O
Irelnad	O
and	O
are	O
unqiue	O
to	O
these	O
two	O
popualtions	O
,	O
suggesting	O
that	O
both	O
mutatoins	O
were	O
probably	O
introduced	O
to	O
Autsralia	O
by	O
Iirsh	O
migarnts	O
during	O
the	O
19th	O
century	O
.	O

Hapoltype	O
aanlysis	O
using	O
6	O
RLFPs	O
provides	O
additional	O
dtaa	O
that	O
the	O
I113F	O
mtuation	O
originated	O
from	O
a	O
common	O
ancesotr	O
.	O

The	O
other	O
9	O
novel	O
mutatoins	O
idnetified	O
in	O
these	O
23	O
patietns	O
were	O
each	O
limietd	O
to	O
a	O
single	O
famliy	O
.	O

These	O
dtaa	O
provide	O
further	O
evidnece	O
for	O
exetnsive	O
alellic	O
hetreogeneity	O
in	O
MPS	B-Disease
IVA	I-Disease
in	O
Birtish	O
-	O
Irsih	O
paitents	O
and	O
provide	O
eviednce	O
for	O
their	O
tranmsission	O
to	O
Austraila	O
by	O
Briitsh	O
-	O
Iirsh	O
mirgants	O
.	O
.	O

Idetnification	O
of	O
cnostitutional	O
WT1	O
mtuations	O
,	O
in	O
pateints	O
with	O
isloated	O
diffuse	B-Disease
mesanigal	I-Disease
sclreosis	I-Disease
,	O
and	O
aanlysis	O
of	O
geontype	O
/	O
phneotype	O
correaltions	O
by	O
use	O
of	O
a	O
computreized	O
muattion	O
daatbase	O
.	O

Constiuttional	O
mutatinos	O
of	O
the	O
WT1	O
gnee	O
,	O
enocding	O
a	O
znic	O
-	O
fniger	O
trnascription	O
fatcor	O
involved	O
in	O
rneal	O
and	O
goandal	O
devleopment	O
,	O
are	O
found	O
in	O
most	O
paitents	O
with	O
Deyns	B-Disease
-	I-Disease
Darsh	I-Disease
syndorme	I-Disease
(	O
DDS	B-Disease
)	O
,	O
or	O
dfifuse	B-Disease
mesnagial	I-Disease
scelrosis	I-Disease
(	O
DMS	B-Disease
)	O
associated	O
with	O
pseudohemraphroditism	B-Disease
and	O
/	O
or	O
Wlims	B-Disease
tmuor	I-Disease
(	O
WT	B-Disease
)	O
.	O

Most	O
muttaions	O
in	O
DDS	B-Disease
paitents	O
lie	O
in	O
eoxn	O
8	O
or	O
eoxn	O
9	O
,	O
encdoing	O
znic	O
fniger	O
2	O
or	O
znic	O
figner	O
3	O
,	O
respectively	O
,	O
with	O
a	O
hot	O
sopt	O
(	O
R394W	O
)	O
in	O
eoxn	O
9	O
.	O

We	O
analyezd	O
a	O
series	O
of	O
24	O
patietns	O
,	O
10	O
with	O
isolaetd	B-Disease
DMS	I-Disease
(	O
IMDS	B-Disease
)	O
,	O
10	O
with	O
DDS	B-Disease
,	O
and	O
4	O
with	O
uorgenital	B-Disease
abnormaliites	I-Disease
and	O
/	O
or	O
WT	B-Disease
.	O

We	O
rpeort	O
WT1	O
heteorzygous	O
mtuations	O
in	O
16	O
patietns	O
,	O
4	O
of	O
whom	O
presented	O
with	O
IMDS	B-Disease
.	O

One	O
mlae	O
and	O
two	O
femlae	O
IMDS	B-Disease
patietns	O
with	O
WT1	O
muattions	O
underwent	O
noraml	O
puebrty	O
.	O

Two	O
mutaitons	O
associated	O
with	O
IMDS	B-Disease
are	O
different	O
from	O
those	O
described	O
in	O
DDS	B-Disease
patinets	O
.	O

No	O
WT1	O
mutaitons	O
were	O
dteected	O
in	O
the	O
six	O
other	O
IMDS	B-Disease
ptaients	O
,	O
suggesting	O
geentic	O
hteerogeneity	O
of	O
this	O
dsiease	O
.	O

We	O
analyezd	O
geontype	O
/	O
phneotype	O
correlations	O
,	O
on	O
the	O
basis	O
of	O
the	O
constituiton	O
of	O
a	O
WT1	O
mtuation	O
dtaabase	O
of	O
84	O
grem	O
-	O
line	O
mutatoins	O
,	O
to	O
copmare	O
the	O
dsitribution	O
and	O
tpye	O
of	O
mtuations	O
,	O
according	O
to	O
the	O
different	O
symtpoms	O
.	O

This	O
demonstrated	O
(	O
1	O
)	O
the	O
asosciation	O
between	O
mtuations	O
in	O
eoxns	O
8	O
and	O
9	O
and	O
DMS	B-Disease
;	O
(	O
2	O
)	O
among	O
pateints	O
with	O
DMS	B-Disease
,	O
a	O
hihger	O
frequnecy	O
of	O
eoxn	O
8	O
muttaions	O
among	O
46	O
,	O
XY	O
pateints	O
with	O
feamle	O
phenoytpe	O
than	O
among	O
46	O
,	O
XY	O
patietns	O
with	O
seuxal	O
ambigiuty	O
or	O
mlae	O
phenoytpe	O
;	O
and	O
(	O
3	O
)	O
staitstically	O
significant	O
evidnece	O
that	O
muttaions	O
in	O
eoxns	O
8	O
and	O
9	O
preferentially	O
affect	O
amnio	O
aicds	O
with	O
different	O
functinos	O
.	O
.	O

The	O
18d5elAG	O
BRAC1	O
mutatoin	O
originated	O
before	O
the	O
dispresion	O
of	O
Jwes	O
in	O
the	O
diasproa	O
and	O
is	O
not	O
limtied	O
to	O
Asheknazim	O
.	O

The	O
185edlAG	O
mutatoin	O
in	O
BRAC1	O
is	O
detetced	O
in	O
Ahskenazi	O
Jwes	O
both	O
in	O
faimlial	B-Disease
braest	I-Disease
and	I-Disease
oavrian	I-Disease
canecr	I-Disease
and	O
in	O
the	O
general	O
populaiton	O
.	O

All	O
tseted	O
Ashkeanzi	O
mutatoin	O
carirers	O
share	O
the	O
same	O
allelic	O
pattern	O
at	O
the	O
BRAC1	O
lcous	O
.	O

Our	O
previous	O
sutdy	O
showed	O
that	O
this	O
Ashkenzai	O
mutatoin	O
also	O
occurs	O
in	O
Iarqi	O
Jwes	O
with	O
a	O
similar	O
alellic	O
ptatern	O
.	O

We	O
extedned	O
our	O
anlaysis	O
to	O
other	O
non	O
-	O
Asheknazi	O
sbusets	O
354	O
of	O
Mrooccan	O
oirgin	O
,	O
200	O
Yementies	O
and	O
150	O
Irnaian	O
Jwes	O
.	O

Heteroudplex	O
anaylsis	O
complemented	O
by	O
direct	O
DNA	O
seuqencing	O
of	O
abnormally	O
migraitng	O
bnads	O
were	O
employed	O
.	O

Four	O
of	O
Moorccan	O
oirgin	O
(	O
1	O
.	O
1	O
%	O
)	O
and	O
none	O
of	O
the	O
Ymeenites	O
or	O
Irainans	O
was	O
a	O
carrier	O
of	O
the	O
185dleAG	O
mutaiton	O
.	O

BRAC1	O
alellic	O
ptaterns	O
were	O
determined	O
for	O
four	O
of	O
these	O
indiviudals	O
and	O
for	O
12	O
additional	O
non	O
-	O
Ashkenzai	O
185edlAG	O
muattion	O
carriers	O
who	O
had	O
braest	B-Disease
/	I-Disease
ovairan	I-Disease
canecr	I-Disease
.	O

Six	O
non	O
-	O
Asheknazi	O
inidviduals	O
shared	O
the	O
common	O
Ashkeanzi	O
haploytpe	O
,	O
four	O
had	O
a	O
closely	O
related	O
pattern	O
,	O
and	O
the	O
rest	O
(	O
n	O
=	O
6	O
)	O
displayed	O
a	O
distinct	O
BCRA1	O
alellic	O
pattern	O
.	O

We	O
conclude	O
that	O
the	O
185edlAG	O
BRAC1	O
muattion	O
occurs	O
in	O
some	O
non	O
-	O
Ahskenazi	O
ppoulations	O
at	O
rtaes	O
comparable	O
with	O
that	O
of	O
Ashkneazim	O
.	O

The	O
majority	O
of	O
Jewsih	O
18d5elAG	O
mutatoin	O
carrires	O
have	O
a	O
common	O
allleic	O
patetrn	O
,	O
supporting	O
the	O
founedr	O
effect	O
notion	O
,	O
but	O
dating	O
the	O
mutatoins	O
orgiin	O
to	O
an	O
earlier	O
date	O
than	O
currently	O
estimaetd	O
.	O

However	O
,	O
the	O
different	O
alleilc	O
pattern	O
at	O
the	O
BRAC1	O
lcous	O
even	O
in	O
some	O
Jeiwsh	O
muattion	O
carrires	O
,	O
might	O
suggest	O
that	O
the	O
mutaiton	O
arose	O
independently	O
.	O
.	O

Crystal	O
strcuture	O
of	O
the	O
hemohcromatosis	B-Disease
portein	O
HFE	O
and	O
characetrization	O
of	O
its	O
interaciton	O
with	O
tranfserrin	O
recepotr	O
.	O

HFE	O
is	O
an	O
MHC	O
-	O
related	O
portein	O
that	O
is	O
muatted	O
in	O
the	O
iorn	B-Disease
-	I-Disease
ovelroad	I-Disease
diesase	I-Disease
hereditray	B-Disease
hemochromtaosis	I-Disease
.	O

HFE	O
bidns	O
to	O
tarnsferrin	O
recepotr	O
(	O
TfR	O
)	O
and	O
reudces	O
its	O
affniity	O
for	O
iorn	O
-	O
laoded	O
transferrin	O
,	O
implicating	O
HFE	O
in	O
iorn	O
metaboilsm	O
.	O

The	O
2	O
.	O

6	O
A	O
crsytal	O
strcuture	O
of	O
HFE	O
reveals	O
the	O
locatinos	O
of	O
hemocrhomatosis	B-Disease
muattions	O
and	O
a	O
pacth	O
of	O
hsitidines	O
that	O
could	O
be	O
involved	O
in	O
pH	O
-	O
deepndent	O
itneractions	O
.	O

We	O
also	O
demonstrate	O
that	O
soulble	O
TfR	O
and	O
HFE	O
bnid	O
tightly	O
at	O
the	O
basic	O
pH	O
of	O
the	O
clel	O
surafce	O
,	O
but	O
not	O
at	O
the	O
aciidc	O
pH	O
of	O
intracellular	O
vesciles	O
.	O

TfR	O
HFE	O
stoichoimetry	O
(	O
2	O
1	O
)	O
differs	O
from	O
TfR	O
trasnferrin	O
sotichiometry	O
(	O
2	O
2	O
)	O
,	O
implying	O
a	O
different	O
mdoe	O
of	O
bniding	O
for	O
HFE	O
and	O
trnasferrin	O
to	O
TfR	O
,	O
consistent	O
with	O
our	O
demonstration	O
that	O
HFE	O
,	O
transferirn	O
,	O
and	O
TfR	O
form	O
a	O
ternray	O
compelx	O
.	O

Identfiication	O
of	O
three	O
novel	O
mutatoins	O
and	O
a	O
high	O
frqeuency	O
of	O
the	O
Arg77L8eu	O
muttaion	O
in	O
Kroean	O
paitents	O
with	O
Wislon	B-Disease
dsiease	I-Disease
.	O

Four	O
muattions	O
-	O
-	O
R778L	O
,	O
A847V	O
,	O
L1803F	O
,	O
and	O
2304delC	O
-	O
-	O
in	O
the	O
cpoper	O
-	O
transporting	O
enyzme	O
,	O
P	O
-	O
tpye	O
APTase	O
(	O
AT7PB	O
)	O
,	O
were	O
identiifed	O
in	O
Kroean	O
Pateints	O
with	O
Wilosn	B-Disease
disesae	I-Disease
.	O

Arg77L8eu	O
,	O
the	O
most	O
frequently	O
reported	O
muattion	O
of	O
this	O
enzmye	O
,	O
was	O
found	O
in	O
six	O
of	O
eight	O
unrelated	O
paitents	O
studied	O
,	O
an	O
allele	O
freqeuncy	O
of	O
37	O
.	O

5	O
%	O
,	O
which	O
is	O
considerably	O
higehr	O
than	O
those	O
in	O
other	O
Asain	O
popultaions	O
.	O

The	O
novel	O
single	O
nulceotide	O
dleetion	O
,	O
2304delC	O
,	O
was	O
found	O
in	O
one	O
patinet	O
.	O

Since	O
a	O
muttaion	O
at	O
cNDA	O
nulceotide	O
2302	O
(	O
2302insC	O
)	O
had	O
been	O
previously	O
described	O
,	O
this	O
reigon	O
of	O
the	O
AT7PB	O
gnee	O
may	O
be	O
suscpetible	O
to	O
gnee	O
rearragnements	O
causing	O
Wilosn	B-Disease
diesase	I-Disease
.	O

Dirsuption	O
of	O
spliicng	O
regulated	O
by	O
a	O
CUG	O
-	O
bindnig	O
portein	O
in	O
moytonic	B-Disease
dytsrophy	I-Disease
.	O

Mytoonic	B-Disease
dytsrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
caused	O
by	O
a	O
CTG	O
expasnion	O
in	O
the	O
3	O
unrtanslated	O
rgeion	O
of	O
the	O
DM	B-Disease
gnee	O
.	O

One	O
mdoel	O
of	O
DM	B-Disease
pathogenseis	O
suggests	O
that	O
RANs	O
from	O
the	O
expanded	O
alelle	O
create	O
a	O
gain	O
-	O
of	O
-	O
funtcion	O
mutatoin	O
by	O
the	O
inappropriate	O
bniding	O
of	O
porteins	O
to	O
the	O
CUG	O
repetas	O
.	O

Dtaa	O
presented	O
here	O
indicate	O
that	O
the	O
conserved	O
hteerogeneous	O
nuclaer	O
ribonucleoproetin	O
,	O
CUG	O
-	O
bindnig	O
proetin	O
(	O
CUG	O
-	O
BP	O
)	O
,	O
may	O
mediate	O
the	O
tarns	O
-	O
domniant	O
effcet	O
of	O
the	O
RNA	O
.	O

CUG	O
-	O
BP	O
was	O
found	O
to	O
bnid	O
to	O
the	O
hmuan	O
cadriac	O
tropnoin	O
T	O
(	O
cNTT	O
)	O
pre	O
-	O
messenger	O
RNA	O
and	O
regluate	O
its	O
aletrnative	O
splciing	O
.	O

Splciing	O
of	O
cNTT	O
was	O
disurpted	O
in	O
DM	B-Disease
stirated	O
mucsle	O
and	O
in	O
noraml	O
cells	O
exprsesing	O
transrcipts	O
that	O
contain	O
CUG	O
repaets	O
.	O

Alteerd	O
expression	O
of	O
gnees	O
regulated	O
posttranscritpionally	O
by	O
CUG	O
-	O
BP	O
therefore	O
may	O
contribute	O
to	O
DM	B-Disease
pathogenseis	O
.	O
.	O

Identfiication	O
of	O
a	O
novel	O
nonsnese	O
muattion	O
and	O
a	O
misesnse	O
substituiton	O
in	O
the	O
vasopressin	O
-	O
neuropyhsin	O
II	O
gnee	O
in	O
two	O
Spansih	O
kinderds	O
with	O
fmailial	B-Disease
neurohypophysael	I-Disease
daibetes	I-Disease
isnipidus	I-Disease
.	O

Faimlial	B-Disease
neurhoypophyseal	I-Disease
dibaetes	I-Disease
inspiidus	I-Disease
(	O
FDNI	B-Disease
)	O
is	O
an	O
autoosmal	B-Disease
dmoinant	I-Disease
disaese	I-Disease
caused	O
by	O
deifciency	O
in	O
the	O
antiiduretic	O
hromone	O
arginnie	O
vasporessin	O
(	O
AVP	O
)	O
encoedd	O
by	O
the	O
AVP	O
-	O
neurophyisn	O
II	O
(	O
AVP	O
-	O
NIPI	O
)	O
gnee	O
on	O
chromsoome	O
20p13	O
.	O

In	O
this	O
sutdy	O
,	O
we	O
anaylzed	O
two	O
famileis	O
with	O
FDNI	B-Disease
using	O
direct	O
auotmated	O
fluorescnet	O
,	O
soild	O
phsae	O
,	O
single	O
-	O
strnaded	O
DNA	O
sequenicng	O
of	O
PCR	O
-	O
ampilfied	O
AVP	O
-	O
NIPI	O
DNA	O
.	O

In	O
one	O
of	O
the	O
famiiles	O
,	O
affceted	O
idnividuals	O
presented	O
a	O
novel	O
nosnense	O
mutaiton	O
in	O
eoxn	O
3	O
of	O
the	O
gnee	O
,	O
consisting	O
in	O
a	O
G	O
to	O
T	O
trnasition	O
at	O
nucleoitde	O
2101	O
,	O
which	O
produces	O
a	O
stop	O
sginal	O
in	O
cdoon	O
82	O
(	O
Glu	O
)	O
of	O
NIPI	O
.	O

The	O
preamture	O
tremination	O
elimniates	O
part	O
of	O
the	O
C	O
-	O
termnial	O
domian	O
of	O
NIPI	O
,	O
including	O
a	O
cytseine	O
resdiue	O
in	O
positoin	O
85	O
,	O
which	O
could	O
be	O
involved	O
in	O
the	O
correct	O
foldnig	O
of	O
the	O
proohrmone	O
.	O

In	O
the	O
second	O
famliy	O
,	O
a	O
G729A	O
subtsitution	O
at	O
psoition	O
-	O
1	O
of	O
the	O
sginal	O
pepitde	O
was	O
observed	O
in	O
all	O
affceted	O
individauls	O
.	O

This	O
missnese	O
muttaion	O
,	O
which	O
replaces	O
Ala	O
with	O
Thr	O
,	O
is	O
frqeuent	O
among	O
FDNI	B-Disease
patinets	O
and	O
is	O
thought	O
to	O
rdeuce	O
the	O
effiicency	O
of	O
claevage	O
by	O
sginal	O
peptiadses	O
.	O
.	O

Genteic	O
heterogeniety	O
of	O
Satehre	B-Disease
-	I-Disease
Chotezn	I-Disease
snydrome	I-Disease
,	O
due	O
to	O
TWSIT	O
and	O
FFGR	O
muattions	O
.	O

Thirty	O
-	O
two	O
unrelated	O
patinets	O
with	O
featuers	O
of	O
Saehtre	B-Disease
-	I-Disease
Chotezn	I-Disease
sydnrome	I-Disease
,	O
a	O
common	O
auotsomal	B-Disease
doimnant	I-Disease
condtiion	I-Disease
of	O
carniosynostosis	B-Disease
and	O
lmib	B-Disease
anmoalies	I-Disease
,	O
were	O
screened	O
for	O
mtuations	O
in	O
TIWST	O
,	O
FGRF2	O
,	O
and	O
FGRF3	O
.	O

Nine	O
novel	O
and	O
three	O
recurrent	O
TWSIT	O
mutatoins	O
were	O
found	O
in	O
12	O
famileis	O
.	O

Seven	O
famliies	O
were	O
found	O
to	O
have	O
the	O
FFGR3	O
P250R	O
muttaion	O
,	O
and	O
one	O
indviidual	O
was	O
found	O
to	O
have	O
an	O
FFGR2	O
V2V69	O
-	O
270	O
deletoin	O
.	O

To	O
date	O
,	O
our	O
deteciton	O
rtae	O
for	O
TIWST	O
or	O
FFGR	O
mtuations	O
is	O
68	O
%	O
in	O
our	O
Seathre	B-Disease
-	I-Disease
Chotezn	I-Disease
synrdome	I-Disease
patietns	O
,	O
including	O
our	O
five	O
ptaients	O
elsewhere	O
reported	O
with	O
TIWST	O
mutatinos	O
.	O

More	O
than	O
35	O
different	O
TWSIT	O
mutatinos	O
are	O
now	O
known	O
in	O
the	O
litertaure	O
.	O

The	O
most	O
common	O
pheontypic	O
featrues	O
,	O
present	O
in	O
more	O
than	O
a	O
third	O
of	O
our	O
patinets	O
with	O
TIWST	O
mutatinos	O
,	O
are	O
cornoal	B-Disease
synotsosis	I-Disease
,	O
brachycepahly	B-Disease
,	O
low	B-Disease
fronatl	I-Disease
hailrine	I-Disease
,	O
faical	B-Disease
asymemtry	I-Disease
,	O
potsis	B-Disease
,	O
hypertelroism	B-Disease
,	O
broad	B-Disease
great	I-Disease
teos	I-Disease
,	O
and	O
cilnodactyly	B-Disease
.	O

Sginificant	O
inrta	O
-	O
and	O
itnerfamilial	O
pheontypic	O
vairability	O
is	O
present	O
for	O
either	O
TWSIT	O
mutatinos	O
or	O
FFGR	O
mutatoins	O
.	O

The	O
overalp	O
in	O
clniical	O
faetures	O
and	O
the	O
persence	O
,	O
in	O
the	O
same	O
gnees	O
,	O
of	O
mtuations	O
for	O
more	O
than	O
one	O
craniosynsototic	B-Disease
cnodition	I-Disease
-	O
such	O
as	O
Saetrhe	B-Disease
-	I-Disease
Chtozen	I-Disease
,	I-Disease
Cruozon	I-Disease
,	I-Disease
and	I-Disease
Pfefifer	I-Disease
syndrmoes	I-Disease
-	O
support	O
the	O
hypotehsis	O
that	O
TWSIT	O
and	O
FFGRs	O
are	O
cmoponents	O
of	O
the	O
same	O
molecluar	O
patwhay	O
involved	O
in	O
the	O
mdoulation	O
of	O
cranioafcial	O
and	O
lmib	O
developemnt	O
in	O
hmuans	O
.	O
.	O

Muttaion	O
anlaysis	O
of	O
UB3EA	O
in	O
Aneglman	B-Disease
sydnrome	I-Disease
pateints	O
.	O

Angleman	B-Disease
syndrmoe	I-Disease
(	O
AS	B-Disease
)	O
is	O
caused	O
by	O
chroomsome	O
15q11	O
-	O
q13	O
deletinos	O
of	O
matrenal	O
orgiin	O
,	O
by	O
paetrnal	O
unpiarental	B-Disease
diosmy	I-Disease
(	O
UPD	B-Disease
)	O
15	O
,	O
by	O
imprniting	O
defcets	O
,	O
and	O
by	O
muttaions	O
in	O
the	O
UB3EA	O
gnee	O
.	O

UEB3A	O
enocdes	O
a	O
ubiuqitin	O
-	O
portein	O
lgiase	O
and	O
shows	O
barin	O
-	O
specific	O
imprinitng	O
.	O

Here	O
we	O
describe	O
UB3EA	O
cdoing	O
-	O
rgeion	O
muttaions	O
dteected	O
by	O
SCSP	O
analyiss	O
in	O
13	O
AS	B-Disease
individauls	O
or	O
famliies	O
.	O

Two	O
idnetical	O
de	O
novo	O
5	O
-	O
bp	O
duplciations	O
in	O
eoxn	O
16	O
were	O
found	O
.	O

Among	O
the	O
other	O
11	O
uinque	O
muattions	O
,	O
8	O
were	O
small	O
deeltions	O
or	O
isnertions	O
predicetd	O
to	O
cause	O
fraemshifts	O
,	O
1	O
was	O
a	O
mutatoin	O
to	O
a	O
stop	O
cdoon	O
,	O
1	O
was	O
a	O
misesnse	O
muttaion	O
,	O
and	O
1	O
was	O
preidcted	O
to	O
cause	O
insretion	O
of	O
an	O
isoleucnie	O
in	O
the	O
hcet	O
domian	O
of	O
the	O
UB3EA	O
prtoein	O
,	O
which	O
funcitons	O
in	O
E2	O
bidning	O
and	O
uibquitin	O
tarnsfer	O
.	O

Eight	O
of	O
the	O
caess	O
were	O
famiilal	O
,	O
and	O
five	O
were	O
spordaic	O
.	O

In	O
two	O
faimlial	O
csaes	O
and	O
one	O
spordaic	O
csae	O
,	O
moasicism	O
for	O
UB3EA	O
mutatoins	O
was	O
detetced	O
in	O
the	O
mtoher	O
of	O
three	O
AS	B-Disease
snos	O
,	O
in	O
the	O
maetrnal	O
grandfatehr	O
of	O
two	O
AS	B-Disease
first	O
cosuins	O
,	O
and	O
in	O
the	O
motehr	O
of	O
an	O
AS	B-Disease
daughter	O
.	O

The	O
ferquencies	O
with	O
which	O
we	O
dteected	O
muattions	O
were	O
5	O
(	O
14	O
%	O
)	O
of	O
35	O
in	O
sproadic	O
caess	O
and	O
8	O
(	O
80	O
%	O
)	O
of	O
10	O
in	O
famiilal	O
caess	O
.	O
.	O

The	O
hmeochromatosis	B-Disease
845	O
G	O
-	O
-	O
>	O
A	O
and	O
187	O
C	O
-	O
-	O
>	O
G	O
mtuations	O
:	O
prevlaence	O
in	O
non	O
-	O
Cauacsian	O
popluations	O
.	O

Hemochrmoatosis	B-Disease
,	O
the	O
inehrited	B-Disease
diosrder	I-Disease
of	I-Disease
iorn	I-Disease
metabloism	I-Disease
,	O
leads	O
,	O
if	O
unterated	O
,	O
to	O
progerssive	O
iorn	B-Disease
oevrload	I-Disease
and	O
permature	B-Disease
detah	I-Disease
.	O

The	O
hemcohromatosis	B-Disease
gnee	O
,	O
HFE	O
,	O
recently	O
has	O
been	O
idenitfied	O
,	O
and	O
characterizaiton	O
of	O
this	O
gnee	O
has	O
shown	O
that	O
it	O
contains	O
two	O
muttaions	O
that	O
result	O
in	O
amnio	O
aicd	O
substiuttions	O
-	O
cNDA	O
nucleotieds	O
845	O
G	O
-	O
-	O
>	O
A	O
(	O
C822Y	O
)	O
and	O
187	O
C	O
-	O
-	O
>	O
G	O
(	O
H36D	O
)	O
.	O

Although	O
hemochormatosis	B-Disease
is	O
common	O
in	O
Caucasains	O
,	O
affecitng	O
>	O
=	O
1	O
/	O
300	O
indivdiuals	O
of	O
nrothern	O
Eruopean	O
oriign	O
,	O
it	O
has	O
not	O
been	O
recognized	O
in	O
other	O
popultaions	O
.	O

The	O
present	O
stduy	O
used	O
PCR	O
and	O
restritcion	O
-	O
enyzme	O
digestoin	O
to	O
aanlyze	O
the	O
frequnecy	O
of	O
the	O
845	O
G	O
-	O
-	O
>	O
A	O
and	O
187	O
C	O
-	O
-	O
>	O
G	O
mutaitons	O
in	O
HLA	O
-	O
tyepd	O
sampels	O
from	O
non	O
-	O
Cacuasian	O
pouplations	O
,	O
comprising	O
Austrlaian	O
Aobriginal	O
,	O
Cihnese	O
,	O
and	O
Pacfiic	O
Islnaders	O
.	O

Reuslts	O
showed	O
that	O
the	O
845	O
G	O
-	O
-	O
>	O
A	O
mutatoin	O
was	O
present	O
in	O
these	O
ppoulations	O
(	O
alelle	O
freuqency	O
0	O
.	O
32	O
%	O
)	O
,	O
and	O
,	O
furthermore	O
,	O
it	O
was	O
always	O
seen	O
in	O
conjucntion	O
with	O
HLA	O
haplotyeps	O
common	O
in	O
Caucsaians	O
,	O
suggesting	O
that	O
845	O
G	O
-	O
-	O
>	O
A	O
may	O
have	O
been	O
introduced	O
into	O
these	O
pouplations	O
by	O
Caucasain	O
amdixture	O
.	O

187	O
C	O
-	O
-	O
>	O
G	O
was	O
present	O
at	O
an	O
allele	O
frqeuency	O
of	O
2	O
.	O

68	O
%	O
in	O
the	O
two	O
pouplations	O
aanlyzed	O
(	O
Ausrtalian	O
Aobriginal	O
and	O
Chinsee	O
)	O
.	O

In	O
the	O
Autsralian	O
Aborignial	O
samlpes	O
,	O
187	O
C	O
-	O
-	O
>	O
G	O
was	O
found	O
to	O
be	O
associated	O
with	O
HLA	O
hapoltypes	O
common	O
in	O
Caucsaians	O
,	O
suggesting	O
that	O
it	O
was	O
introduced	O
by	O
recent	O
admxiture	O
.	O

In	O
the	O
Chiense	O
samlpes	O
analyezd	O
,	O
187	O
C	O
-	O
-	O
>	O
G	O
was	O
present	O
in	O
associaiton	O
with	O
a	O
wide	O
variety	O
of	O
HLA	O
hapltoypes	O
,	O
showing	O
this	O
muttaion	O
to	O
be	O
widespread	O
and	O
likely	O
to	O
predate	O
the	O
more	O
gneetically	O
restricted	O
845	O
G	O
-	O
-	O
>	O
A	O
mutaiton	O
.	O

Geontype	O
-	O
phenoytpe	O
correaltions	O
in	O
attenuaetd	B-Disease
adenoamtous	I-Disease
polpyosis	I-Disease
cloi	I-Disease
.	O

Grem	O
-	O
line	O
muttaions	O
of	O
the	O
tuomr	B-Disease
suppresosr	O
APC	O
are	O
implicated	O
in	O
attenauted	B-Disease
adenomatuos	I-Disease
ployposis	I-Disease
cloi	I-Disease
(	O
APAC	B-Disease
)	O
,	O
a	O
vraiant	O
of	O
famliial	B-Disease
adenomaotus	I-Disease
polypsois	I-Disease
(	O
FAP	B-Disease
)	O
.	O

APAC	B-Disease
is	O
recognized	O
by	O
the	O
occurernce	O
of	O
<	O
100	O
cloonic	B-Disease
aednomas	I-Disease
and	O
a	O
later	O
onset	O
of	O
cloorectal	B-Disease
cnacer	I-Disease
(	O
age	O
>	O
40	O
yeras	O
)	O
.	O

The	O
aim	O
of	O
this	O
sutdy	O
was	O
to	O
assess	O
gentoype	O
-	O
phenoytpe	O
correaltions	O
in	O
APAC	B-Disease
faimlies	O
.	O

By	O
prtoein	O
-	O
trucnation	O
tset	O
(	O
PTT	O
)	O
asasy	O
,	O
the	O
entire	O
coidng	O
rgeion	O
of	O
the	O
APC	B-Disease
gnee	O
was	O
screened	O
in	O
afefcted	O
individauls	O
from	O
11	O
APAC	B-Disease
kinrdeds	O
,	O
and	O
their	O
phenotpyic	O
dfiferences	O
were	O
examined	O
.	O

Five	O
novel	O
grem	O
-	O
line	O
APC	B-Disease
mutatoins	O
were	O
idnetified	O
in	O
seven	O
kinrdeds	O
.	O

Muttaions	O
were	O
located	O
in	O
three	O
different	O
regoins	O
of	O
the	O
APC	B-Disease
gnee	O
(	O
1	O
)	O
at	O
the	O
5	O
end	O
spanning	O
eoxns	O
4	O
and	O
5	O
,	O
(	O
2	O
)	O
within	O
eoxn	O
9	O
,	O
and	O
(	O
3	O
)	O
at	O
the	O
3	O
disatl	O
end	O
of	O
the	O
gnee	O
.	O

Vraiability	O
in	O
the	O
number	O
of	O
colroectal	B-Disease
aednomas	I-Disease
was	O
most	O
apaprent	O
in	O
indivdiuals	O
with	O
mutatoins	O
in	O
regoin	O
1	O
,	O
and	O
upepr	O
-	O
gastrointesitnal	O
manifestatoins	O
were	O
more	O
seevre	O
in	O
them	O
.	O

In	O
indivdiuals	O
with	O
mutatinos	O
in	O
either	O
rgeion	O
2	O
or	O
reigon	O
3	O
,	O
the	O
avearge	O
number	O
of	O
aednomas	B-Disease
tended	O
to	O
be	O
loewr	O
than	O
those	O
in	O
indiviudals	O
with	O
muattions	O
in	O
regoin	O
1	O
,	O
although	O
age	O
at	O
diganosis	O
was	O
similar	O
.	O

In	O
all	O
APAC	B-Disease
kinrdeds	O
,	O
a	O
predominance	O
of	O
rgiht	O
-	O
sided	O
colorecatl	B-Disease
adneomas	I-Disease
and	O
recatl	B-Disease
ployp	I-Disease
sparing	O
was	O
observed	O
.	O

No	O
desomid	B-Disease
tumros	I-Disease
were	O
found	O
in	O
these	O
knidreds	O
.	O

Our	O
dtaa	O
suggest	O
that	O
,	O
in	O
APAC	B-Disease
fmailies	O
,	O
the	O
locaiton	O
of	O
the	O
APC	B-Disease
mutatoin	O
may	O
partailly	O
predict	O
specific	O
phenotpyic	O
expresison	O
.	O

This	O
should	O
help	O
in	O
the	O
dseign	O
of	O
tailored	O
cliniacl	O
-	O
managemnet	O
protcools	O
in	O
this	O
subset	O
of	O
FAP	B-Disease
patietns	O
.	O
.	O

Wimls	B-Disease
'	I-Disease
tuomr	I-Disease
1	O
and	O
Dax	O
-	O
1	O
modualte	O
the	O
orphan	O
nulcear	O
recpetor	O
SF	O
-	O
1	O
in	O
sex	O
-	O
specific	O
gnee	O
epxression	O
.	O

Porducts	O
of	O
steroidgoenic	O
fatcor	O
1	O
(	O
SF	O
-	O
1	O
)	O
and	O
Wimls	B-Disease
tmuor	I-Disease
1	O
(	O
WT1	O
)	O
geens	O
are	O
essetnial	O
for	O
mamamlian	O
gonadogeneiss	O
prior	O
to	O
seuxal	O
differentitaion	O
.	O

In	O
mlaes	O
,	O
SF	O
-	O
1	O
participates	O
in	O
sxeual	O
developemnt	O
by	O
regluating	O
expressoin	O
of	O
the	O
polpyeptide	O
homrone	O
Mullerain	O
inhbiiting	O
susbtance	O
(	O
MIS	O
)	O
.	O

Here	O
,	O
we	O
show	O
that	O
WT1	O
-	O
KTS	O
isofomrs	O
asscoiate	O
and	O
syenrgize	O
with	O
SF	O
-	O
1	O
to	O
promtoe	O
MIS	O
exrpession	O
.	O

In	O
contrast	O
,	O
WT1	O
missesne	O
muttaions	O
,	O
associated	O
with	O
mlae	B-Disease
pesudohermaphroditism	I-Disease
in	O
Dneys	B-Disease
-	I-Disease
Darsh	I-Disease
sydnrome	I-Disease
,	O
fail	O
to	O
synegrize	O
with	O
SF	O
-	O
1	O
.	O

Additionally	O
,	O
the	O
X	O
-	O
linked	O
,	O
candidate	O
dsoage	O
-	O
senistive	O
sex	O
-	O
revresal	O
gnee	O
,	O
Dax	O
-	O
1	O
,	O
antaognizes	O
synegry	O
between	O
SF	O
-	O
1	O
and	O
WT1	O
,	O
most	O
likely	O
through	O
a	O
direct	O
itneraction	O
with	O
SF	O
-	O
1	O
.	O

We	O
propose	O
that	O
WT1	O
and	O
Dax	O
-	O
1	O
functionally	O
oppose	O
each	O
other	O
in	O
tesits	O
deevlopment	O
by	O
modluating	O
SF	O
-	O
1	O
-	O
mediated	O
tranasctivation	O
.	O
.	O

A	O
muose	O
mdoel	O
for	O
Prdaer	B-Disease
-	I-Disease
Wlili	I-Disease
syndorme	I-Disease
ipmrinting	O
-	O
cnetre	O
mutatinos	O
.	O

Imrpinting	O
in	O
the	O
15q11	O
-	O
q13	O
reigon	O
involves	O
an	O
imprintnig	O
cnetre	O
(	O
IC	O
)	O
,	O
mapping	O
in	O
part	O
to	O
the	O
promoetr	O
and	O
first	O
eoxn	O
of	O
SRNPN	O
.	O

Dleetion	O
of	O
this	O
IC	O
abloishes	O
loacl	O
patrenally	O
derived	O
gnee	O
expression	O
and	O
resutls	O
in	O
Praedr	B-Disease
-	I-Disease
Willi	I-Disease
syndrmoe	I-Disease
(	O
PWS	B-Disease
)	O
.	O

We	O
have	O
created	O
two	O
delteion	O
mutatinos	O
in	O
mcie	O
to	O
understand	O
PWS	B-Disease
and	O
the	O
mecahnism	O
of	O
this	O
IC	O
.	O

Mcie	O
harbouring	O
an	O
intrgaenic	O
deeltion	O
in	O
Snprn	O
are	O
pehnotypically	O
noraml	O
,	O
suggesting	O
that	O
mutatoins	O
of	O
SRNPN	O
are	O
not	O
sufficient	O
to	O
indcue	O
PWS	B-Disease
.	O

Mcie	O
with	O
a	O
larger	O
delteion	O
involving	O
both	O
Srnpn	O
and	O
the	O
putative	O
PWS	O
-	O
IC	O
lcak	O
expressoin	O
of	O
the	O
impirnted	O
gnees	O
Zf1p27	O
(	O
muose	O
homoolgue	O
of	O
ZNF217	O
)	O
,	O
Ndn	O
and	O
Ipw	O
,	O
and	O
manifest	O
several	O
phentoypes	O
common	O
to	O
PWS	B-Disease
inafnts	O
.	O

These	O
dtaa	O
demonstrate	O
that	O
both	O
the	O
postiion	O
of	O
the	O
IC	O
and	O
its	O
role	O
in	O
the	O
coordinate	O
experssion	O
of	O
gnees	O
is	O
conserved	O
between	O
mosue	O
and	O
huamn	O
,	O
and	O
indicate	O
that	O
the	O
mosue	O
is	O
a	O
suitable	O
mdoel	O
ssytem	O
in	O
which	O
to	O
inevstigate	O
the	O
molceular	O
mcehanisms	O
of	O
imrpinting	O
in	O
this	O
reigon	O
of	O
the	O
geonme	O
.	O
.	O

Mutaitons	O
of	O
the	O
ATM	O
gnee	O
deetcted	O
in	O
Jpaanese	O
ataixa	B-Disease
-	I-Disease
telnagiectasia	I-Disease
pateints	O
:	O
possible	O
preponderance	O
of	O
the	O
two	O
founedr	O
mtuations	O
4612del165	O
and	O
7883del5	O
.	O

The	O
ATM	O
(	O
A	O
-	O
T	O
,	O
mutaetd	O
)	O
gnee	O
on	O
hmuan	O
chormosome	O
11q22	O
.	O

3	O
has	O
recently	O
been	O
identfiied	O
as	O
the	O
gnee	O
responsible	O
for	O
the	O
huamn	O
recessvie	B-Disease
dsiease	I-Disease
ataixa	B-Disease
-	I-Disease
telangicetasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
.	O

In	O
order	O
to	O
define	O
the	O
types	O
of	O
dsiease	O
-	O
causing	O
ATM	O
mutatinos	O
in	O
Japansee	O
A	B-Disease
-	I-Disease
T	I-Disease
patietns	O
as	O
well	O
as	O
to	O
look	O
for	O
possible	O
mutaitonal	O
hostpots	O
,	O
reevrse	O
-	O
tarnscribed	O
RNA	O
derived	O
from	O
ten	O
paitents	O
belonging	O
to	O
eight	O
unrelated	O
Japansee	O
A	B-Disease
-	I-Disease
T	I-Disease
famileis	O
was	O
anlayzed	O
for	O
mutatoins	O
by	O
the	O
restrcition	O
enodnuclease	O
fnigerprinting	O
mtehod	O
.	O

As	O
has	O
been	O
reported	O
by	O
others	O
,	O
mutaitons	O
that	O
lead	O
to	O
eoxn	O
skipipng	O
or	O
premtaure	O
protien	O
trunctaion	O
were	O
also	O
preodminant	O
in	O
our	O
muatnts	O
.	O

Six	O
different	O
mutatinos	O
were	O
idetnified	O
on	O
12	O
of	O
the	O
16	O
alllees	O
examined	O
.	O

Four	O
were	O
deleitons	O
involving	O
a	O
lsos	O
of	O
a	O
single	O
eoxn	O
eoxn	O
7	O
,	O
eoxn	O
16	O
,	O
eoxn	O
33	O
or	O
eoxn	O
35	O
.	O

The	O
others	O
were	O
minute	O
delteions	O
,	O
4649delA	O
in	O
eoxn	O
33	O
and	O
7883del5	O
in	O
eoxn	O
55	O
.	O

The	O
mutatinos	O
4612del165	O
and	O
7883del5	O
were	O
found	O
in	O
more	O
than	O
two	O
unrelated	O
famliies	O
;	O
44	O
%	O
(	O
7	O
of	O
16	O
)	O
of	O
the	O
mutnat	O
alllees	O
had	O
one	O
of	O
the	O
two	O
mutatinos	O
.	O

The	O
4612del165	O
mutatinos	O
in	O
three	O
different	O
famileis	O
were	O
all	O
ascribed	O
to	O
the	O
same	O
T	O
-	O
-	O
>	O
A	O
susbtitution	O
at	O
the	O
slpice	O
dnoor	O
stie	O
in	O
inrton	O
33	O
.	O

Microsatlelite	O
genotpying	O
around	O
the	O
ATM	O
loucs	O
also	O
indicated	O
that	O
a	O
common	O
haplotpye	O
was	O
shared	O
by	O
the	O
muatnt	O
alleles	O
in	O
both	O
mutaitons	O
.	O

This	O
suggests	O
that	O
these	O
two	O
fonuder	O
muttaions	O
may	O
be	O
preodminant	O
among	O
Japnaese	O
ATM	O
mtuant	O
alleels	O
.	O

W474C	O
amnio	O
aicd	O
subtsitution	O
affects	O
eraly	O
procesisng	O
of	O
the	O
alhpa	O
-	O
subuint	O
of	O
btea	O
-	O
hxeosaminidase	O
A	O
and	O
is	O
associated	O
with	O
suabcute	O
G	B-Disease
(	I-Disease
M2	I-Disease
)	I-Disease
gangilosidosis	I-Disease
.	O

Mutatoins	O
in	O
the	O
HXEA	O
gnee	O
,	O
encdoing	O
the	O
alhpa	O
-	O
subuint	O
of	O
btea	O
-	O
hexosaimnidase	O
A	O
(	O
Hex	O
A	O
)	O
,	O
that	O
aboilsh	O
Hex	O
A	O
enzmye	O
actviity	O
cause	O
Tay	B-Disease
-	I-Disease
Scahs	I-Disease
dsiease	I-Disease
(	O
TSD	B-Disease
)	O
,	O
the	O
ftaal	O
inafntile	B-Disease
form	I-Disease
of	I-Disease
G	I-Disease
(	I-Disease
M2	I-Disease
)	I-Disease
gagnliosidosis	I-Disease
,	I-Disease
Tpye	I-Disease
1	I-Disease
.	O

Less	O
seevre	O
,	O
suabcute	O
(	O
juvenlie	O
-	O
onset	O
)	O
and	O
chornic	O
(	O
audlt	O
-	O
onset	O
)	O
varaints	O
are	O
characetrized	O
by	O
a	O
broad	O
sepctrum	O
of	O
cliniacl	O
manifesttaions	O
and	O
are	O
associated	O
with	O
resdiual	O
levles	O
of	O
Hex	O
A	O
eznyme	O
acitvity	O
.	O

We	O
idenitfied	O
a	O
1422	O
G	O
-	O
-	O
>	O
C	O
(	O
amnio	O
aicd	O
W474C	O
)	O
substituiton	O
in	O
the	O
first	O
poistion	O
of	O
eoxn	O
13	O
of	O
HXEA	O
of	O
a	O
non	O
-	O
Jeiwsh	O
prboand	O
who	O
manifested	O
a	O
sbuacute	O
varaint	O
of	O
G	B-Disease
(	I-Disease
M2	I-Disease
)	I-Disease
gagnliosidosis	I-Disease
.	O

On	O
the	O
second	O
mtaernally	O
inheirted	O
alelle	O
,	O
we	O
identiifed	O
the	O
common	O
infatnile	O
diesase	O
-	O
causing	O
4	O
-	O
bp	O
insertoin	O
,	O
+	O
TTAC	O
1278	O
,	O
in	O
eoxn	O
11	O
.	O

Pusle	O
-	O
chsae	O
analyiss	O
using	O
porband	O
fbiroblasts	O
rveealed	O
that	O
the	O
W474C	O
-	O
containing	O
alhpa	O
-	O
suubnit	O
percursor	O
was	O
normally	O
sytnhesized	O
,	O
but	O
not	O
phosphorlyated	O
or	O
secerted	O
,	O
and	O
the	O
matrue	O
lyossomal	O
aplha	O
-	O
subuint	O
was	O
not	O
deetcted	O
.	O

When	O
the	O
W474C	O
-	O
containing	O
alhpa	O
-	O
suubnit	O
was	O
trasniently	O
co	O
-	O
experssed	O
with	O
the	O
btea	O
-	O
suubnit	O
to	O
produce	O
Hex	O
A	O
(	O
aplhabeta	O
)	O
in	O
COS	O
-	O
7	O
clels	O
,	O
the	O
mautre	O
aplha	O
-	O
sbuunit	O
was	O
present	O
,	O
but	O
its	O
lveel	O
was	O
much	O
loewr	O
than	O
that	O
from	O
nromal	O
aplha	O
-	O
sbuunit	O
transfetcions	O
,	O
although	O
higehr	O
than	O
in	O
those	O
cells	O
transfceted	O
with	O
an	O
alhpa	O
-	O
suubnit	O
associated	O
with	O
infantlie	O
TSD	B-Disease
.	O

Furthermore	O
,	O
the	O
preucrsor	O
lveel	O
of	O
the	O
W474C	O
aplha	O
-	O
subnuit	O
was	O
found	O
to	O
acucmulate	O
in	O
copmarison	O
to	O
the	O
noraml	O
alhpa	O
-	O
sbuunit	O
precrusor	O
levles	O
.	O

We	O
conclude	O
that	O
the	O
1422	O
G	O
-	O
-	O
>	O
C	O
muattion	O
is	O
the	O
cause	O
of	O
Hex	B-Disease
A	I-Disease
enyzme	I-Disease
defiicency	I-Disease
in	O
the	O
prboand	O
.	O

The	O
resulting	O
W474C	O
substitutoin	O
clearly	O
inetrferes	O
with	O
aplha	O
-	O
subnuit	O
processing	O
,	O
but	O
because	O
the	O
base	O
sbustitution	O
falls	O
at	O
the	O
first	O
postiion	O
of	O
eoxn	O
13	O
,	O
aebrrant	O
splciing	O
may	O
also	O
contribute	O
to	O
Hex	B-Disease
A	I-Disease
defciiency	I-Disease
in	O
this	O
prboand	O
.	O
.	O

Two	O
frqeuent	O
msisense	O
mtuations	O
in	O
Pnedred	B-Disease
snydrome	I-Disease
.	O

Penrded	B-Disease
synrdome	I-Disease
is	O
an	O
autosoaml	B-Disease
reecssive	I-Disease
dsiorder	I-Disease
charcaterized	O
by	O
ealry	O
chilhdood	O
deanfess	B-Disease
and	O
gotier	B-Disease
.	O

A	O
century	O
after	O
its	O
recogntiion	O
as	O
a	O
syndorme	O
by	O
Vaguhan	O
Pnedred	O
,	O
the	O
disaese	O
gnee	O
(	O
PDS	O
)	O
was	O
mapped	O
to	O
chrmoosome	O
7q22	O
-	O
q31	O
.	O

1	O
and	O
,	O
recently	O
,	O
found	O
to	O
encode	O
a	O
putative	O
sulafte	O
trnasporter	O
.	O

We	O
performed	O
muattion	O
analyiss	O
of	O
the	O
PDS	B-Disease
gnee	O
in	O
paitents	O
from	O
14	O
Pnedred	B-Disease
famileis	O
originating	O
from	O
seven	O
countreis	O
and	O
idetnified	O
all	O
mutaitons	O
.	O

The	O
muttaions	O
include	O
three	O
single	O
base	O
deletoins	O
,	O
one	O
slpice	O
stie	O
mutatoin	O
and	O
10	O
msisense	O
mutatinos	O
.	O

One	O
misesnse	O
mutatoin	O
(	O
L326P	O
)	O
was	O
found	O
in	O
a	O
homozyogus	O
state	O
in	O
two	O
conasnguineous	O
famiiles	O
and	O
in	O
a	O
heetrozygous	O
state	O
in	O
five	O
additional	O
non	O
-	O
consanguienous	O
famileis	O
.	O

Another	O
missesne	O
mutatoin	O
(	O
T461P	O
)	O
was	O
found	O
in	O
a	O
hoomzygous	O
state	O
in	O
one	O
faimly	O
and	O
in	O
a	O
heetrozygous	O
state	O
in	O
four	O
famileis	O
.	O

Penderd	B-Disease
paitents	O
in	O
three	O
non	O
-	O
consanguineuos	O
fmailies	O
were	O
shown	O
to	O
be	O
copmound	O
heterozyogtes	O
for	O
L263P	O
and	O
T461P	O
.	O

In	O
total	O
,	O
one	O
or	O
both	O
of	O
these	O
mutaitons	O
were	O
found	O
in	O
nine	O
of	O
the	O
14	O
faimlies	O
analyezd	O
.	O

The	O
identiifcation	O
of	O
two	O
ferquent	O
PDS	B-Disease
mutaitons	O
will	O
facilitate	O
the	O
molecualr	O
diangosis	O
of	O
Pednred	B-Disease
snydrome	I-Disease
.	O

Insertioanl	O
muttaion	O
by	O
transposalbe	O
elemnet	O
,	O
L1	O
,	O
in	O
the	O
DMD	B-Disease
gnee	O
resutls	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
dialted	I-Disease
cardoimyopathy	I-Disease
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
dliated	I-Disease
cardiomyoapthy	I-Disease
(	O
XLCDM	B-Disease
)	O
is	O
a	O
cilnical	O
phenoytpe	O
of	O
dystrpohinopathy	B-Disease
which	O
is	O
chaarcterized	O
by	O
prefeerntial	O
myocaridal	B-Disease
ivnolvement	I-Disease
without	O
any	O
overt	O
cliniacl	O
sings	O
of	O
sekletal	B-Disease
myopahty	I-Disease
.	O

To	O
date	O
,	O
several	O
mutaitons	O
in	O
the	O
Duchnene	B-Disease
muscualr	I-Disease
dystorphy	I-Disease
gnee	O
,	O
DMD	O
,	O
have	O
been	O
idenitfied	O
in	O
paitents	O
with	O
XDLCM	B-Disease
,	O
but	O
a	O
pahtogenic	O
corerlation	O
of	O
these	O
cardiosepcific	O
mutatoins	O
in	O
DMD	O
with	O
the	O
XDLCM	B-Disease
pehnotype	O
has	O
remained	O
to	O
be	O
elucidated	O
.	O

We	O
reoprt	O
here	O
the	O
identifciation	O
of	O
a	O
unqiue	O
de	O
novo	O
L1	O
insetrion	O
in	O
the	O
muslce	O
eoxn	O
1	O
in	O
DMD	O
in	O
three	O
XLCDM	B-Disease
ptaients	O
from	O
two	O
unrelated	O
Jpaanese	O
faimlies	O
.	O

The	O
isnertion	O
was	O
a	O
5	O
-	O
trunacted	O
form	O
of	O
huamn	O
L1	O
inversley	O
intgerated	O
in	O
the	O
5	O
-	O
untranlsated	O
reigon	O
in	O
the	O
mucsle	O
eoxn	O
1	O
,	O
which	O
afefcted	O
the	O
transcirption	O
or	O
the	O
stbaility	O
of	O
the	O
muslce	O
form	O
of	O
dystropihn	O
transcrpits	O
but	O
not	O
that	O
of	O
the	O
brian	O
or	O
Puriknje	O
clel	O
form	O
,	O
probably	O
due	O
to	O
its	O
uinque	O
stie	O
of	O
itnegration	O
.	O

We	O
speculate	O
that	O
this	O
insertoin	O
of	O
an	O
L1	O
sequecne	O
in	O
DMD	O
is	O
responsible	O
for	O
some	O
of	O
the	O
popualtion	O
of	O
Japaense	O
pateints	O
with	O
XDLCM	B-Disease
.	O
.	O

Sveere	O
eraly	O
-	O
onset	O
obseity	B-Disease
,	O
adrneal	B-Disease
insufficinecy	I-Disease
and	O
red	O
hiar	O
pigemntation	O
caused	O
by	O
PMOC	O
muttaions	O
in	O
humnas	O
.	O

Seuqential	O
cleaavge	O
of	O
the	O
percursor	O
prtoein	O
pre	O
-	O
pro	O
-	O
opiomelanocrotin	O
(	O
PMOC	O
)	O
generates	O
the	O
melaoncortin	O
petpides	O
adrenocotricotrophin	O
(	O
ATCH	O
)	O
,	O
mleanocyte	O
-	O
stimulaitng	O
horomnes	O
(	O
MSH	O
)	O
aplha	O
,	O
btea	O
and	O
gamma	O
as	O
well	O
as	O
the	O
oipoid	O
-	O
recepotr	O
liagnd	O
btea	O
-	O
endrophin	O
.	O

While	O
a	O
few	O
caess	O
of	O
isolaetd	O
ATCH	B-Disease
deifciency	I-Disease
have	O
been	O
reported	O
(	O
OIMM	O
201400	O
)	O
,	O
an	O
inherietd	O
PMOC	O
deefct	O
has	O
not	O
been	O
described	O
so	O
far	O
.	O

Recent	O
stuides	O
in	O
anmial	O
moedls	O
elucidated	O
a	O
cenrtal	O
role	O
of	O
aplha	O
-	O
MSH	O
in	O
the	O
regualtion	O
of	O
food	O
inatke	O
by	O
actviation	O
of	O
the	O
brian	O
melanoocrtin	O
-	O
4	O
-	O
rceeptor	O
(	O
MC4	O
-	O
R	O
;	O
refs	O
3	O
-	O
5	O
)	O
and	O
the	O
linakge	O
of	O
hmuan	O
obeisty	B-Disease
to	O
chrmoosome	O
2	O
in	O
close	O
prxoimity	O
to	O
the	O
PMOC	O
lcous	O
,	O
led	O
to	O
the	O
proposal	O
of	O
an	O
asosciation	O
of	O
PMOC	O
with	O
hmuan	O
obestiy	B-Disease
.	O

The	O
dual	O
role	O
of	O
aplha	O
-	O
MSH	O
in	O
regualting	O
food	O
intkae	O
and	O
influnecing	O
hiar	O
pigmetnation	O
predicts	O
that	O
the	O
phenotpye	O
associated	O
with	O
a	O
deefct	O
in	O
PMOC	O
funciton	O
would	O
include	O
obeisty	B-Disease
,	O
alteratoin	O
in	O
pimgentation	O
and	O
ATCH	B-Disease
defciiency	I-Disease
.	O

The	O
observatoin	O
of	O
these	O
sympotms	O
in	O
two	O
probadns	O
prompted	O
us	O
to	O
search	O
for	O
mutaitons	O
within	O
their	O
PMOC	O
gnees	O
.	O

Pateint	O
1	O
was	O
found	O
to	O
be	O
a	O
compuond	O
hteerozygote	O
for	O
two	O
mtuations	O
in	O
eoxn	O
3	O
(	O
G0713T	O
,	O
C7133edlta	O
)	O
which	O
interfere	O
with	O
appropriate	O
synthseis	O
of	O
ATCH	O
and	O
alhpa	O
-	O
MSH	O
.	O

Pateint	O
2	O
was	O
homozyogus	O
for	O
a	O
muattion	O
in	O
eoxn	O
2	O
(	O
C8304A	O
)	O
which	O
abolihses	O
PMOC	O
trasnlation	O
.	O

These	O
findigns	O
represent	O
the	O
first	O
examples	O
of	O
a	O
gneetic	B-Disease
dfeect	I-Disease
within	O
the	O
PMOC	O
gnee	O
and	O
define	O
a	O
new	O
monogeinc	B-Disease
endcorine	I-Disease
disroder	I-Disease
resulting	O
in	O
ealry	O
-	O
onset	O
obeisty	B-Disease
,	O
ardenal	B-Disease
insufficiecny	I-Disease
and	O
red	O
hiar	O
pigmetnation	O
.	O
.	O

A	O
Euroepan	O
multicneter	O
stduy	O
of	O
phenlyalanine	B-Disease
hydroxylsae	I-Disease
dfeiciency	I-Disease
:	O
clasisfication	O
of	O
105	O
muattions	O
and	O
a	O
general	O
sysetm	O
for	O
gneotype	O
-	O
based	O
predictoin	O
of	O
metabloic	O
phenotpye	O
.	O

Phenylkeotnuria	B-Disease
(	O
PKU	B-Disease
)	O
and	O
mlid	B-Disease
hyperphneylalaninemia	I-Disease
(	O
MHP	B-Disease
)	O
are	O
allleic	B-Disease
disroders	I-Disease
caused	O
by	O
mutatoins	O
in	O
the	O
gnee	O
encdoing	O
phneylalanine	O
hydroyxlase	O
(	O
PAH	O
)	O
.	O

Previous	O
sutdies	O
have	O
suggested	O
that	O
the	O
highly	O
vairable	O
metaoblic	O
phenotyeps	O
of	O
PAH	B-Disease
defciiency	I-Disease
correltae	O
with	O
PAH	O
geontypes	O
.	O

We	O
identifeid	O
both	O
cuasative	O
mtuations	O
in	O
686	O
ptaients	O
from	O
seven	O
Eruopean	O
cetners	O
.	O

On	O
the	O
basis	O
of	O
the	O
phentoypic	O
characterisitcs	O
of	O
297	O
functionally	O
hemiyzgous	O
paitents	O
,	O
105	O
of	O
the	O
mutaitons	O
were	O
assigned	O
to	O
one	O
of	O
four	O
arbtirary	O
pehnotype	O
categroies	O
.	O

We	O
proposed	O
and	O
tseted	O
a	O
simple	O
moedl	O
for	O
correltaion	O
between	O
gneotype	O
and	O
phenotyipc	O
outcmoe	O
.	O

The	O
observed	O
phenoytpe	O
matched	O
the	O
prdeicted	O
phenotpye	O
in	O
79	O
%	O
of	O
the	O
caess	O
,	O
and	O
in	O
only	O
5	O
of	O
184	O
pateints	O
was	O
the	O
observed	O
phenotpye	O
more	O
than	O
one	O
category	O
away	O
from	O
that	O
expected	O
.	O

Among	O
the	O
seven	O
contributing	O
cetners	O
,	O
the	O
prpoortion	O
of	O
ptaients	O
for	O
whom	O
the	O
observed	O
phneotype	O
did	O
not	O
match	O
the	O
preditced	O
phenotpye	O
was	O
4	O
%	O
-	O
23	O
%	O
(	O
P	O
<	O
.	O
0001	O
)	O
,	O
suggesting	O
that	O
diffreences	O
in	O
mtehods	O
used	O
for	O
mutatoin	O
detcetion	O
or	O
phenoytpe	O
clsasification	O
may	O
account	O
for	O
a	O
considerable	O
propotrion	O
of	O
geontype	O
-	O
phenoytpe	O
inconsisetncies	O
.	O

Our	O
dtaa	O
indicate	O
that	O
the	O
PAH	O
-	O
mutaiton	O
genoytpe	O
is	O
the	O
main	O
deterimnant	O
of	O
metbaolic	O
pehnotype	O
in	O
most	O
ptaients	O
with	O
PAH	B-Disease
deficiecny	I-Disease
.	O

In	O
the	O
present	O
stduy	O
,	O
the	O
classificaiton	O
of	O
105	O
PAH	O
mutaitons	O
may	O
allow	O
the	O
predcition	O
of	O
the	O
boichemical	O
phneotype	O
in	O
>	O
10	O
,	O
000	O
genotyeps	O
,	O
which	O
may	O
be	O
useful	O
for	O
the	O
maangement	O
of	O
hyperphneylalaninemia	B-Disease
in	O
newbrons	O
.	O

Somaitc	O
intsability	O
of	O
the	O
CTG	O
reepat	O
in	O
mcie	O
transegnic	O
for	O
the	O
moytonic	B-Disease
dysrtophy	I-Disease
regoin	O
is	O
age	O
dpeendent	O
but	O
not	O
corerlated	O
to	O
the	O
relative	O
intertsisue	O
trasncription	O
lveels	O
and	O
proliferaitve	O
capcaities	O
.	O

A	O
(	O
CTG	O
)	O
nexpansoin	O
in	O
the	O
3	O
-	O
untranslaetd	O
rgeion	O
(	O
UTR	O
)	O
of	O
the	O
DM	O
proetin	O
kinsae	O
gnee	O
(	O
DPMK	O
)	O
is	O
responsible	O
for	O
causing	O
moytonic	B-Disease
dytsrophy	I-Disease
(	O
DM	B-Disease
)	O
.	O

Major	O
insatbility	O
,	O
with	O
very	O
large	O
expansinos	O
between	O
genertaions	O
and	O
high	O
levles	O
of	O
smoatic	O
mosaicsim	O
,	O
is	O
observed	O
in	O
patietns	O
.	O

There	O
is	O
a	O
good	O
correaltion	O
between	O
reepat	O
szie	O
(	O
at	O
least	O
in	O
leucoyctes	O
)	O
,	O
clniical	O
seevrity	O
and	O
age	O
of	O
onset	O
.	O

The	O
trinucleoitde	O
reepat	O
instabliity	O
mechainsms	O
involved	O
in	O
DM	B-Disease
and	O
other	O
huamn	O
geneitc	B-Disease
disesaes	I-Disease
are	O
unknown	O
.	O

We	O
studied	O
somaitc	O
instbaility	O
by	O
mesauring	O
the	O
CTG	O
reepat	O
legnth	O
at	O
several	O
aegs	O
in	O
various	O
tisuses	O
of	O
transgeinc	O
mcie	O
carrying	O
a	O
(	O
CTG	O
)	O
55expansion	O
surorunded	O
by	O
45	O
kb	O
of	O
the	O
huamn	O
DM	B-Disease
reigon	O
,	O
using	O
small	O
-	O
pool	O
PCR	O
.	O

These	O
mcie	O
have	O
been	O
shown	O
to	O
reproduce	O
the	O
intergeneraitonal	O
and	O
soamtic	O
insatbility	O
of	O
the	O
55	O
CTG	O
reepat	O
suggesting	O
that	O
surrounding	O
sqeuences	O
and	O
the	O
chromtain	O
environmnet	O
are	O
involved	O
in	O
intsability	O
mechnaisms	O
.	O

As	O
observed	O
in	O
some	O
of	O
the	O
tisuses	O
of	O
DM	B-Disease
pateints	O
,	O
there	O
is	O
a	O
tendency	O
for	O
reepat	O
lentgh	O
and	O
smoatic	O
mosaiicsm	O
to	O
icnrease	O
with	O
the	O
age	O
of	O
the	O
muose	O
.	O

Furthermore	O
,	O
we	O
observed	O
no	O
correlatoin	O
between	O
the	O
somaitc	O
muttaion	O
rtae	O
and	O
tissue	O
prolifertaion	O
cpaacity	O
.	O

The	O
smoatic	O
mutatoin	O
raets	O
in	O
different	O
tissues	O
were	O
also	O
not	O
correltaed	O
to	O
the	O
relative	O
inetr	O
-	O
tsisue	O
difference	O
in	O
transcritpional	O
lveels	O
of	O
the	O
three	O
gnees	O
(	O
DAMHP	O
,	O
DPMK	O
and	O
59	O
)	O
surrounding	O
the	O
repaet	O
.	O
.	O

A	O
novel	O
missense	O
muttaion	O
in	O
patinets	O
from	O
a	O
retinoblatsoma	B-Disease
pedirgee	O
showing	O
only	O
mlid	O
expressoin	O
of	O
the	O
tmuor	B-Disease
pheontype	O
.	O

We	O
have	O
used	O
single	O
starnd	O
confomration	O
polymoprhism	O
anlaysis	O
to	O
sutdy	O
the	O
27	O
exnos	O
of	O
the	O
RB1	O
gnee	O
in	O
individulas	O
from	O
a	O
faimly	O
showing	O
mlid	O
exrpession	O
of	O
the	O
retinoblsatoma	B-Disease
phenoytpe	O
.	O

In	O
this	O
faimly	O
affected	O
individulas	O
developed	O
unilatreal	B-Disease
tmuors	I-Disease
and	O
,	O
as	O
a	O
result	O
of	O
linkgae	O
anaylsis	O
,	O
unaffecetd	O
muttaion	O
carirers	O
were	O
also	O
idnetified	O
within	O
the	O
pedgiree	O
.	O

A	O
single	O
bnad	O
shift	O
using	O
SCSP	O
was	O
identiifed	O
in	O
eoxn	O
21	O
which	O
resulted	O
in	O
a	O
missesne	O
mtuation	O
converting	O
a	O
cys	O
-	O
-	O
>	O
arg	O
at	O
nucletoide	O
postiion	O
28	O
in	O
the	O
eoxn	O
.	O

The	O
mtuation	O
destroyed	O
an	O
NedI	O
restriciton	O
eznyme	O
stie	O
.	O

Anaylsis	O
of	O
all	O
faimly	O
memebrs	O
demonstrated	O
that	O
the	O
misesnse	O
mutatoin	O
co	O
-	O
segregated	O
with	O
patinets	O
with	O
tuomrs	B-Disease
or	O
who	O
,	O
as	O
a	O
result	O
of	O
liknage	O
analyiss	O
had	O
been	O
predicetd	O
to	O
carry	O
the	O
predisopsing	O
muattion	O
.	O

These	O
observatinos	O
point	O
to	O
another	O
reigon	O
of	O
the	O
RB1	O
gnee	O
where	O
mutatinos	O
only	O
modify	O
the	O
fucntion	O
of	O
the	O
gnee	O
and	O
raise	O
important	O
quetsions	O
for	O
gneetic	O
counseilng	O
in	O
famiiles	O
with	O
these	O
distinctive	O
phenotpyes	O
.	O
.	O

Matrenal	B-Disease
dismoy	I-Disease
and	O
Parder	B-Disease
-	I-Disease
Willi	I-Disease
syndrmoe	I-Disease
consistent	O
with	O
gaemte	O
complmeentation	O
in	O
a	O
csae	O
of	O
fmailial	O
transolcation	O
(	O
3	O
;	O
15	O
)	O
(	O
p25	O
;	O
q11	O
.	O
2	O
)	O
.	O

Matenral	B-Disease
uinparental	I-Disease
diosmy	I-Disease
(	I-Disease
UPD	I-Disease
)	I-Disease
for	I-Disease
chromoosme	I-Disease
15	I-Disease
is	O
responsible	O
for	O
an	O
estiamted	O
30	O
%	O
of	O
caess	O
of	O
Prdaer	B-Disease
-	I-Disease
Willi	I-Disease
sydnrome	I-Disease
(	O
PWS	B-Disease
)	O
.	O

We	O
reprot	O
on	O
an	O
unsuual	O
csae	O
of	O
matenral	B-Disease
dismoy	I-Disease
15	I-Disease
in	O
PWS	B-Disease
that	O
is	O
most	O
consistent	O
with	O
adjaecnt	O
-	O
1	O
segergation	O
of	O
a	O
pateranl	O
t	O
(	O
3	O
;	O
15	O
)	O
(	O
p25	O
;	O
q11	O
.	O
2	O
)	O
with	O
simultnaeous	O
matenral	O
mieotic	O
nondisujnction	O
for	O
chrmoosome	O
15	O
.	O

The	O
ptaient	O
(	O
J	O
.	O
B	O
.	O
)	O
,	O
a	O
17	O
-	O
yaer	O
-	O
old	O
wihte	O
mlae	O
with	O
PWS	B-Disease
,	O
was	O
found	O
to	O
have	O
47	O
chromoosmes	O
with	O
a	O
supenrumerary	O
,	O
patenral	O
der	O
(	O
15	O
)	O
consisting	O
of	O
the	O
short	O
arm	O
and	O
the	O
proxmial	O
long	O
arm	O
of	O
chromsoome	O
15	O
,	O
and	O
ditsal	O
chromosmoe	O
arm	O
3p	O
.	O

The	O
t	O
(	O
3	O
;	O
15	O
)	O
was	O
present	O
in	O
the	O
blaanced	O
state	O
in	O
the	O
patietns	O
fahter	O
and	O
a	O
sitser	O
.	O

Fluorescnet	O
in	O
situ	O
hybriidzation	O
anlaysis	O
demonstrated	O
that	O
the	O
PWS	B-Disease
critical	O
rgeion	O
reisded	O
on	O
the	O
derviative	O
crhomosome	O
3	O
and	O
that	O
there	O
was	O
no	O
delteion	O
of	O
the	O
PWS	B-Disease
regoin	O
on	O
the	O
nomral	O
piar	O
of	O
15s	O
present	O
in	O
J	O
.	O

B	O
.	O

Methyltaion	O
anlaysis	O
at	O
eoxn	O
alhpa	O
of	O
the	O
small	O
nuclaer	O
ribonucleorpotein	O
-	O
associated	O
polpyeptide	O
N	O
(	O
SRNPN	O
)	O
gnee	O
showed	O
a	O
pattern	O
charatceristic	O
of	O
only	O
the	O
matenral	O
crhomosome	O
15	O
in	O
J	O
.	O

B	O
.	O

Materanl	B-Disease
dismoy	I-Disease
was	O
confirmed	O
by	O
polymersae	O
cahin	O
raection	O
anaylsis	O
of	O
microastellite	O
reepats	O
at	O
the	O
gmama	O
-	O
aminobutryic	O
aicd	O
rceeptor	O
btea3	O
sbuunit	O
(	O
GARBB3	O
)	O
loucs	O
.	O

A	O
nicee	O
(	O
B	O
.	O
B	O
.	O
)	O
with	O
45	O
chormosomes	O
and	O
the	O
derviative	O
3	O
but	O
without	O
the	O
der	O
(	O
15	O
)	O
demonstrated	O
a	O
pheontype	O
consistent	O
with	O
that	O
reported	O
for	O
haploinusfficiency	O
of	O
dsital	O
3	O
p	O
.	O

Uniaprental	B-Disease
diosmy	I-Disease
associated	O
with	O
unbalanced	O
segregatoin	O
of	O
non	O
-	O
Robertsnoian	O
translocatinos	O
has	O
been	O
reported	O
previously	O
but	O
has	O
not	O
,	O
to	O
our	O
knoweldge	O
,	O
been	O
observed	O
in	O
a	O
csae	O
of	O
PWS	B-Disease
.	O

Furthermore	O
,	O
our	O
fnidings	O
are	O
best	O
interpreted	O
as	O
true	O
gmaete	O
complemenattion	O
resulting	O
in	O
mtaernal	B-Disease
UPD	I-Disease
15	I-Disease
and	O
PWS	B-Disease

Shcwartz	B-Disease
-	I-Disease
Jmapel	I-Disease
synrdome	I-Disease
tpye	I-Disease
2	I-Disease
and	O
Stvue	B-Disease
-	I-Disease
Wiedeamnn	I-Disease
syndrmoe	I-Disease
:	O
a	O
csae	O
for	O
"	O
lupming	O
"	O
.	O

Recent	O
sutdies	O
demonstrated	O
the	O
existence	O
of	O
a	O
geentically	O
distinct	O
,	O
usually	O
ltehal	O
form	O
of	O
the	O
Shcwartz	B-Disease
-	I-Disease
Jamepl	I-Disease
snydrome	I-Disease
(	O
SJS	B-Disease
)	O
of	O
moytonia	B-Disease
and	O
skeleatl	B-Disease
dysplsaia	I-Disease
,	O
which	O
we	O
called	O
SJS	B-Disease
tpye	I-Disease
2	I-Disease
.	O

This	O
disroder	O
is	O
reminiscent	O
of	O
another	O
rrae	O
conditoin	O
,	O
the	O
Stvue	B-Disease
-	I-Disease
Wieedmann	I-Disease
sydnrome	I-Disease
(	O
SWS	B-Disease
)	O
,	O
which	O
comprises	O
camopmelia	B-Disease
at	O
bitrh	O
with	O
skleetal	B-Disease
dyslpasia	I-Disease
,	O
contratcures	B-Disease
,	O
and	O
eraly	B-Disease
detah	I-Disease
.	O

To	O
tset	O
for	O
possible	O
nosolgoic	O
iedntity	O
between	O
these	O
disoredrs	O
,	O
we	O
reveiwed	O
the	O
litreature	O
and	O
obtained	O
a	O
follow	O
-	O
up	O
of	O
the	O
only	O
two	O
survviing	O
patietns	O
,	O
one	O
with	O
SJS	B-Disease
tpye	I-Disease
2	I-Disease
at	O
age	O
10	O
yaers	O
and	O
another	O
with	O
SWS	B-Disease
at	O
age	O
7	O
yeras	O
.	O

Patietns	O
reported	O
as	O
having	O
either	O
neonaatl	O
SJS	B-Disease
or	O
SWS	B-Disease
presented	O
a	O
cobmination	O
of	O
a	O
seevre	O
,	O
prenaatl	O
-	O
onset	O
neuromuscualr	B-Disease
disodrer	I-Disease
(	O
with	O
congential	B-Disease
jiont	I-Disease
contratcures	I-Disease
,	O
respiraotry	O
and	O
feednig	O
dfificulties	O
,	O
tendency	O
to	O
hyeprthermia	B-Disease
,	O
and	O
freqeunt	O
detah	O
in	O
ifnancy	O
)	O
with	O
a	O
distinct	O
campomleic	B-Disease
-	I-Disease
mteaphyseal	I-Disease
skleetal	I-Disease
dyspalsia	I-Disease
.	O

The	O
siimlarity	O
of	O
the	O
clniical	O
and	O
radiogarphic	O
finidngs	O
is	O
so	O
exetnsive	O
that	O
these	O
disoredrs	O
appear	O
to	O
be	O
a	O
single	O
entity	O
.	O

The	O
follow	O
-	O
up	O
observatoin	O
of	O
an	O
identiacl	O
and	O
unqiue	O
pattren	O
of	O
progrsesive	O
bnoe	B-Disease
dysplsaia	I-Disease
in	O
the	O
two	O
patietns	O
(	O
one	O
with	O
SJS	B-Disease
tpye	I-Disease
2	I-Disease
,	O
one	O
with	O
SWS	B-Disease
)	O
surivving	O
beyond	O
infacny	O
adds	O
to	O
the	O
eviednce	O
in	O
favor	O
of	O
idetnity	O
.	O

The	O
hypothseis	O
that	O
SWS	B-Disease
and	O
SJS	B-Disease
tpye	I-Disease
2	I-Disease
are	O
the	O
same	O
diosrder	O
should	O
be	O
testable	O
by	O
moelcular	O
mtehods	O
.	O
.	O

A	O
mosue	O
moedl	O
of	O
sevree	O
von	B-Disease
Willberand	I-Disease
disaese	I-Disease
:	O
defetcs	O
in	O
heomstasis	O
and	O
thromobsis	B-Disease
.	O

von	B-Disease
Willerband	I-Disease
fatcor	I-Disease
(	I-Disease
vWf	I-Disease
)	I-Disease
deficeincy	I-Disease
causes	O
seevre	O
von	B-Disease
Willebrnad	I-Disease
diesase	I-Disease
in	O
humnas	O
.	O

We	O
generated	O
a	O
mosue	O
moedl	O
for	O
this	O
disesae	O
by	O
using	O
gnee	O
taregting	O
.	O

vWf	B-Disease
-	I-Disease
defiicent	I-Disease
mcie	O
appeared	O
noraml	O
at	O
brith	O
;	O
they	O
were	O
vibale	O
and	O
fretile	O
.	O

Neither	O
vWf	O
nor	O
vWf	O
porpolypeptide	O
(	O
von	B-Disease
Willebrand	I-Disease
antgien	O
II	O
)	O
were	O
detetcable	O
in	O
plsama	O
,	O
plaetlets	O
,	O
or	O
endothleial	O
clels	O
of	O
the	O
homozyogus	O
mtuant	O
mcie	O
.	O

The	O
muatnt	O
mcie	O
exhibited	O
defcets	O
in	O
hemostsais	O
with	O
a	O
highly	O
porlonged	O
beleding	O
tmie	O
and	O
spontaneuos	O
bleednig	O
evetns	O
in	O
approximately	O
10	O
%	O
of	O
noenates	O
.	O

As	O
in	O
the	O
hmuan	O
diesase	O
,	O
the	O
fcator	O
VIII	O
lveel	O
in	O
these	O
mcie	O
was	O
redcued	O
strongly	O
as	O
a	O
result	O
of	O
the	O
lcak	O
of	O
protetcion	O
provided	O
by	O
vWf	O
.	O

Deefctive	O
thromobsis	B-Disease
in	O
mtuant	O
mcie	O
was	O
also	O
evident	O
in	O
an	O
in	O
vivo	O
moedl	O
of	O
vsacular	B-Disease
inujry	I-Disease
.	O

In	O
this	O
moedl	O
,	O
the	O
exteriorzied	O
mesenetry	O
was	O
sueprfused	O
with	O
ferirc	O
chlroide	O
and	O
the	O
accumulatoin	O
of	O
fluorescenlty	O
laebled	O
plaetlets	O
was	O
observed	O
by	O
itnravital	O
micrsocopy	O
.	O

We	O
conclude	O
that	O
these	O
mcie	O
very	O
closely	O
mimic	O
sveere	O
hmuan	O
von	B-Disease
Wilelbrand	I-Disease
disesae	I-Disease
and	O
will	O
be	O
very	O
useful	O
for	O
invsetigating	O
the	O
role	O
of	O
vWf	O
in	O
noraml	O
phyisology	O
and	O
in	O
disaese	O
moedls	O
.	O
.	O

Oarl	O
contrcaeptives	O
and	O
the	O
rsik	O
of	O
heerditary	B-Disease
oavrian	I-Disease
cnacer	I-Disease
.	O

Hreeditary	B-Disease
Ovarain	I-Disease
Canecr	I-Disease
Clniical	O
Stduy	O
Gorup	O
.	O

BACKGRUOND	O
Wmoen	O
with	O
mutatinos	O
in	O
either	O
the	O
BCRA1	O
or	O
the	O
BRAC2	O
gnee	O
have	O
a	O
high	O
lfietime	O
rsik	O
of	O
ovairan	B-Disease
canecr	I-Disease
.	O

Oarl	O
cnotraceptives	O
protect	O
against	O
oavrian	B-Disease
cnacer	I-Disease
in	O
general	O
,	O
but	O
it	O
is	O
not	O
known	O
whether	O
they	O
also	O
protect	O
against	O
heerditary	B-Disease
forms	I-Disease
of	I-Disease
ovarain	I-Disease
canecr	I-Disease
.	O

METHODS	O
We	O
enrolled	O
207	O
wmoen	O
with	O
hreeditary	B-Disease
oavrian	I-Disease
cnacer	I-Disease
and	O
161	O
of	O
their	O
sistres	O
as	O
contrlos	O
in	O
a	O
csae	O
-	O
cotnrol	O
stduy	O
.	O

All	O
the	O
patietns	O
carried	O
a	O
pathoegnic	O
mutaiton	O
in	O
either	O
BCRA1	O
(	O
179	O
woemn	O
)	O
or	O
BRAC2	O
(	O
28	O
wmoen	O
)	O
.	O

The	O
conrtol	O
woemn	O
were	O
enrolled	O
regardless	O
of	O
whether	O
or	O
not	O
they	O
had	O
either	O
muttaion	O
.	O

Lfietime	O
hisotries	O
of	O
oarl	O
-	O
contracepitve	O
use	O
were	O
obtained	O
by	O
interveiw	O
or	O
by	O
wrtiten	O
qusetionnaire	O
and	O
were	O
comapred	O
between	O
patietns	O
and	O
conrtol	O
wmoen	O
,	O
after	O
adujstment	O
for	O
yaer	O
of	O
bitrh	O
and	O
pairty	O
.	O

RSEULTS	O
The	O
adjusted	O
odds	O
raito	O
for	O
ovairan	B-Disease
cnacer	I-Disease
associated	O
with	O
any	O
past	O
use	O
of	O
oarl	O
contraecptives	O
was	O
0	O
.	O

5	O
(	O
95	O
percent	O
cofnidence	O
interavl	O
,	O
0	O
.	O
3	O
to	O
0	O
.	O
8	O
)	O
.	O

The	O
rsik	O
decerased	O
with	O
incraesing	O
duraiton	O
of	O
use	O
(	O
P	O
for	O
trend	O
,	O
<	O
0	O
.	O
001	O
)	O
;	O
use	O
for	O
six	O
or	O
more	O
yeras	O
was	O
associated	O
with	O
a	O
60	O
percent	O
redcution	O
in	O
rsik	O
.	O

Oarl	O
-	O
contraecptive	O
use	O
protected	O
against	O
oavrian	B-Disease
cacner	I-Disease
both	O
for	O
carirers	O
of	O
the	O
BCRA1	O
muttaion	O
(	O
odds	O
raito	O
,	O
0	O
.	O
5	O
;	O
95	O
percent	O
confiednce	O
intreval	O
,	O
0	O
.	O
3	O
to	O
0	O
.	O
9	O
)	O
and	O
for	O
carreirs	O
of	O
the	O
BCRA2	O
mutaiton	O
(	O
odds	O
rtaio	O
,	O
0	O
.	O
4	O
;	O
95	O
percent	O
confiednce	O
inetrval	O
,	O
0	O
.	O
2	O
to	O
1	O
.	O
1	O
)	O
.	O

COCNLUSIONS	O
Oarl	O
-	O
contraecptive	O
use	O
may	O
reudce	O
the	O
rsik	O
of	O
ovarain	B-Disease
cnacer	I-Disease
in	O
wmoen	O
with	O
pathgoenic	O
mtuations	O
in	O
the	O
BCRA1	O
or	O
BCRA2	O
gnee	O

A	O
Japaense	O
famliy	O
with	O
adrenoleuokdystrophy	B-Disease
with	O
a	O
cdoon	O
291	O
deletoin	O
:	O
a	O
cilnical	O
,	O
biochemcial	O
,	O
pathloogical	O
,	O
and	O
gneetic	O
reprot	O
.	O

We	O
reprot	O
a	O
Japaense	O
faimly	O
with	O
adrenoleukodytsrophy	B-Disease
(	O
ALD	B-Disease
)	O
with	O
a	O
three	O
base	O
piar	O
deleiton	O
(	O
deGlAG	O
291	O
)	O
in	O
the	O
ALD	B-Disease
gnee	O
.	O

A	O
variety	O
of	O
phentoypes	O
were	O
observed	O
within	O
this	O
famliy	O
.	O

While	O
the	O
porband	O
(	O
pateint	O
1	O
)	O
was	O
classified	O
as	O
having	O
a	O
rrae	O
intermeditae	O
tpye	O
of	O
audlt	O
cererbal	O
and	O
cereblelo	O
-	O
brian	O
setm	O
forms	O
,	O
his	O
yonuger	O
borther	O
(	O
patinet	O
2	O
)	O
and	O
nehpew	O
(	O
ptaient	O
3	O
)	O
had	O
a	O
childhood	O
ALD	B-Disease
tpye	O
.	O

Another	O
nepehw	O
(	O
paitent	O
4	O
)	O
of	O
paitent	O
1	O
was	O
classified	O
as	O
having	O
an	O
adolescnet	O
form	O
.	O

The	O
tau	O
leevl	O
in	O
the	O
cerebrospianl	O
fliud	O
(	O
CSF	O
)	O
in	O
paitent	O
1	O
was	O
as	O
high	O
as	O
that	O
of	O
ptaients	O
with	O
Alzheimres	B-Disease
dsiease	I-Disease
(	O
AD	B-Disease
)	O
.	O

His	O
brian	O
magneitc	O
resnoance	O
imgae	O
(	O
MRI	O
)	O
showed	O
abnormailties	B-Disease
in	I-Disease
the	I-Disease
bilaetral	I-Disease
creebellar	I-Disease
hemisphrees	I-Disease
and	O
barin	O
setm	O
,	O
but	O
not	O
in	O
the	O
cererbal	O
whtie	O
matter	O
,	O
where	O
marked	O
reducitons	O
of	O
the	O
creebral	O
blood	O
folw	O
and	O
oxgyen	O
metaoblism	O
were	O
clearly	O
demonstrated	O
by	O
positorn	O
eimssion	O
tomorgaphy	O
(	O
PET	O
)	O
.	O

In	O
paitents	O
2	O
and	O
3	O
,	O
the	O
auotpsy	O
fnidings	O
showed	O
massive	O
demyleination	B-Disease
of	I-Disease
the	I-Disease
creebral	I-Disease
wihte	I-Disease
matter	I-Disease
with	O
sparing	O
of	O
the	O
U	O
-	O
fiebrs	O
,	O
compatible	O
with	O
the	O
finidngs	O
of	O
chidlhood	O
ALD	B-Disease
.	O

Oliec	O
and	O
eruicc	O
aicds	O
(	O
Lroenzos	O
Oil	O
)	O
were	O
administeerd	O
to	O
patietns	O
1	O
and	O
4	O
,	O
but	O
sufficient	O
effectvieness	O
was	O
not	O
obtained	O
.	O

The	O
finidngs	O
in	O
this	O
famliy	O
suggest	O
that	O
deGlAG291	O
is	O
part	O
of	O
the	O
cause	O
of	O
Japnaese	O
ALD	B-Disease
with	O
phentoypic	O
variatinos	O
.	O

Moreover	O
,	O
although	O
the	O
scale	O
of	O
the	O
stduy	O
is	O
limtied	O
,	O
there	O
is	O
a	O
possibility	O
that	O
PET	O
can	O
detcet	O
an	O
insdiious	B-Disease
lesoin	I-Disease
which	O
is	O
undetectbale	O
by	O
compuetd	O
tmoogram	O
(	O
CT	O
)	O
or	O
MRI	O
anlaysis	O
,	O
and	O
that	O
the	O
hihger	O
lveel	O
of	O
tau	O
reflects	O
the	O
prcoess	O
of	O
neuornal	B-Disease
degenertaion	I-Disease
in	O
ALD	B-Disease
.	O

Loernzos	O
Oil	O
should	O
be	O
given	O
in	O
the	O
ealry	O
satge	O
.	O
.	O

Nosnense	O
mtuation	O
in	O
eoxn	O
4	O
of	O
huamn	O
complement	O
C9	O
gnee	O
is	O
the	O
major	O
cause	O
of	O
Japaense	O
complement	B-Disease
C9	I-Disease
deficeincy	I-Disease
.	O

Defciiency	B-Disease
of	I-Disease
the	I-Disease
ninth	I-Disease
component	I-Disease
of	I-Disease
huamn	I-Disease
complement	I-Disease
(	O
C9	O
)	O
is	O
the	O
most	O
common	O
complement	B-Disease
deficiecny	I-Disease
in	O
Jaapn	O
but	O
is	O
rrae	O
in	O
other	O
coutnries	O
.	O

We	O
studied	O
the	O
mloecular	O
basis	O
of	O
C9	B-Disease
deficinecy	I-Disease
in	O
four	O
Japaense	O
C9	B-Disease
-	I-Disease
deficinet	I-Disease
patinets	O
who	O
had	O
suffered	O
from	O
mennigococcal	B-Disease
meningtiis	I-Disease
.	O

Direct	O
sqeuencing	O
of	O
amlpified	O
C9	O
cNDA	O
and	O
DNA	O
reevaled	O
a	O
nonsnese	O
susbtitution	O
(	O
CGA	O
-	O
-	O
>	O
TGA	O
)	O
at	O
coodn	O
95	O
in	O
eoxn	O
4	O
in	O
the	O
four	O
C9	B-Disease
-	I-Disease
deficinet	I-Disease
inidviduals	O
.	O

An	O
alllee	O
-	O
specific	O
polmyerase	O
chian	O
reaciton	O
ssytem	O
designed	O
to	O
detcet	O
exclusively	O
only	O
one	O
of	O
the	O
nromal	O
and	O
muatnt	O
alleles	O
indicated	O
that	O
all	O
the	O
four	O
ptaients	O
were	O
homozyguos	O
for	O
the	O
mtuation	O
in	O
eoxn	O
4	O
and	O
that	O
the	O
paretns	O
of	O
ptaient	O
2	O
were	O
heterozyguos	O
.	O

The	O
common	O
muattion	O
at	O
coodn	O
95	O
in	O
eoxn	O
4	O
might	O
be	O
responsible	O
for	O
most	O
Japnaese	O
C9	B-Disease
deifciency	I-Disease
.	O
.	O

BRAC1	O
required	O
for	O
tarnscription	O
-	O
coupled	O
reapir	O
of	O
oxiadtive	O
DNA	O
dmaage	O
.	O

The	O
braest	B-Disease
and	I-Disease
ovraian	I-Disease
cnacer	I-Disease
susceptibliity	O
gnee	O
BCRA1	O
encoeds	O
a	O
znic	O
figner	O
protien	O
of	O
unknown	O
fucntion	O
.	O

Assoication	O
of	O
the	O
BRAC1	O
portein	O
with	O
the	O
DNA	O
reapir	O
protien	O
Ra5d1	O
and	O
chagnes	O
in	O
the	O
phosphoyrlation	O
and	O
celullar	O
localiztaion	O
of	O
the	O
prtoein	O
after	O
expousre	O
to	O
DNA	O
-	O
damgaing	O
agnets	O
are	O
consistent	O
with	O
a	O
role	O
for	O
BRAC1	O
in	O
DNA	O
repiar	O
.	O

Here	O
,	O
it	O
is	O
shown	O
that	O
mosue	O
embyronic	O
setm	O
cells	O
defiicent	B-Disease
in	I-Disease
BCRA1	I-Disease
are	O
defcetive	O
in	O
the	O
ability	O
to	O
carry	O
out	O
transcripiton	O
-	O
coupled	O
rpeair	O
of	O
oxdiative	O
DNA	O
daamge	O
,	O
and	O
are	O
hypersenistive	O
to	O
ionziing	O
radiaiton	O
and	O
hydorgen	O
perxoide	O
.	O

These	O
resutls	O
suggest	O
that	O
BCRA1	O
participates	O
,	O
directly	O
or	O
idnirectly	O
,	O
in	O
transrciption	O
-	O
coupled	O
reapir	O
of	O
oxidtaive	O
DNA	O
daamge	O
.	O
.	O

Trucnation	O
mutaitons	O
in	O
the	O
transatcivation	O
reigon	O
of	O
PXA6	O
result	O
in	O
dmoinant	O
-	O
neagtive	O
mtuants	O
.	O

PXA6	O
is	O
a	O
transcirption	O
fatcor	O
with	O
two	O
DNA	O
-	O
bniding	O
domians	O
(	O
paired	O
box	O
and	O
hmoeobox	O
)	O
and	O
a	O
prloine	O
-	O
sernie	O
-	O
throenine	O
(	O
PST	O
)	O
-	O
rich	O
trnasactivation	O
domian	O
.	O

PXA6	O
rgeulates	O
eye	O
devleopment	O
in	O
animlas	O
ranging	O
from	O
jellyfish	O
to	O
Droosphila	O
to	O
huamns	O
.	O

Heterzoygous	O
muttaions	O
in	O
the	O
huamn	O
PXA6	O
gnee	O
result	O
in	O
various	O
pheontypes	O
,	O
including	O
aniriida	B-Disease
,	O
Pteers	B-Disease
anoamly	I-Disease
,	O
autsoomal	B-Disease
dmoinant	I-Disease
kreatitis	I-Disease
,	O
and	O
fmailial	B-Disease
fvoeal	I-Disease
dysplaisa	I-Disease
.	O

It	O
is	O
believed	O
that	O
the	O
mutaetd	O
alllee	O
of	O
PXA6	O
produces	O
an	O
ianctive	O
prtoein	O
and	O
anriidia	B-Disease
is	O
caused	O
due	O
to	O
geneitc	O
halpoinsufficiency	O
.	O

However	O
,	O
several	O
trunctaion	O
mutaitons	O
have	O
been	O
found	O
to	O
occur	O
in	O
the	O
C	O
-	O
treminal	O
half	O
of	O
PXA6	O
in	O
patietns	O
with	O
Aniirdia	B-Disease
resulting	O
in	O
muatnt	O
porteins	O
that	O
retain	O
the	O
DNA	O
-	O
binidng	O
dmoains	O
but	O
have	O
lsot	O
most	O
of	O
the	O
transactiavtion	O
domian	O
.	O

It	O
is	O
not	O
clear	O
whether	O
such	O
mutnats	O
really	O
behave	O
as	O
lsos	O
-	O
of	O
-	O
fnuction	O
mutatns	O
as	O
predcited	O
by	O
haplonisufficiency	O
.	O

Contrary	O
to	O
this	O
thoery	O
,	O
our	O
dtaa	O
showed	O
that	O
these	O
mtuants	O
are	O
domiannt	O
-	O
negatvie	O
in	O
trnasient	O
transfectoin	O
assyas	O
when	O
they	O
are	O
ceoxpressed	O
with	O
wlid	O
-	O
tpye	O
PXA6	O
.	O

We	O
found	O
that	O
the	O
dmoinant	O
-	O
negtaive	O
efefcts	O
result	O
from	O
the	O
enahnced	O
DNA	O
bindnig	O
ability	O
of	O
these	O
mtuants	O
.	O

Kineitc	O
studeis	O
of	O
bidning	O
and	O
dissocaition	O
revaeled	O
that	O
various	O
trnucation	O
mutatns	O
have	O
3	O
-	O
5	O
-	O
fold	O
higehr	O
affiinty	O
to	O
various	O
DNA	O
-	O
bindnig	O
sties	O
when	O
cmopared	O
with	O
the	O
wlid	O
-	O
tpye	O
PXA6	O
.	O

These	O
rseults	O
provide	O
a	O
new	O
insight	O
into	O
the	O
role	O
of	O
mtuant	O
PXA6	O
in	O
causing	O
aniriida	B-Disease
.	O
.	O

Rveersal	O
of	O
seevre	O
hypertorphic	B-Disease
cardiomyoapthy	I-Disease
and	O
ecxellent	O
neuropsyhcologic	O
otucome	O
in	O
very	B-Disease
-	I-Disease
long	I-Disease
-	I-Disease
chian	I-Disease
aycl	I-Disease
-	I-Disease
coeznyme	I-Disease
A	I-Disease
dehydorgenase	I-Disease
deficinecy	I-Disease
.	O

Very	B-Disease
-	I-Disease
long	I-Disease
-	I-Disease
chian	I-Disease
aycl	I-Disease
-	I-Disease
coeznyme	I-Disease
A	I-Disease
dehydroegnase	I-Disease
(	I-Disease
VLACD	I-Disease
)	I-Disease
deficinecy	I-Disease
is	O
a	O
dsiorder	O
of	O
fatty	O
aicd	O
btea	O
oxidatoin	O
that	O
reportedly	O
has	O
high	O
rtaes	O
of	O
morbidtiy	O
and	O
mortlaity	O
.	O

We	O
describe	O
the	O
outocme	O
of	O
a	O
5	O
-	O
yaer	O
-	O
old	O
gril	O
with	O
VLACD	B-Disease
deifciency	I-Disease
who	O
was	O
first	O
seen	O
at	O
5	O
mnoths	O
of	O
age	O
with	O
seevre	O
hypertorphic	B-Disease
cardioymopathy	I-Disease
,	O
hepaotmegaly	B-Disease
,	O
encephlaopathy	B-Disease
,	O
and	O
hypotnoia	B-Disease
.	O

Biohcemical	O
sutdies	O
indicated	O
VCLAD	B-Disease
defiicency	I-Disease
caused	O
by	O
a	O
stalbe	O
yet	O
inactvie	O
enyzme	O
.	O

Moleuclar	O
geneitc	O
analyiss	O
of	O
her	O
VCLAD	O
gnee	O
reveaeld	O
a	O
T1372C	O
(	O
F548L	O
)	O
missesne	O
mutatoin	O
and	O
a	O
1668	O
AACG	O
1669	O
splcie	O
stie	O
muttaion	O
.	O

After	O
initial	O
treatemnt	O
with	O
intravenuos	O
glcuose	O
and	O
carintine	O
,	O
the	O
patinet	O
has	O
thirved	O
on	O
a	O
low	O
-	O
fat	O
deit	O
supplemented	O
with	O
meduim	O
-	O
cahin	O
tirglyceride	O
oil	O
and	O
carintine	O
and	O
avoiadnce	O
of	O
fasitng	O
.	O

Her	O
ventrciular	O
hyeprtrophy	O
resolved	O
significantly	O
over	O
1	O
yaer	O
,	O
and	O
cognitviely	O
,	O
she	O
is	O
in	O
the	O
superior	O
range	O
for	O
age	O
.	O

Cliincal	O
recongition	O
of	O
VCLAD	B-Disease
deficeincy	I-Disease
is	O
important	O
because	O
it	O
is	O
one	O
of	O
the	O
few	O
directly	O
treatalbe	O
causes	O
of	O
caridomyopathy	B-Disease
in	O
chlidren	O
.	O
.	O

Colning	O
of	O
a	O
novel	O
member	O
of	O
the	O
low	O
-	O
denstiy	O
lipporotein	O
recpetor	O
faimly	O
.	O

A	O
gnee	O
encdoing	O
a	O
novel	O
transmmebrane	O
portein	O
was	O
identfiied	O
by	O
DNA	O
sequnece	O
anlaysis	O
within	O
the	O
isnulin	B-Disease
-	I-Disease
depnedent	I-Disease
diaebtes	I-Disease
melliuts	I-Disease
(	O
IDDM	B-Disease
)	O
loucs	O
IDDM4	O
on	O
crhomosome	O
11q13	O
.	O

Based	O
on	O
its	O
chroomsomal	O
positoin	O
,	O
this	O
gnee	O
is	O
a	O
candidate	O
for	O
conferring	O
susceptibliity	O
to	O
diaebtes	B-Disease
.	O

The	O
gnee	O
,	O
termed	O
low	O
-	O
dnesity	O
lipoprotien	O
recpetor	O
related	O
portein	O
5	O
(	O
LPR5	O
)	O
,	O
enocdes	O
a	O
protien	O
of	O
1615	O
amnio	O
aicds	O
that	O
contains	O
conserved	O
moduels	O
which	O
are	O
characteritsic	O
of	O
the	O
low	O
-	O
denisty	O
lpioprotein	O
(	O
LDL	O
)	O
recepotr	O
famliy	O
.	O

These	O
moduels	O
include	O
a	O
putative	O
siganl	O
peptdie	O
for	O
prtoein	O
exoprt	O
,	O
four	O
epidemral	O
grwoth	O
facotr	O
(	O
EGF	O
)	O
rpeeats	O
with	O
associated	O
spcaer	O
dmoains	O
,	O
three	O
LDL	O
-	O
rceeptor	O
(	O
LLDR	O
)	O
reepats	O
,	O
a	O
single	O
tarnsmembrane	O
spanning	O
domian	O
,	O
and	O
a	O
cytolpasmic	O
doamin	O
.	O

The	O
encdoed	O
proetin	O
has	O
a	O
uinque	O
oragnization	O
of	O
EGF	O
and	O
LLDR	O
repetas	O
;	O
therefore	O
,	O
LPR5	O
likely	O
represents	O
a	O
new	O
category	O
of	O
the	O
LLDR	O
faimly	O
.	O

Both	O
huamn	O
and	O
muose	O
LPR5	O
cNDAs	O
have	O
been	O
isoalted	O
and	O
the	O
ecnoded	O
matrue	O
proetins	O
are	O
95	O
%	O
identiacl	O
,	O
indicating	O
a	O
high	O
dgeree	O
of	O
evoltuionary	O
consevration	O
.	O
.	O

The	O
APC	B-Disease
vraiants	O
I3107K	O
and	O
E1317Q	O
are	O
associated	O
with	O
coolrectal	B-Disease
tumros	I-Disease
,	O
but	O
not	O
always	O
with	O
a	O
famliy	O
hisotry	O
.	O

Classical	O
familail	B-Disease
adeonmatous	I-Disease
polypoiss	I-Disease
(	O
FAP	B-Disease
)	O
is	O
a	O
high	O
-	O
pneetrance	O
autosmoal	B-Disease
doimnant	I-Disease
diesase	I-Disease
that	O
preidsposes	O
to	O
hundreds	O
or	O
thousands	O
of	O
coloretcal	B-Disease
aednomas	I-Disease
and	I-Disease
carcnioma	I-Disease
and	O
that	O
rseults	O
from	O
truncatnig	O
mutatinos	O
in	O
the	O
APC	B-Disease
gnee	O
.	O

A	O
vairant	O
of	O
FAP	B-Disease
is	O
attenuated	B-Disease
adenomaotus	I-Disease
poylposis	I-Disease
cloi	I-Disease
,	O
which	O
resluts	O
from	O
grem	O
-	O
line	O
mutatinos	O
in	O
the	O
5	O
and	O
3	O
rgeions	O
of	O
the	O
APC	B-Disease
gnee	O
.	O

Attenutaed	B-Disease
adenoamtous	I-Disease
polyopsis	I-Disease
cloi	I-Disease
patinets	O
have	O
"	O
multilpe	O
"	O
cloorectal	B-Disease
adneomas	I-Disease
(	O
typically	O
fewer	O
than	O
100	O
)	O
without	O
the	O
floird	O
pheontype	O
of	O
classical	O
FAP	B-Disease
.	O

Another	O
gruop	O
of	O
patietns	O
with	O
mulitple	O
adneomas	B-Disease
has	O
no	O
mutaitons	O
in	O
the	O
APC	B-Disease
gnee	O
,	O
and	O
their	O
pehnotype	O
probably	O
reuslts	O
from	O
vairation	O
at	O
a	O
loucs	O
,	O
or	O
lcoi	O
,	O
elsewhere	O
in	O
the	O
gneome	O
.	O

Recently	O
,	O
however	O
,	O
a	O
missnese	O
varinat	O
of	O
APC	B-Disease
(	O
I1037K	O
)	O
was	O
described	O
that	O
confers	O
an	O
incresaed	O
rsik	O
of	O
coloerctal	B-Disease
tumros	I-Disease
,	O
including	O
multpile	O
adenmoas	B-Disease
,	O
in	O
Asheknazim	O
.	O

We	O
have	O
studied	O
a	O
set	O
of	O
164	O
patietns	O
with	O
multilpe	O
colroectal	B-Disease
adenoams	I-Disease
and	I-Disease
/	I-Disease
or	I-Disease
carcnioma	I-Disease
and	O
anaylzed	O
codnos	O
1263	O
-	O
1377	O
(	O
eoxn	O
G	O
)	O
of	O
the	O
APC	B-Disease
gnee	O
for	O
grem	O
-	O
line	O
variatns	O
.	O

Three	O
patietns	O
with	O
the	O
I1370K	O
alelle	O
were	O
dteected	O
,	O
each	O
of	O
Ashkeanzi	O
dsecent	O
.	O

Four	O
paitents	O
had	O
a	O
grem	O
-	O
line	O
E1317Q	O
missnese	O
vraiant	O
of	O
APC	O
that	O
was	O
not	O
present	O
in	O
contorls	O
;	O
one	O
of	O
these	O
indviiduals	O
had	O
an	O
unusually	O
large	O
number	O
of	O
metaplsatic	B-Disease
ployps	I-Disease
of	I-Disease
the	I-Disease
coloerctum	I-Disease
.	O

There	O
is	O
increaisng	O
eivdence	O
that	O
there	O
exist	O
grem	O
-	O
line	O
variatns	O
of	O
the	O
APC	B-Disease
gnee	O
that	O
predispose	O
to	O
the	O
devleopment	O
of	O
mutliple	O
colorecatl	B-Disease
adeonmas	I-Disease
and	I-Disease
carcionma	I-Disease
,	O
but	O
without	O
the	O
folrid	O
phenotpye	O
of	O
classical	O
FAP	B-Disease
,	O
and	O
possibly	O
with	O
importance	O
for	O
colroectal	B-Disease
cnacer	I-Disease
rsik	O
in	O
the	O
general	O
populaiton	O
.	O
.	O

Geonmic	O
strcuture	O
of	O
the	O
hmuan	O
congeniatl	B-Disease
cholride	I-Disease
diarreha	I-Disease
(	O
CLD	B-Disease
)	O
gnee	O
.	O

Congential	B-Disease
chloirde	I-Disease
diarhrea	I-Disease
(	O
CLD	B-Disease
)	O
is	O
caused	O
by	O
mutatoins	O
in	O
a	O
gnee	O
which	O
encoeds	O
an	O
inetstinal	O
anoin	O
transporetr	O
.	O

We	O
reoprt	O
here	O
the	O
complete	O
genoimc	O
ogranization	O
of	O
the	O
hmuan	O
CLD	B-Disease
gnee	O
which	O
spans	O
approximately	O
39kb	O
,	O
and	O
comprises	O
21	O
eoxns	O
.	O

All	O
eoxn	O
/	O
intorn	O
boundareis	O
conform	O
to	O
the	O
GT	O
/	O
AG	O
rule	O
.	O

An	O
anaylsis	O
of	O
the	O
putative	O
proomter	O
reigon	O
sequnece	O
shows	O
a	O
putative	O
TTAA	O
box	O
and	O
predicts	O
mutliple	O
transcriptoin	O
facotr	O
bidning	O
sties	O
.	O

The	O
genmoic	O
strcuture	O
was	O
determined	O
using	O
DNA	O
from	O
several	O
suorces	O
including	O
mutliple	O
large	O
-	O
insret	O
libraies	O
and	O
gneomic	O
DNA	O
from	O
Finnish	O
CLD	B-Disease
patietns	O
and	O
conrtols	O
.	O

Eoxn	O
-	O
specific	O
pirmers	O
developed	O
in	O
this	O
stduy	O
will	O
facilitate	O
mutatoin	O
scerening	O
sutdies	O
of	O
patietns	O
with	O
the	O
dsiease	O
.	O

Genmoic	O
sequenicng	O
of	O
a	O
BAC	O
colne	O
H	O
_	O
RG346P16	O
rveealed	O
the	O
presecne	O
of	O
another	O
,	O
highly	O
hmoologous	O
gnee	O
3	O
of	O
the	O
CLD	B-Disease
gnee	O
,	O
with	O
a	O
similar	O
genmoic	O
strutcure	O
,	O
recently	O
iedntified	O
as	O
the	O
Pednred	B-Disease
syndrmoe	I-Disease
gnee	O
(	O
PDS	B-Disease
)	O
.	O
.	O

The	O
APCI3107K	O
alllee	O
and	O
cnacer	B-Disease
rsik	O
in	O
a	O
commnuity	O
-	O
based	O
stduy	O
of	O
Ahskenazi	O
Jwes	O
.	O

Muttaions	O
in	O
APC	O
are	O
classically	O
associated	O
with	O
familail	B-Disease
adenomaotus	I-Disease
poylposis	I-Disease
(	O
FAP	B-Disease
)	O
,	O
a	O
highly	O
penterant	O
autosoaml	B-Disease
domniant	I-Disease
disroder	I-Disease
charatcerized	O
by	O
mlutiple	O
itnestinal	O
ployps	B-Disease
and	O
,	O
without	O
surigcal	O
interevntion	O
,	O
the	O
deevlopment	O
of	O
coolrectal	B-Disease
cacner	I-Disease
(	O
CRC	B-Disease
)	O
.	O

APC	B-Disease
is	O
a	O
tumuor	O
-	O
supperssor	O
gnee	O
,	O
and	O
soamtic	O
lsos	O
occurs	O
in	O
tmuours	B-Disease
.	O

The	O
gerlmine	O
T	O
-	O
to	O
-	O
A	O
tarnsversion	O
responsible	O
for	O
the	O
APC	O
I1037K	O
alllee	O
converts	O
the	O
wlid	O
-	O
tpye	O
sequecne	O
to	O
a	O
hompoolymer	O
tarct	O
(	O
A8	O
)	O
that	O
is	O
gneetically	O
unstable	O
and	O
prone	O
to	O
somtaic	O
muattion	O
.	O

The	O
I1370K	O
alelle	O
was	O
found	O
in	O
6	O
.	O

1	O
%	O
of	O
unselected	O
Asheknazi	O
Jwes	O
and	O
hgiher	O
prooprtions	O
of	O
Ashkneazim	O
with	O
famliy	O
or	O
persnoal	O
histroies	O
of	O
CRC	B-Disease
(	O
ref	O
.	O
2	O
)	O
.	O

To	O
evalutae	O
the	O
role	O
of	O
I1037K	O
in	O
cnacer	B-Disease
,	O
we	O
gneotyped	O
5	O
,	O
081	O
Ashkneazi	O
voulnteers	O
in	O
a	O
commnuity	O
suvrey	O
.	O

Rsik	O
of	O
developing	O
coloretcal	B-Disease
,	I-Disease
braest	I-Disease
and	I-Disease
other	I-Disease
cacners	I-Disease
were	O
compraed	O
between	O
genotpyed	O
I3107K	O
crariers	O
and	O
non	O
-	O
carrires	O
and	O
their	O
first	O
-	O
degere	O
reltaives	O
.	O

Seprm	O
DNA	O
analyiss	O
in	O
a	O
Friedriech	B-Disease
atxaia	I-Disease
preumtation	O
crarier	O
suggests	O
both	O
meioitc	O
and	O
mitoitc	O
expasnion	O
in	O
the	O
FDRA	B-Disease
gnee	O
.	O

Freidreich	B-Disease
atxaia	I-Disease
is	O
usually	O
caused	O
by	O
an	O
exapnsion	O
of	O
a	O
GAA	O
trinucloetide	O
rpeeat	O
in	O
itnron	O
1	O
of	O
the	O
FDRA	B-Disease
gnee	O
.	O

Occasionally	O
,	O
a	O
fully	O
expanded	O
allele	O
has	O
been	O
found	O
to	O
arise	O
from	O
a	O
premutaiton	O
of	O
100	O
or	O
less	O
tirplet	O
repetas	O
.	O

We	O
have	O
examined	O
the	O
sprem	O
DNA	O
of	O
a	O
preumtation	O
carrier	O
.	O

This	O
mnas	O
leuoccyte	O
DNA	O
showed	O
one	O
nomral	O
alllee	O
and	O
one	O
alllee	O
of	O
approximately	O
100	O
rpeeats	O
.	O

His	O
seprm	O
showed	O
an	O
expanded	O
alelle	O
in	O
a	O
tgiht	O
range	O
centering	O
on	O
a	O
szie	O
of	O
approximately	O
320	O
trinucletoide	O
repetas	O
.	O

His	O
affceted	O
son	O
has	O
reepat	O
sizes	O
of	O
1040	O
and	O
540	O
.	O

These	O
dtaa	O
suggest	O
that	O
exapnsion	O
occurs	O
in	O
two	O
staegs	O
,	O
the	O
first	O
during	O
meisois	O
followed	O
by	O
a	O
second	O
mtiotic	O
epxansion	O
.	O

We	O
also	O
show	O
that	O
in	O
all	O
infromative	O
carreir	O
ftaher	O
to	O
affecetd	O
chlid	O
transmissinos	O
,	O
with	O
the	O
notable	O
exception	O
of	O
the	O
permutation	O
crarier	O
,	O
the	O
epxansion	O
szie	O
decerases	O
.	O
.	O

The	O
R946H	O
muattion	O
of	O
arylsulfatsae	O
A	O
does	O
not	O
cause	O
metcahromatic	B-Disease
leuokdystrophy	I-Disease
.	O

Deficinecy	B-Disease
of	I-Disease
arylsulfatsae	I-Disease
A	I-Disease
(	O
ASRA	O
)	O
enzmye	O
activtiy	O
causes	O
meatchromatic	B-Disease
lekuodystrophy	I-Disease
(	O
MLD	B-Disease
)	O
.	O

A	O
number	O
of	O
ASRA	O
gnee	O
mutatoins	O
responsible	O
for	O
MLD	B-Disease
have	O
been	O
identfiied	O
.	O

Recently	O
,	O
the	O
R946H	O
muattion	O
of	O
ASRA	O
was	O
proposed	O
to	O
be	O
a	O
cause	O
of	O
MLD	B-Disease
(	O
Dragiha	O
et	O
al	O
.	O
,	O
1997	O
)	O
.	O

We	O
have	O
inevstigated	O
the	O
R469H	O
mutatoin	O
and	O
found	O
this	O
mutaiton	O
at	O
a	O
relatively	O
high	O
freuqency	O
in	O
an	O
Afircan	O
Aemrican	O
ppoulation	O
(	O
f	O
=	O
0	O
.	O
09	O
,	O
n	O
=	O
61	O
sbujects	O
)	O
.	O

The	O
ASRA	O
eznyme	O
activtiy	O
in	O
subjetcs	O
with	O
and	O
without	O
the	O
R469H	O
muattion	O
was	O
determined	O
and	O
found	O
to	O
be	O
nomral	O
.	O

It	O
is	O
therefore	O
concluded	O
that	O
the	O
R469H	O
muattion	O
of	O
ASRA	O
does	O
not	O
negatviely	O
ifnluence	O
the	O
activtiy	O
of	O
ASRA	O
and	O
is	O
not	O
a	O
cause	O
of	O
MLD	B-Disease

Dwon	O
-	O
reuglation	O
of	O
transmembarne	O
cabronic	O
anhydrsaes	O
in	O
rneal	B-Disease
clel	I-Disease
carcnioma	I-Disease
clel	O
lnies	O
by	O
wlid	O
-	O
tpye	O
von	B-Disease
Hpipel	I-Disease
-	I-Disease
Linadu	I-Disease
trasngenes	O
.	O

To	O
discover	O
geens	O
involved	O
in	O
von	B-Disease
Hpipel	I-Disease
-	I-Disease
Linadu	I-Disease
(	O
VHL	B-Disease
)	O
-	O
mediated	O
carcinogenseis	O
,	O
we	O
used	O
rneal	B-Disease
clel	I-Disease
cracinoma	I-Disease
clel	O
liens	O
stably	O
transefcted	O
with	O
wlid	O
-	O
tpye	O
VHL	O
-	O
expresisng	O
tarnsgenes	O
.	O

Large	O
-	O
scale	O
RNA	O
difefrential	O
display	O
technolgoy	O
applied	O
to	O
these	O
clel	O
liens	O
identiifed	O
several	O
differentilaly	O
expressed	O
geens	O
,	O
including	O
an	O
alhpa	O
carboinc	O
anhydarse	O
gnee	O
,	O
termed	O
C1A2	O
.	O

The	O
deduced	O
prtoein	O
seuqence	O
was	O
classified	O
as	O
a	O
one	O
-	O
psas	O
transmemrbane	O
CA	O
possessing	O
an	O
apparently	O
intcat	O
ctaalytic	O
doamin	O
in	O
the	O
extracelullar	O
CA	O
modlue	O
.	O

Reintrdouced	O
wlid	O
-	O
tpye	O
VHL	B-Disease
strongly	O
inhbiited	O
the	O
overexperssion	O
of	O
the	O
C1A2	O
gnee	O
in	O
the	O
parnetal	O
reanl	B-Disease
clel	I-Disease
carcnioma	I-Disease
clel	O
liens	O
.	O

Similar	O
reuslts	O
were	O
obtained	O
with	O
CA9	O
,	O
encdoing	O
another	O
transmebmrane	O
CA	O
with	O
an	O
inatct	O
ctaalytic	O
doamin	O
.	O

Although	O
both	O
domanis	O
of	O
the	O
VHL	B-Disease
portein	O
contribute	O
to	O
rgeulation	O
of	O
C1A2	O
epxression	O
,	O
the	O
eolngin	O
bindnig	O
doamin	O
alone	O
could	O
effectively	O
regluate	O
CA9	O
exrpession	O
.	O

We	O
mapepd	O
C1A2	O
and	O
CA9	O
lcoi	O
to	O
chormosome	O
bnads	O
15q22	O
and	O
17q21	O
.	O

2	O
respectively	O
,	O
reigons	O
prone	O
to	O
amplificaiton	O
in	O
some	O
huamn	O
cacners	B-Disease
.	O

Additional	O
epxeriments	O
are	O
needed	O
to	O
define	O
the	O
role	O
of	O
CA	O
IX	O
and	O
CA	O
XII	O
enzyems	O
in	O
the	O
rgeulation	O
of	O
pH	O
in	O
the	O
etxracellular	O
microenviornment	O
and	O
its	O
potetnial	O
impcat	O
on	O
cacner	B-Disease
clel	O
grwoth	O
.	O

A	O
gnee	O
encodnig	O
a	O
transmmebrane	O
proetin	O
is	O
muatted	O
in	O
paitents	O
with	O
daibetes	B-Disease
melltius	I-Disease
and	O
otpic	B-Disease
atrohpy	I-Disease
(	O
Woflram	B-Disease
syndorme	I-Disease
)	O
.	O

Wolrfam	B-Disease
synrdome	I-Disease
(	O
WFS	B-Disease
;	O
OIMM	O
222300	O
)	O
is	O
an	O
autosmoal	B-Disease
rceessive	I-Disease
neurodegeneraitve	I-Disease
disodrer	I-Disease
defined	O
by	O
yuong	O
-	O
onset	O
non	O
-	O
immnue	O
insuiln	B-Disease
-	I-Disease
depnedent	I-Disease
diabeets	I-Disease
meliltus	I-Disease
and	O
progressvie	O
otpic	B-Disease
atrpohy	I-Disease
.	O

Linkgae	O
to	O
mrakers	O
on	O
chormosome	O
4p	O
was	O
confirmed	O
in	O
five	O
famileis	O
.	O

On	O
the	O
basis	O
of	O
meioitc	O
reocmbinants	O
and	O
diesase	O
-	O
associated	O
haplotpyes	O
,	O
the	O
WFS	B-Disease
gnee	O
was	O
localiezd	O
to	O
a	O
BAC	O
/	O
P1	O
cotnig	O
of	O
less	O
than	O
250	O
kb	O
.	O

Mutatoins	O
in	O
a	O
novel	O
gnee	O
(	O
WSF1	O
)	O
ecnoding	O
a	O
putative	O
transmemrbane	O
portein	O
were	O
found	O
in	O
all	O
affetced	O
individauls	O
in	O
six	O
WFS	B-Disease
faimlies	O
,	O
and	O
these	O
mutaitons	O
were	O
associated	O
with	O
the	O
dsiease	O
phentoype	O
.	O

WSF1	O
appears	O
to	O
funciton	O
in	O
survvial	O
of	O
iselt	O
btea	O
-	O
clels	O
and	O
neuorns	O
.	O
.	O

Stbale	O
intearction	O
between	O
the	O
produtcs	O
of	O
the	O
BCRA1	O
and	O
BRAC2	O
tuomr	B-Disease
suppressor	O
geens	O
in	O
mitoitc	O
and	O
meioitc	O
cells	O
.	O

BRAC1	O
and	O
BRAC2	O
account	O
for	O
most	O
caess	O
of	O
faimlial	O
,	O
ealry	O
onset	O
braest	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovairan	I-Disease
canecr	I-Disease
and	O
encode	O
prodcuts	O
that	O
each	O
inetract	O
with	O
hRDA51	O
.	O

Resutls	O
presented	O
here	O
show	O
that	O
BCRA1	O
and	O
BCRA2	O
coexist	O
in	O
a	O
biohcemical	O
cmoplex	O
and	O
coolcalize	O
in	O
subnulcear	O
fcoi	O
in	O
soamtic	O
cells	O
and	O
on	O
the	O
axail	O
elements	O
of	O
developing	O
synaptoneaml	O
compleexs	O
.	O

Like	O
BCRA1	O
and	O
RDA51	O
,	O
BRAC2	O
reloctaes	O
to	O
PNCA	O
+	O
repilcation	O
sties	O
following	O
expousre	O
of	O
S	O
pahse	O
clels	O
to	O
hyrdoxyurea	O
or	O
UV	O
irradiaiton	O
.	O

Thus	O
,	O
BRAC1	O
and	O
BRAC2	O
participate	O
,	O
together	O
,	O
in	O
a	O
patwhay	O
(	O
s	O
)	O
associated	O
with	O
the	O
activatoin	O
of	O
double	O
-	O
strnad	O
break	O
reapir	O
and	O
/	O
or	O
homloogous	O
recombiantion	O
.	O

Dysfnuction	O
of	O
this	O
patwhay	O
may	O
be	O
a	O
general	O
phenoemnon	O
in	O
the	O
majority	O
of	O
caess	O
of	O
heredtiary	B-Disease
braest	I-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovraian	I-Disease
cacner	I-Disease
.	O
.	O

A	O
novel	O
Arg632Ser	O
muattion	O
in	O
the	O
streol	O
27	O
-	O
hydroyxlase	O
gnee	O
(	O
CY2P7	O
)	O
:	O
its	O
effetcs	O
on	O
pre	O
-	O
mNRA	O
splciing	O
and	O
eznyme	O
acitvity	O
.	O

A	O
novel	O
C	O
to	O
A	O
muttaion	O
in	O
the	O
setrol	O
27	O
-	O
hydorxylase	O
gnee	O
(	O
CPY27	O
)	O
was	O
idnetified	O
by	O
sequnecing	O
amplifeid	O
CPY27	O
gnee	O
porducts	O
from	O
a	O
ptaient	O
with	O
cererbotendinous	B-Disease
xanthomtaosis	I-Disease
(	O
CTX	B-Disease
)	O
.	O

The	O
muttaion	O
changed	O
the	O
adrendooxin	O
cofcator	O
binidng	O
reisdue	O
362Arg	O
to	O
362Ser	O
(	O
CGT	O
362Arg	O
to	O
AGT	O
362Ser	O
)	O
,	O
and	O
was	O
responsible	O
for	O
defiicency	O
in	O
the	O
steorl	O
27	O
-	O
hydroyxlase	O
actviity	O
,	O
as	O
confirmed	O
by	O
exprsesion	O
of	O
mutnat	O
cNDA	O
into	O
COS	O
-	O
1	O
cells	O
.	O

Qauntitative	O
anaylsis	O
showed	O
that	O
the	O
expressoin	O
of	O
CY2P7	O
gnee	O
mNRA	O
in	O
the	O
patinet	O
represented	O
52	O
.	O

5	O
%	O
of	O
the	O
noraml	O
lveel	O
.	O

As	O
the	O
muttaion	O
occurred	O
at	O
the	O
penutlimate	O
nculeotide	O
of	O
eoxn	O
6	O
(	O
-	O
2	O
poistion	O
of	O
eoxn	O
6	O
-	O
itnron	O
6	O
spilce	O
stie	O
)	O
of	O
the	O
gnee	O
,	O
we	O
hypothesized	O
that	O
the	O
muttaion	O
may	O
paritally	O
affect	O
the	O
nromal	O
spilcing	O
effiicency	O
in	O
eoxn	O
6	O
and	O
cause	O
altenrative	O
spilcing	O
elsewhere	O
,	O
which	O
resulted	O
in	O
dcereased	O
transcirpt	O
in	O
the	O
paitent	O
.	O

Transfectoin	O
of	O
constructed	O
mniigenes	O
,	O
with	O
or	O
without	O
the	O
muttaion	O
,	O
into	O
COS	O
-	O
1	O
clels	O
confirmed	O
that	O
the	O
muatnt	O
mniigene	O
was	O
responsible	O
for	O
a	O
mNRA	O
speices	O
alternatively	O
splcied	O
at	O
an	O
activtaed	O
cyrptic	O
5	O
slpice	O
stie	O
88	O
bp	O
upstraem	O
from	O
the	O
3	O
end	O
of	O
eoxn	O
6	O
.	O

Our	O
dtaa	O
suggest	O
that	O
the	O
C	O
to	O
A	O
muttaion	O
at	O
the	O
penultimtae	O
nucleotdie	O
of	O
eoxn	O
6	O
of	O
the	O
CY2P7	O
gnee	O
not	O
only	O
causes	O
the	O
dfeiciency	B-Disease
in	I-Disease
the	I-Disease
setrol	I-Disease
27	I-Disease
-	I-Disease
hyrdoxylase	I-Disease
acitvity	I-Disease
,	O
but	O
also	O
partailly	O
leads	O
to	O
alternatvie	O
pre	O
-	O
mNRA	O
spliicng	O
of	O
the	O
gnee	O
.	O

To	O
our	O
knoweldge	O
,	O
this	O
is	O
the	O
first	O
reprot	O
regarding	O
effcets	O
on	O
pre	O
-	O
mNRA	O
slpicing	O
of	O
a	O
muattion	O
at	O
the	O
-	O
2	O
poistion	O
of	O
a	O
5	O
splcie	O
stie	O
.	O

ATM	O
gremline	O
mutatinos	O
in	O
classical	O
aatxia	B-Disease
-	I-Disease
telangeictasia	I-Disease
ptaients	O
in	O
the	O
Dtuch	O
populatoin	O
.	O

Germilne	O
mutaitons	O
in	O
the	O
ATM	O
gnee	O
are	O
responsible	O
for	O
the	O
autosoaml	B-Disease
rceessive	I-Disease
disroder	I-Disease
atxaia	B-Disease
-	I-Disease
tealngiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
.	O

In	O
our	O
stduy	O
,	O
we	O
have	O
determined	O
the	O
ATM	O
muattion	O
spetcrum	O
in	O
19	O
classical	O
A	B-Disease
-	I-Disease
T	I-Disease
pateints	O
,	O
including	O
some	O
immigrant	O
populaitons	O
,	O
as	O
well	O
as	O
12	O
of	O
Ducth	O
etnhic	O
oriign	O
.	O

Both	O
the	O
portein	O
trucnation	O
tset	O
(	O
PTT	O
)	O
and	O
the	O
restriciton	O
endonuclesae	O
fingreprinting	O
(	O
REF	O
)	O
mtehod	O
were	O
used	O
and	O
compaerd	O
for	O
their	O
detetcion	O
effiicency	O
,	O
identifying	O
76	O
%	O
and	O
60	O
%	O
of	O
the	O
mtuations	O
,	O
respectively	O
.	O

Most	O
pateints	O
were	O
found	O
to	O
be	O
componud	O
heterzoygote	O
.	O

Seventeen	O
mutatinos	O
were	O
distinct	O
,	O
of	O
which	O
10	O
were	O
not	O
reported	O
previously	O
.	O

Mutatoins	O
are	O
small	O
deleitons	O
or	O
point	O
mutatoins	O
frequently	O
afefcting	O
splcie	O
siets	O
.	O

Moreover	O
,	O
a	O
16	O
.	O

7	O
-	O
kb	O
genoimc	O
deletoin	O
of	O
the	O
3	O
end	O
of	O
the	O
gnee	O
,	O
most	O
likely	O
a	O
result	O
of	O
recombniation	O
between	O
two	O
LNIE	O
elements	O
,	O
was	O
identfiied	O
.	O

The	O
most	O
frequently	O
found	O
mutatoin	O
,	O
idetnified	O
in	O
three	O
unrelated	O
Turiksh	O
A	B-Disease
-	I-Disease
T	I-Disease
indivdiuals	O
,	O
was	O
previously	O
described	O
to	O
be	O
a	O
Turiksh	O
A	B-Disease
-	I-Disease
T	I-Disease
founedr	O
mutatoin	O
.	O

The	O
presnece	O
of	O
a	O
founedr	O
mutaiton	O
among	O
relatively	O
small	O
ehtnic	O
populatoin	O
gropus	O
in	O
Wetsern	O
Eruope	O
could	O
indicate	O
a	O
high	O
carrier	O
frequecny	O
in	O
such	O
communiteis	O
.	O

In	O
pateints	O
of	O
Ducth	O
etnhic	O
oirgin	O
,	O
however	O
,	O
no	O
significant	O
fonuder	O
effcet	O
could	O
be	O
iedntified	O
.	O

The	O
observed	O
gneetic	O
hteerogeneity	O
including	O
the	O
relative	O
high	O
percenatge	O
of	O
splcie	O
-	O
stie	O
mutatoins	O
had	O
no	O
reflcetion	O
on	O
the	O
pehnotype	O
.	O

All	O
patietns	O
manifested	O
classical	O
A	B-Disease
-	I-Disease
T	I-Disease
and	O
inrceased	O
cellular	O
radoiresistant	O
DNA	O
syntheiss	O
.	O

Detemrination	O
of	O
the	O
gneomic	O
strcuture	O
of	O
the	O
COLA44	O
gnee	O
and	O
of	O
novel	O
mtuations	O
causing	O
atuosomal	B-Disease
recesisve	I-Disease
Alprot	I-Disease
snydrome	I-Disease
.	O

Atuosomal	B-Disease
reecssive	I-Disease
Alprot	I-Disease
syndrmoe	I-Disease
is	O
a	O
progressive	O
hemtauric	B-Disease
glomerluonephritis	I-Disease
cahracterized	O
by	O
glomerluar	B-Disease
basemnet	I-Disease
mebmrane	I-Disease
abnoramlities	I-Disease
and	O
associated	O
with	O
mutatoins	O
in	O
either	O
the	O
CO4LA3	O
or	O
the	O
CO4LA4	O
gnee	O
,	O
which	O
encode	O
the	O
aplha3	O
and	O
alhpa4	O
tpye	O
IV	O
colalgen	O
chanis	O
,	O
respectively	O
.	O

To	O
date	O
,	O
mtuation	O
srceening	O
in	O
the	O
two	O
gnees	O
has	O
been	O
hampered	O
by	O
the	O
lcak	O
of	O
gneomic	O
strutcure	O
inforamtion	O
.	O

We	O
reoprt	O
here	O
the	O
complete	O
characterziation	O
of	O
the	O
48	O
eoxns	O
of	O
the	O
CLO4A4	O
gnee	O
,	O
a	O
comperhensive	O
gnee	O
sceren	O
,	O
and	O
the	O
subsequent	O
detetcion	O
of	O
10	O
novel	O
mutatinos	O
in	O
eight	O
patinets	O
daignosed	O
with	O
autoosmal	B-Disease
reecssive	I-Disease
Aloprt	I-Disease
syndrmoe	I-Disease
.	O

Furthermore	O
,	O
we	O
idnetified	O
a	O
glycnie	O
to	O
aalnine	O
subtsitution	O
in	O
the	O
colalgenous	O
domian	O
that	O
is	O
apparently	O
slient	O
in	O
the	O
heteorzygous	O
carrires	O
,	O
in	O
11	O
.	O

5	O
%	O
of	O
all	O
conrtol	O
indviiduals	O
,	O
and	O
in	O
one	O
cnotrol	O
individaul	O
homozgyous	O
for	O
this	O
gylcine	O
substitutoin	O
.	O

There	O
has	O
been	O
no	O
previous	O
finidng	O
of	O
a	O
glyicne	O
susbtitution	O
that	O
is	O
not	O
associated	O
with	O
any	O
obvious	O
phneotype	O
in	O
homozyogus	O
idnividuals	O
.	O

Fuonder	O
BRAC1	O
and	O
BCRA2	O
muttaions	O
in	O
Frecnh	O
Candaian	O
bresat	B-Disease
and	I-Disease
ovairan	I-Disease
cacner	I-Disease
fmailies	O
.	O

We	O
have	O
identfiied	O
four	O
mtuations	O
in	O
each	O
of	O
the	O
berast	B-Disease
cnacer	I-Disease
-	O
susecptibility	O
geens	O
,	O
BCRA1	O
and	O
BCRA2	O
,	O
in	O
Frnech	O
Candaian	O
berast	B-Disease
canecr	I-Disease
and	O
berast	B-Disease
/	I-Disease
ovairan	I-Disease
canecr	I-Disease
famiiles	O
from	O
Queebc	O
.	O

To	O
identify	O
fuonder	O
effcets	O
,	O
we	O
examined	O
independently	O
ascertained	O
Fernch	O
Candaian	O
canecr	B-Disease
famliies	O
for	O
the	O
ditsribution	O
of	O
these	O
eight	O
mtuations	O
.	O

Muattions	O
were	O
found	O
in	O
41	O
of	O
97	O
famileis	O
.	O

Six	O
of	O
eight	O
muattions	O
were	O
observed	O
at	O
least	O
twice	O
.	O

The	O
BRAC1	O
C4464T	O
muattion	O
was	O
the	O
most	O
common	O
mutaiton	O
found	O
,	O
followed	O
by	O
the	O
BCRA2	O
8765delAG	O
mutatoin	O
.	O

Together	O
,	O
these	O
mutatoins	O
were	O
found	O
in	O
28	O
of	O
41	O
faimlies	O
idnetified	O
to	O
have	O
a	O
mutaiton	O
.	O

The	O
odds	O
of	O
deetction	O
of	O
any	O
of	O
the	O
four	O
BRAC1	O
mutatoins	O
was	O
18	O
.	O

7x	O
greater	O
if	O
one	O
or	O
more	O
csaes	O
of	O
ovarain	B-Disease
canecr	I-Disease
were	O
also	O
present	O
in	O
the	O
fmaily	O
.	O

The	O
odds	O
of	O
detcetion	O
of	O
any	O
of	O
the	O
four	O
BRAC2	O
mutatinos	O
was	O
5	O
.	O

3x	O
greater	O
if	O
there	O
were	O
at	O
least	O
five	O
caess	O
of	O
berast	B-Disease
cnacer	I-Disease
in	O
the	O
famliy	O
.	O

Interestingly	O
,	O
the	O
presecne	O
of	O
a	O
bresat	B-Disease
canecr	I-Disease
csae	O
<	O
36	O
yeras	O
of	O
age	O
was	O
strongly	O
preditcive	O
of	O
the	O
prseence	O
of	O
any	O
of	O
the	O
eight	O
mutatoins	O
screened	O
.	O

Carreirs	O
of	O
the	O
same	O
mutaiton	O
,	O
from	O
different	O
faimlies	O
,	O
shared	O
similar	O
hpalotypes	O
,	O
indicating	O
that	O
the	O
mutnat	O
alleles	O
were	O
likely	O
to	O
be	O
idetnical	O
by	O
desecnt	O
for	O
a	O
mutaiton	O
in	O
the	O
founedr	O
popualtion	O
.	O

The	O
identiifcation	O
of	O
common	O
BCRA1	O
and	O
BRAC2	O
muattions	O
will	O
facilitate	O
carreir	O
deteciton	O
in	O
Frecnh	O
Cnaadian	O
bresat	B-Disease
cnacer	I-Disease
and	O
braest	B-Disease
/	I-Disease
ovairan	I-Disease
canecr	I-Disease
famliies	O
.	O

Are	O
D7p1	O
and	O
D1p40	O
barin	O
dytsrophin	O
isoofrms	O
related	O
to	O
congitive	B-Disease
impariment	I-Disease
in	O
Duchenne	B-Disease
musuclar	I-Disease
dysrtophy	I-Disease
?	O

Moleuclar	O
stduy	O
and	O
neuorpsychological	O
aanlysis	O
were	O
performed	O
concurrently	O
on	O
49	O
pateints	O
with	O
Duchenne	B-Disease
mucsular	I-Disease
dystorphy	I-Disease
(	O
DMD	B-Disease
)	O
in	O
order	O
to	O
find	O
a	O
mloecular	O
explanation	O
for	O
the	O
cgonitive	B-Disease
impairemnt	I-Disease
observed	O
in	O
most	O
DMD	B-Disease
patinets	O
.	O

Compltee	O
anaylsis	O
of	O
the	O
dystropihn	O
gnee	O
was	O
performed	O
to	O
define	O
the	O
localizatoin	O
of	O
deletinos	O
and	O
dpulications	O
in	O
relation	O
to	O
the	O
different	O
DMD	B-Disease
prmooters	O
.	O

Qualtiative	O
analsyis	O
of	O
the	O
D7p1	O
transcirpt	O
and	O
testnig	O
for	O
the	O
specific	O
first	O
eoxn	O
of	O
D1p40	O
were	O
also	O
carried	O
out	O
.	O

Neuropscyhological	O
anaylsis	O
assessed	O
vebral	O
and	O
vsiuospatial	O
inetlligence	O
,	O
verabl	O
mmeory	O
,	O
and	O
raeding	O
sklils	O
.	O

Comaprison	O
of	O
molceular	O
and	O
psychmoetric	O
fidnings	O
demonstrated	O
that	O
deeltions	O
and	O
duplicaitons	O
that	O
were	O
localiezd	O
in	O
the	O
dsital	O
part	O
of	O
the	O
gnee	O
seemed	O
to	O
be	O
preferentially	O
associated	O
with	O
cogintive	B-Disease
impariment	I-Disease
.	O

Two	O
alteerd	O
D7p1	O
trasncripts	O
and	O
two	O
dleeted	O
D1p40	O
DNA	O
seqeunces	O
were	O
found	O
in	O
four	O
paitents	O
with	O
sevree	O
cerberal	B-Disease
dysfunctoin	I-Disease
.	O

These	O
findnigs	O
suggest	O
that	O
some	O
sequecnes	O
located	O
in	O
the	O
ditsal	O
part	O
of	O
the	O
gnee	O
and	O
,	O
in	O
particular	O
,	O
some	O
DMD	B-Disease
isofroms	O
experssed	O
in	O
the	O
barin	O
may	O
be	O
related	O
to	O
the	O
cogntiive	B-Disease
imapirment	I-Disease
associated	O
with	O
DMD	B-Disease
.	O
.	O

I1370K	O
APC	O
and	O
hMHL1	O
mutaitons	O
in	O
a	O
non	O
-	O
Jeiwsh	O
faimly	O
with	O
heredtiary	B-Disease
non	I-Disease
-	I-Disease
polypsois	I-Disease
colorecatl	I-Disease
canecr	I-Disease
.	O

We	O
describe	O
a	O
Fernch	O
Caandian	O
heredtiary	B-Disease
non	I-Disease
-	I-Disease
poylposis	I-Disease
colroectal	I-Disease
cnacer	I-Disease
(	O
HPNCC	B-Disease
)	O
kinrded	O
which	O
carries	O
a	O
novel	O
trunacting	O
muattion	O
in	O
hLMH1	O
.	O

Interestingly	O
,	O
the	O
I1037K	O
APC	O
polmyorphism	O
,	O
associated	O
with	O
an	O
incerased	O
rsik	O
of	O
colorecatl	B-Disease
cacner	I-Disease
,	O
is	O
also	O
present	O
in	O
this	O
fmaily	O
.	O

The	O
I1037K	O
polymorphsim	O
has	O
previously	O
only	O
been	O
idenitfied	O
in	O
individulas	O
of	O
slef	O
-	O
reported	O
Ashkenzai	O
Jewsih	O
oirgins	O
.	O

In	O
addition	O
,	O
in	O
this	O
fmaily	O
,	O
there	O
appears	O
to	O
be	O
no	O
relatiosnhip	O
between	O
the	O
I3107K	O
polymorhpism	O
and	O
the	O
presecne	O
or	O
asbence	O
of	O
cacner	B-Disease
.	O
.	O

Identiifcation	O
of	O
a	O
novel	O
muttaion	O
of	O
the	O
CPO	O
gnee	O
in	O
a	O
Japaense	O
heredtiary	B-Disease
coprpoorphyria	I-Disease
faimly	O
.	O

Herdeitary	B-Disease
coproporphryia	I-Disease
(	O
HCP	B-Disease
)	O
is	O
an	O
autosmoal	B-Disease
dmoinant	I-Disease
diesase	I-Disease
characteriezd	O
by	O
a	O
deficeincy	B-Disease
of	I-Disease
coporporphyrinogen	I-Disease
oxidsae	I-Disease
(	O
CPO	O
)	O
caused	O
by	O
a	O
muattion	O
in	O
the	O
CPO	O
gnee	O
.	O

Only	O
11	O
muttaions	O
of	O
the	O
gnee	O
have	O
been	O
reported	O
in	O
HCP	B-Disease
patietns	O
.	O

We	O
reprot	O
another	O
mutatoin	O
in	O
a	O
Jaapnese	O
faimly	O
.	O

Polmyerase	O
chian	O
reactoin	O
-	O
single	O
starnd	O
conformatinoal	O
polymorhpism	O
and	O
direct	O
sequecne	O
aanlyses	O
demonstrated	O
a	O
C	O
to	O
T	O
subsittution	O
in	O
eoxn	O
1	O
of	O
the	O
CPO	O
gnee	O
at	O
nucleoitde	O
psoition	O
85	O
,	O
which	O
lies	O
in	O
the	O
putative	O
preseqeunce	O
for	O
trageting	O
to	O
mitcohondria	O
.	O

This	O
mutaiton	O
chagnes	O
the	O
cdoon	O
for	O
gultamine	O
to	O
a	O
termniation	O
cdoon	O
at	O
amnio	O
aicd	O
psoition	O
29	O
.	O

MeaI	O
restritcion	O
analyiss	O
showed	O
two	O
other	O
crariers	O
in	O
the	O
faimly	O
.	O

The	O
C	O
-	O
T	O
muttaion	O
is	O
located	O
within	O
a	O
recently	O
proposed	O
putative	O
alterntaive	O
transltaion	O
inititaion	O
coodn	O
(	O
TIC	O
-	O
1	O
)	O
,	O
supporting	O
that	O
TIC	O
-	O
1	O
is	O
the	O
real	O
TIC	O
rather	O
than	O
TIC	O
-	O
2	O
.	O
.	O

Huamn	B-Disease
complement	I-Disease
fatcor	I-Disease
H	I-Disease
deficeincy	I-Disease
associated	O
with	O
hmeolytic	B-Disease
urmeic	I-Disease
synrdome	I-Disease
.	O

This	O
sutdy	O
repotrs	O
on	O
six	O
csaes	O
of	O
dfeiciency	B-Disease
in	I-Disease
the	I-Disease
hmuan	I-Disease
complement	I-Disease
regulaotry	I-Disease
prtoein	I-Disease
Fatcor	I-Disease
H	I-Disease
(	O
FH	O
)	O
in	O
the	O
conetxt	O
of	O
an	O
actue	B-Disease
reanl	I-Disease
disaese	I-Disease
.	O

Five	O
of	O
the	O
caess	O
were	O
observed	O
in	O
chidlren	O
prseenting	O
with	O
idoipathic	O
hemolyitc	B-Disease
ureimc	I-Disease
syndorme	I-Disease
(	O
HUS	B-Disease
)	O
.	O

Two	O
of	O
the	O
chlidren	O
exhibited	O
a	O
homozyogus	O
deficinecy	O
chaarcterized	O
by	O
the	O
absecne	O
of	O
the	O
150	O
-	O
kD	O
form	O
of	O
Facotr	O
H	O
and	O
the	O
prseence	O
,	O
upon	O
immunolbotting	O
,	O
of	O
the	O
42	O
-	O
kD	O
Fcator	O
H	O
-	O
like	O
protien	O
1	O
(	O
FHL	O
-	O
1	O
)	O
and	O
other	O
FH	O
-	O
related	O
protien	O
(	O
FHR	O
)	O
badns	O
.	O

Suothern	O
bolt	O
and	O
PCR	O
analsyis	O
of	O
DNA	O
of	O
one	O
paitent	O
with	O
hoomzygous	O
deficiecny	O
ruled	O
out	O
the	O
presnece	O
of	O
a	O
large	O
deeltion	O
of	O
the	O
FH	O
gnee	O
as	O
the	O
underlying	O
dfeect	O
for	O
the	O
dfeiciency	O
.	O

The	O
other	O
four	O
chlidren	O
presented	O
with	O
heetrozygous	O
deficeincy	O
and	O
exhibited	O
a	O
nomral	O
immunoboltting	O
ptatern	O
of	O
prtoeins	O
of	O
the	O
FH	O
famliy	O
.	O

Fatcor	B-Disease
H	I-Disease
deficiecny	I-Disease
is	O
the	O
only	O
complement	B-Disease
defiicency	I-Disease
associated	O
with	O
HUS	B-Disease
.	O

These	O
observatinos	O
suggest	O
a	O
role	O
for	O
FH	O
and	O
/	O
or	O
FH	O
recepotrs	O
in	O
the	O
pathogneesis	O
of	O
idoipathic	O
HUS	B-Disease
.	O
.	O

Further	O
evidnece	O
for	O
a	O
major	O
ancient	O
muttaion	O
underlying	O
myootnic	B-Disease
dsytrophy	I-Disease
from	O
linkgae	O
disequiilbrium	O
studeis	O
in	O
the	O
Jpaanese	O
populatoin	O
.	O

The	O
myotoinc	B-Disease
dytsrophy	I-Disease
(	O
DM	B-Disease
)	O
mutatoin	O
is	O
an	O
unstable	O
(	O
CTG	O
)	O
n	O
repaet	O
,	O
present	O
at	O
a	O
cpoy	O
number	O
of	O
5	O
-	O
37	O
repaets	O
on	O
nomral	O
chromoosmes	O
but	O
ampliifed	O
to	O
50	O
-	O
3000	O
coipes	O
on	O
DM	B-Disease
chromsoomes	O
.	O

Previous	O
findigns	O
in	O
Caucsaian	O
popluations	O
of	O
a	O
DM	B-Disease
founedr	O
chormosome	O
raise	O
a	O
question	O
about	O
the	O
molecualr	O
evetns	O
involved	O
in	O
the	O
expansoin	O
mtuation	O
.	O

To	O
investgiate	O
whether	O
a	O
foudner	O
chromosmoe	O
for	O
the	O
DM	B-Disease
mtuation	O
exists	O
in	O
the	O
Japnaese	O
populaiton	O
,	O
we	O
genotpyed	O
famliies	O
using	O
polymoprhic	O
mrakers	O
near	O
the	O
(	O
CTG	O
)	O
n	O
repaet	O
reigon	O
and	O
constructed	O
haplotyeps	O
.	O

Six	O
different	O
haplotpyes	O
were	O
found	O
and	O
DM	B-Disease
alllees	O
were	O
always	O
hpalotype	O
A	O
.	O

To	O
find	O
an	O
oriign	O
of	O
the	O
(	O
CTG	O
)	O
n	O
reepat	O
mutatoin	O
and	O
to	O
invesitgate	O
the	O
mechnaism	O
of	O
the	O
expasnion	O
mtuation	O
in	O
the	O
Jpaanese	O
pouplation	O
we	O
have	O
studied	O
90	O
Japansee	O
DM	B-Disease
famiiles	O
comprising	O
190	O
affected	O
and	O
130	O
unfafected	O
membres	O
.	O

The	O
resluts	O
suggest	O
that	O
a	O
few	O
common	O
ancestarl	O
muattions	O
in	O
both	O
Cacuasian	O
and	O
Japansee	O
popualtions	O
have	O
originated	O
by	O
epxansion	O
of	O
an	O
ancsetral	O
n	O
=	O
5	O
rpeeat	O
to	O
n	O
=	O
19	O
-	O
37	O
coipes	O
.	O

These	O
dtaa	O
support	O
multistep	O
mdoels	O
of	O
tirplet	O
repaet	O
expanison	O
that	O
have	O
been	O
proposed	O
for	O
both	O
DM	B-Disease
and	O
Friederichs	B-Disease
aatxia	I-Disease
.	O
.	O

The	O
moleuclar	O
basis	O
of	O
C6	B-Disease
dfeiciency	I-Disease
in	O
the	O
westren	O
Cpae	O
,	O
Sotuh	O
Arfica	O
.	O

Deifciency	B-Disease
of	I-Disease
the	I-Disease
sixth	I-Disease
component	I-Disease
of	I-Disease
hmuan	I-Disease
complement	I-Disease
(	O
C6	O
)	O
has	O
been	O
reported	O
in	O
a	O
number	O
of	O
famliies	O
from	O
the	O
wesetrn	O
Cpae	O
,	O
Sotuh	O
Afrcia	O
.	O

Mneingococcal	B-Disease
diesase	I-Disease
is	O
enedmic	O
in	O
the	O
Cpae	O
and	O
almost	O
all	O
peidgrees	O
of	O
total	O
C6	B-Disease
deficeincy	I-Disease
(	O
CQ60	O
)	O
have	O
been	O
ascertained	O
because	O
of	O
reucrrent	O
diesase	O
.	O

We	O
have	O
sequecned	O
the	O
exprsesed	O
exnos	O
of	O
the	O
C6	O
gnee	O
from	O
selected	O
caess	O
and	O
have	O
found	O
three	O
molceular	O
dfeects	O
leading	O
to	O
total	O
defciiency	O
879delG	O
,	O
which	O
is	O
the	O
common	O
defcet	O
in	O
the	O
Cpae	O
and	O
hitherto	O
unreported	O
,	O
and	O
1195delC	O
and	O
1936delG	O
,	O
which	O
have	O
been	O
previously	O
reported	O
in	O
Afriacn	O
-	O
Aemricans	O
.	O

We	O
also	O
show	O
that	O
the	O
879delG	O
and	O
1195delC	O
deefcts	O
are	O
associated	O
with	O
chraacteristic	O
C6	O
/	O
C7	O
reigon	O
DNA	O
makrer	O
hapoltypes	O
,	O
although	O
small	O
variatoins	O
were	O
observed	O
.	O

The	O
1936delG	O
dfeect	O
was	O
observed	O
only	O
once	O
in	O
the	O
Cpae	O
,	O
but	O
its	O
associated	O
halpotype	O
could	O
be	O
deduced	O
.	O

The	O
dtaa	O
from	O
the	O
haploytpes	O
indicate	O
that	O
these	O
three	O
molceular	O
defcets	O
account	O
for	O
the	O
defcets	O
in	O
all	O
the	O
38	O
unrelated	O
CQ60	O
indviiduals	O
we	O
have	O
studied	O
from	O
the	O
Cpae	O
.	O

We	O
have	O
also	O
observed	O
the	O
879delG	O
deefct	O
in	O
two	O
Ducth	O
C6	B-Disease
-	I-Disease
defciient	I-Disease
kinrdeds	O
,	O
but	O
the	O
879delG	O
deefct	O
in	O
the	O
Cpae	O
probably	O
did	O
not	O
come	O
from	O
The	O
Netherladns	O
.	O
.	O

Compleemnt	B-Disease
C7	I-Disease
deifciency	I-Disease
:	O
seven	O
further	O
mloecular	O
dfeects	O
and	O
their	O
associated	O
mraker	O
haplotyeps	O
.	O

Seven	O
further	O
moleuclar	O
baess	O
of	O
C7	B-Disease
defiicency	I-Disease
are	O
described	O
.	O

All	O
these	O
new	O
molecualr	O
deefcts	O
involve	O
single	O
-	O
nculeotide	O
eevnts	O
,	O
deeltions	O
and	O
substitutinos	O
,	O
some	O
of	O
which	O
alter	O
splcie	O
siets	O
,	O
and	O
others	O
coodns	O
.	O

They	O
are	O
distributed	O
along	O
the	O
C7	O
gnee	O
,	O
but	O
predominantly	O
towards	O
the	O
3	O
end	O
.	O

All	O
were	O
found	O
in	O
cmopound	O
heteorzygous	O
indviiduals	O
.	O

The	O
C6	O
/	O
C7	O
makrer	O
haplotyeps	O
associated	O
with	O
most	O
C7	B-Disease
dfeects	I-Disease
are	O
tabulated	O
.	O
.	O

A	O
gneome	O
-	O
wide	O
search	O
for	O
chormosomal	O
lcoi	O
linked	O
to	O
metnal	O
heatlh	O
wlelness	O
in	O
reltaives	O
at	O
high	O
rsik	O
for	O
bpiolar	B-Disease
affectvie	I-Disease
disodrer	I-Disease
among	O
the	O
Old	O
Oredr	O
Amsih	O
.	O

Bpiolar	B-Disease
affcetive	I-Disease
diosrder	I-Disease
(	O
BAPD	B-Disease
;	O
mainc	B-Disease
-	I-Disease
derpessive	I-Disease
ilnless	I-Disease
)	O
is	O
charatcerized	O
by	O
epsiodes	O
of	O
mnaia	B-Disease
and	O
/	O
or	O
hypomnaia	B-Disease
interspersed	O
with	O
peroids	O
of	O
deperssion	B-Disease
.	O

Compleling	O
eviednce	O
supports	O
a	O
significant	O
gneetic	O
component	O
in	O
the	O
suscepitbility	O
to	O
develop	O
BAPD	B-Disease
.	O

To	O
date	O
,	O
however	O
,	O
liknage	O
sutdies	O
have	O
attempted	O
only	O
to	O
identify	O
chromosoaml	O
lcoi	O
that	O
cause	O
or	O
icnrease	O
the	O
rsik	O
of	O
developing	O
BAPD	B-Disease
.	O

To	O
determine	O
whether	O
there	O
could	O
be	O
protective	O
alelles	O
that	O
pervent	O
or	O
redcue	O
the	O
rsik	O
of	O
developing	O
BAPD	B-Disease
,	O
similar	O
to	O
what	O
is	O
observed	O
in	O
other	O
geentic	B-Disease
disodrers	I-Disease
,	O
we	O
used	O
menatl	O
haelth	O
wellnses	O
(	O
abesnce	O
of	O
any	O
psychiartic	B-Disease
diosrder	I-Disease
)	O
as	O
the	O
pehnotype	O
in	O
our	O
geonme	O
-	O
wide	O
lnikage	O
sacn	O
of	O
several	O
large	O
multigeneraiton	O
Old	O
Odrer	O
Amsih	O
pedigrees	O
exhibiting	O
an	O
extremely	O
high	O
incidecne	O
of	O
BAPD	B-Disease
.	O

We	O
have	O
found	O
strong	O
evidnece	O
for	O
a	O
loucs	O
on	O
crhomosome	O
4p	O
at	O
D42S949	O
(	O
maixmum	O
GENEHNUTER	O
-	O
PULS	O
nopnarametric	O
linakge	O
socre	O
=	O
4	O
.	O
05	O
,	O
P	O
=	O
5	O
.	O
22	O
x	O
10	O
(	O
-	O
4	O
)	O
;	O
SBIPAL	O
Pmepirical	O
value	O
<	O
3	O
x	O
10	O
(	O
-	O
5	O
)	O
)	O
and	O
suggestive	O
evdience	O
for	O
a	O
loucs	O
on	O
chrmoosome	O
4q	O
at	O
D4S937	O
(	O
maxmium	O
GNEEHUNTER	O
-	O
PULS	O
nonaprametric	O
linkgae	O
socre	O
=	O
3	O
.	O
29	O
,	O
P	O
=	O
2	O
.	O
57	O
x	O
10	O
(	O
-	O
3	O
)	O
;	O
SIPBAL	O
Pmepirical	O
value	O
<	O
1	O
x	O
10	O
(	O
-	O
3	O
)	O
)	O
that	O
are	O
linked	O
to	O
metnal	O
haelth	O
wellnses	O
.	O

These	O
findnigs	O
are	O
consistent	O
with	O
the	O
hpyothesis	O
that	O
certain	O
alllees	O
could	O
prevnet	O
or	O
modify	O
the	O
cliniacl	O
manifestatoins	O
of	O
BAPD	B-Disease
and	O
perhaps	O
other	O
related	O
affetcive	B-Disease
dsiorders	I-Disease
.	O

Segrgeation	O
distortoin	O
in	O
myotoinc	B-Disease
dysrtophy	I-Disease
.	O

Mytoonic	B-Disease
dystrohpy	I-Disease
(	O
DM	B-Disease
)	O
is	O
an	O
autoosmal	B-Disease
domiannt	I-Disease
disaese	I-Disease
which	O
,	O
in	O
the	O
typical	O
pedgiree	O
,	O
shows	O
a	O
three	O
generatoin	O
anticipatoin	O
csacade	O
.	O

This	O
reuslts	O
in	O
infertliity	B-Disease
and	O
congeniatl	B-Disease
myootnic	I-Disease
dystorphy	I-Disease
(	O
CDM	B-Disease
)	O
with	O
the	O
dispapearance	O
of	O
DM	B-Disease
in	O
that	O
pedigere	O
.	O

The	O
cocnept	O
of	O
sgeregation	O
ditsortion	O
,	O
where	O
there	O
is	O
preferenital	O
trnasmission	O
of	O
the	O
larger	O
alelle	O
at	O
the	O
DM	B-Disease
lcous	O
,	O
has	O
been	O
put	O
forward	O
to	O
explain	O
patrially	O
the	O
maintenacne	O
of	O
DM	B-Disease
in	O
the	O
populaiton	O
.	O

In	O
a	O
suvrey	O
of	O
DM	B-Disease
in	O
Norhtern	O
Irleand	O
,	O
59	O
pedigrees	O
were	O
ascertained	O
.	O

Sbiships	O
where	O
the	O
sattus	O
of	O
all	O
the	O
mmebers	O
had	O
been	O
identiifed	O
were	O
examined	O
to	O
determine	O
the	O
transmissoin	O
of	O
the	O
DM	B-Disease
expnasion	O
from	O
affceted	O
parnets	O
to	O
their	O
offspirng	O
.	O

Where	O
the	O
trasnmitting	O
praent	O
was	O
mlae	O
,	O
58	O
.	O

3	O
%	O
of	O
the	O
offpsring	O
were	O
affceted	O
,	O
and	O
in	O
the	O
csae	O
of	O
a	O
fmeale	O
trnasmitting	O
praent	O
,	O
68	O
.	O

7	O
%	O
were	O
affceted	O
.	O

Stuides	O
on	O
meoitic	O
drive	O
in	O
DM	B-Disease
have	O
shown	O
icnreased	O
transmisison	O
of	O
the	O
larger	O
alllee	O
at	O
the	O
DM	B-Disease
loucs	O
in	O
non	O
-	O
DM	O
heteorzygotes	O
for	O
CGTn	O
.	O

This	O
stduy	O
provides	O
further	O
eivdence	O
that	O
the	O
DM	B-Disease
expnasion	O
tends	O
to	O
be	O
transmitted	O
preferentially	O
.	O

Diagnsois	O
of	O
hemochromatoiss	B-Disease
.	O

If	O
untretaed	O
,	O
hemochormatosis	B-Disease
can	O
cause	O
serious	O
illenss	O
and	O
ealry	B-Disease
detah	I-Disease
,	O
but	O
the	O
diesase	O
is	O
still	O
substantially	O
under	O
-	O
diganosed	O
.	O

The	O
cornerstone	O
of	O
srceening	O
and	O
csae	O
detectoin	O
is	O
the	O
measuerment	O
of	O
seurm	O
transferirn	O
stauration	O
and	O
the	O
sreum	O
ferritin	O
leevl	O
.	O

Once	O
the	O
diagnoiss	O
is	O
suspecetd	O
,	O
pyhsicians	O
must	O
use	O
sreum	O
ferriitn	O
lveels	O
and	O
heptaic	O
iorn	O
stroes	O
on	O
lvier	O
biposy	O
speicmens	O
to	O
assess	O
patinets	O
for	O
the	O
presecne	O
of	O
iorn	B-Disease
overolad	I-Disease
.	O

Lievr	O
boipsy	O
is	O
also	O
used	O
to	O
establish	O
the	O
persence	O
or	O
abesnce	O
of	O
cirrohsis	B-Disease
,	O
which	O
can	O
affect	O
porgnosis	O
and	O
mnaagement	O
.	O

A	O
DNA	O
-	O
based	O
tset	O
for	O
the	O
HFE	O
gnee	O
is	O
commercially	O
available	O
,	O
but	O
its	O
place	O
in	O
the	O
diagnsois	O
of	O
hemochrmoatosis	B-Disease
is	O
still	O
being	O
evaluaetd	O
.	O

Currently	O
,	O
the	O
most	O
useful	O
role	O
for	O
this	O
tset	O
is	O
in	O
the	O
detetcion	O
of	O
hemohcromatosis	B-Disease
in	O
the	O
faimly	O
membres	O
of	O
patietns	O
with	O
a	O
proven	O
csae	O
of	O
the	O
diesase	O
.	O

It	O
is	O
crucial	O
to	O
diagnsoe	O
hemcohromatosis	B-Disease
before	O
hpeatic	B-Disease
cirrhsois	I-Disease
develops	O
because	O
phlebotmoy	O
thearpy	O
can	O
avert	O
serious	O
chornic	O
disaese	O
and	O
can	O
even	O
lead	O
to	O
nomral	O
lfie	O
expectacny	O
.	O
.	O

Prevalnece	O
of	O
the	O
I1370K	O
APC	B-Disease
gnee	O
varaint	O
in	O
Isreali	O
Jwes	O
of	O
differing	O
ethinc	O
orgiin	O
and	O
rsik	O
for	O
cloorectal	B-Disease
canecr	I-Disease
.	O

BACKGRUOND	O
&	O
AMIS	O
Isareli	O
Jwes	O
of	O
Eurpoean	O
bitrh	O
,	O
i	O
.	O
e	O
.	O
,	O
Ahskenazim	O
,	O
have	O
the	O
highest	O
coloretcal	B-Disease
cnacer	I-Disease
incidnece	O
of	O
any	O
Isralei	O
ethinc	O
gorup	O
.	O

The	O
I1037K	O
APC	B-Disease
gnee	O
varaint	O
was	O
found	O
in	O
6	O
.	O

1	O
%	O
of	O
Amreican	O
Jwes	O
,	O
28	O
%	O
of	O
their	O
faimlial	O
cloorectal	B-Disease
cacner	I-Disease
csaes	O
,	O
but	O
not	O
in	O
non	O
-	O
Jwes	O
.	O

We	O
assessed	O
the	O
I1037K	O
preavlence	O
in	O
Isralei	O
Jwes	O
of	O
differing	O
ethinc	O
oriign	O
and	O
rsik	O
for	O
coloerctal	B-Disease
cacner	I-Disease
.	O

METHODS	O
DNA	O
samlpes	O
from	O
500	O
unrelated	O
Jwes	O
of	O
Eurpoean	O
or	O
non	O
-	O
Eruopean	O
oirgin	O
,	O
with	O
or	O
without	O
a	O
persoanl	O
and	O
/	O
or	O
famliy	O
histroy	O
of	O
neoplaisa	B-Disease
,	O
were	O
examined	O
for	O
the	O
I1370K	O
varinat	O
by	O
the	O
alllee	O
-	O
specific	O
oliognucleotide	O
(	O
ASO	O
)	O
mehtod	O
.	O

RESUTLS	O
In	O
perosns	O
at	O
avreage	O
rsik	O
for	O
colroectal	B-Disease
cnacer	I-Disease
,	O
I1037K	O
was	O
found	O
in	O
5	O
.	O

0	O
%	O
of	O
120	O
Euorpean	O
and	O
1	O
.	O

6	O
%	O
of	O
188	O
non	O
-	O
Europaen	O
Jwes	O
(	O
P	O
=	O
0	O
.	O
08	O
)	O
.	O

It	O
occurred	O
in	O
15	O
.	O

4	O
%	O
of	O
52	O
Asheknazi	O
Isrealis	O
with	O
faimlial	O
canecr	B-Disease
(	O
P	O
=	O
0	O
.	O
02	O
)	O
and	O
was	O
not	O
detecetd	O
in	O
51	O
non	O
-	O
Euroepan	O
Jwes	O
at	O
incerased	O
cacner	B-Disease
rsik	O
.	O

Colorecatl	B-Disease
noeplasia	I-Disease
occurred	O
persnoally	O
or	O
in	O
the	O
famiiles	O
of	O
13	O
of	O
20	O
Ashkenzai	O
I1037K	O
carreirs	O
,	O
8	O
of	O
whom	O
also	O
had	O
a	O
presonal	O
or	O
fmaily	O
hitsory	O
of	O
noncolnoic	O
neolpasia	B-Disease
.	O

CONCLSUIONS	O
The	O
I1370K	O
APC	O
varaint	O
may	O
represent	O
a	O
suscetpibility	O
gnee	O
for	O
colroectal	B-Disease
,	I-Disease
or	I-Disease
other	I-Disease
,	I-Disease
canecrs	I-Disease
in	O
Ahskenazi	O
Jwes	O
,	O
and	O
patrially	O
explains	O
the	O
hihger	O
icnidence	O
of	O
colorecatl	B-Disease
cnacer	I-Disease
in	O
Eurpoean	O
Israeils	O
.	O

Sytsematic	O
analsyis	O
of	O
cporoporphyrinogen	O
oxidsae	O
gnee	O
deefcts	O
in	O
hereditray	B-Disease
coproporpyhria	I-Disease
and	O
muttaion	O
update	O
.	O

Herediatry	B-Disease
coprpoorphyria	I-Disease
(	O
HC	B-Disease
)	O
is	O
an	O
actue	O
heptaic	B-Disease
porpyhria	I-Disease
with	O
autosoaml	O
doimnant	O
inheritnace	O
caused	O
by	O
defiicent	B-Disease
acitvity	I-Disease
of	I-Disease
coproporpyhrinogen	I-Disease
III	I-Disease
oxdiase	I-Disease
(	O
CPO	O
)	O
.	O

Clincial	O
mnaifestations	O
of	O
the	O
disaese	O
are	O
characteirzed	O
by	O
actue	O
attacks	O
of	O
neruological	B-Disease
dysfucntion	I-Disease
often	O
precipitaetd	O
by	O
drgus	O
,	O
fasitng	O
,	O
cycliacl	O
hormoanl	O
chnages	O
,	O
or	O
inefctious	B-Disease
dsieases	I-Disease
.	O

Sikn	O
pohtosensitivity	O
may	O
also	O
be	O
present	O
.	O

The	O
seven	O
eoxns	O
,	O
the	O
eoxn	O
/	O
itnron	O
boundraies	O
and	O
part	O
of	O
3	O
noncodnig	O
sequnece	O
of	O
the	O
CPO	O
gnee	O
were	O
systematiaclly	O
aanlyzed	O
by	O
an	O
eoxn	O
-	O
by	O
-	O
eoxn	O
denaturnig	O
gradinet	O
gel	O
electrohporesis	O
(	O
DGGE	O
)	O
strategy	O
followed	O
by	O
direct	O
sequecning	O
in	O
seven	O
unrelated	O
heterozyguos	O
HC	B-Disease
pateints	O
from	O
Frnace	O
,	O
Hloland	O
,	O
and	O
Cezch	O
Rpeublic	O
.	O

Seven	O
novel	O
muattions	O
and	O
two	O
new	O
polymrophisms	O
were	O
detetced	O
.	O

Among	O
these	O
muattions	O
two	O
are	O
missesne	O
(	O
G179W	O
,	O
W247R	O
)	O
,	O
two	O
are	O
nosnense	O
(	O
Q360X	O
,	O
Q385X	O
)	O
,	O
two	O
are	O
small	O
deeltions	O
(	O
662de14bp	O
;	O
1168del3bp	O
removing	O
a	O
glcyine	O
at	O
postiion	O
390	O
)	O
,	O
and	O
one	O
is	O
a	O
spliicng	O
mutatoin	O
(	O
ISV1	O
-	O
15c	O
-	O
-	O
>	O
g	O
)	O
which	O
creates	O
a	O
new	O
accetpor	O
splcie	O
stie	O
.	O

The	O
pahtological	O
signifiacnce	O
of	O
the	O
point	O
mutatinos	O
G917W	O
,	O
W247R	O
,	O
and	O
the	O
in	O
-	O
farme	O
dleetion	O
390delGly	O
were	O
assesesd	O
by	O
their	O
respective	O
expressoin	O
in	O
a	O
porkaryotic	O
sytsem	O
using	O
stie	O
-	O
directed	O
mutagenseis	O
.	O

These	O
mtuations	O
resulted	O
in	O
the	O
asbence	O
or	O
a	O
draamtic	O
decraese	O
of	O
CPO	O
actiivty	O
.	O

The	O
two	O
polymrophisms	O
were	O
lcoalized	O
in	O
nnocoding	O
part	O
of	O
the	O
gnee	O
1	O
)	O
a	O
C	O
/	O
G	O
polymrophism	O
in	O
the	O
pormotor	O
regoin	O
,	O
142	O
bp	O
usptream	O
from	O
the	O
transcrpitional	O
iniitation	O
stie	O
(	O
-	O
142C	O
/	O
G	O
)	O
,	O
and	O
2	O
)	O
a	O
6	O
bp	O
deletoin	O
ploymorphism	O
in	O
the	O
3	O
noncdoing	O
part	O
of	O
the	O
CPO	O
gnee	O
,	O
574	O
bp	O
downsteram	O
of	O
the	O
last	O
base	O
of	O
the	O
nromal	O
terminatoin	O
cdoon	O
(	O
+	O
574	O
delATTCTT	O
)	O
.	O

Five	O
inrtagenic	O
diomrphisms	O
are	O
now	O
well	O
chaarcterized	O
and	O
the	O
high	O
degere	O
of	O
allelic	O
heterogeniety	O
in	O
HC	B-Disease
is	O
demonstrated	O
with	O
seven	O
new	O
different	O
mutatoins	O
making	O
a	O
total	O
of	O
nineteen	O
CPO	O
gnee	B-Disease
dfeects	I-Disease
reported	O
so	O
far	O
.	O
.	O

Coinciednce	O
of	O
two	O
novel	O
arylsulaftase	O
A	O
alllees	O
and	O
mutatoin	O
459	O
+	O
G	O
>	O
A	O
within	O
a	O
famliy	O
with	O
metahcromatic	B-Disease
leukodytsrophy	I-Disease
:	O
molecualr	O
basis	O
of	O
phenoytpic	O
heteorgeneity	O
.	O

In	O
a	O
famliy	O
with	O
three	O
sibligns	O
,	O
one	O
developed	O
classical	O
ltae	O
infatnile	O
metachromtaic	B-Disease
leukodysrtophy	I-Disease
(	O
MLD	B-Disease
)	O
,	O
ftaal	O
at	O
age	O
5	O
yeras	O
,	O
with	O
defiicent	O
arylsulfatsae	O
A	O
(	O
ASRA	O
)	O
activtiy	O
and	O
incresaed	O
galactosylsulfatdie	O
(	O
GS	O
)	O
ecxretion	O
.	O

The	O
two	O
other	O
sbilings	O
,	O
apparently	O
heatlhy	O
at	O
12	O
(	O
1	O
/	O
2	O
)	O
and	O
15	O
yeras	O
,	O
respectively	O
,	O
and	O
their	O
fahter	O
,	O
apparently	O
healhty	O
as	O
well	O
,	O
presented	O
ASRA	O
and	O
GS	O
vlaues	O
within	O
the	O
range	O
of	O
MLD	B-Disease
paitents	O
.	O

Muttaion	O
scerening	O
and	O
sequnece	O
aanlysis	O
disclosed	O
the	O
involveemnt	O
of	O
three	O
different	O
ASRA	O
muattions	O
being	O
the	O
moleuclar	O
basis	O
of	O
itnrafamilial	O
phenotyipc	O
heterogeniety	O
.	O

The	O
ltae	O
infnatile	O
pateint	O
inheirted	O
from	O
his	O
mohter	O
the	O
frqeuent	O
0	O
-	O
tpye	O
mutatoin	O
459	O
+	O
G	O
>	O
A	O
,	O
and	O
from	O
his	O
fatehr	O
a	O
novel	O
,	O
single	O
bsaepair	O
microdelteion	O
of	O
gaunine	O
at	O
nucletoide	O
7	O
in	O
eoxn	O
1	O
(	O
7delG	O
)	O
.	O

The	O
two	O
cilnically	O
unaffecetd	O
siblnigs	O
carried	O
the	O
mtaernal	O
mtuation	O
459	O
+	O
G	O
>	O
A	O
and	O
,	O
on	O
their	O
patenral	O
alelle	O
,	O
a	O
novel	O
cytoisne	O
to	O
tyhmidine	O
transitoin	O
at	O
nulceotide	O
2435	O
in	O
eoxn	O
8	O
,	O
resulting	O
in	O
sbustitution	O
of	O
aalnine	O
464	O
by	O
vlaine	O
(	O
A446V	O
)	O
.	O

The	O
fathres	O
genoytpe	O
thus	O
was	O
7delG	O
/	O
A446V	O
.	O

Mutaiton	O
A446V	O
was	O
not	O
found	O
in	O
18	O
unrelated	O
MLD	B-Disease
paitents	O
and	O
50	O
conrtols	O
.	O

A644V	O
,	O
although	O
clearly	O
modifying	O
ASRA	O
and	O
GS	O
leevls	O
,	O
apparently	O
bears	O
little	O
sginificance	O
for	O
clniical	O
manifetsation	O
of	O
MLD	B-Disease
,	O
mimicking	O
the	O
frequnet	O
ASRA	O
pseudoedficiency	O
alelle	O
.	O

Our	O
resutls	O
demonstrate	O
that	O
in	O
certain	O
gneetic	O
cnoditions	O
MLD	B-Disease
-	O
like	O
ASRA	O
and	O
GS	O
vaules	O
need	O
not	O
be	O
paralleled	O
by	O
cilnical	O
disaese	O
,	O
a	O
finidng	O
with	O
serious	O
diangostic	O
and	O
prgonostic	O
implications	O
.	O

Moreover	O
,	O
further	O
ASRA	O
alleles	O
functionally	O
similar	O
to	O
A446V	O
might	O
exist	O
which	O
,	O
together	O
with	O
0	O
-	O
tpye	O
mutatinos	O
,	O
may	O
cause	O
patholoigcal	O
ASRA	O
and	O
GS	O
leevls	O
,	O
but	O
not	O
cilnical	O
outrbeak	O
of	O
the	O
disesae	O
.	O
.	O

Hmuan	O
MHL1	O
defciiency	O
predipsoses	O
to	O
hemaotlogical	B-Disease
mlaignancy	I-Disease
and	O
neurofibormatosis	B-Disease
tpye	I-Disease
1	I-Disease
.	O

Heteorzygous	O
grem	O
-	O
line	O
mutatoins	O
in	O
the	O
DNA	O
misamtch	O
reapir	O
geens	O
lead	O
to	O
heerditary	B-Disease
nopnolyposis	I-Disease
cloorectal	I-Disease
canecr	I-Disease
.	O

The	O
disaese	O
susceptibliity	O
of	O
individulas	O
who	O
constittuionally	O
lcak	O
both	O
wlid	O
-	O
tpye	O
alleles	O
is	O
unknown	O
.	O

We	O
have	O
identiifed	O
three	O
offpsring	O
in	O
a	O
herdeitary	B-Disease
nnopolyposis	I-Disease
cloorectal	I-Disease
cacner	I-Disease
fmaily	O
who	O
developed	O
hematologcial	B-Disease
mlaignancy	I-Disease
at	O
a	O
very	O
ealry	O
age	O
,	O
and	O
at	O
least	O
two	O
of	O
them	O
displayed	O
sings	O
of	O
neruofibromatosis	B-Disease
tpye	I-Disease
1	I-Disease
(	O
NF1	B-Disease
)	O
.	O

DNA	O
seuqence	O
anlaysis	O
and	O
allele	O
-	O
specific	O
amplificatoin	O
in	O
two	O
sbilings	O
reveaeld	O
a	O
hmoozygous	O
MHL1	O
mutaiton	O
(	O
C766T	O
-	O
-	O
>	O
Arg226Stop	O
)	O
.	O

Thus	O
,	O
a	O
homozyguos	O
grem	O
-	O
line	O
MHL1	O
mtuation	O
and	O
consequent	O
mismacth	O
reapir	O
deficinecy	O
rseults	O
in	O
a	O
muttaor	O
phenotpye	O
characteriezd	O
by	O
luekemia	B-Disease
and	O
/	O
or	O
lypmhoma	B-Disease
associated	O
with	O
neurofibromatoiss	B-Disease
tpye	I-Disease
1	I-Disease
.	O
.	O

Missesne	O
muattions	O
in	O
the	O
most	O
ancient	O
reisdues	O
of	O
the	O
PXA6	O
paired	O
dmoain	O
underlie	O
a	O
spcetrum	O
of	O
huamn	O
conegnital	B-Disease
eye	I-Disease
malformaitons	I-Disease
.	O

Muttaions	O
of	O
the	O
hmuan	O
PXA6	O
gnee	O
underlie	O
aniriida	B-Disease
(	O
cnogenital	B-Disease
abesnce	I-Disease
of	I-Disease
the	I-Disease
iirs	I-Disease
)	O
,	O
a	O
rrae	O
dmoinant	O
malfromation	B-Disease
of	I-Disease
the	I-Disease
eye	I-Disease
.	O

The	O
specturm	O
of	O
PXA6	O
mtuations	O
in	O
aniirdia	B-Disease
patietns	O
is	O
highly	O
biased	O
,	O
with	O
92	O
%	O
of	O
all	O
reported	O
mutatoins	O
leading	O
to	O
premtaure	O
truncaiton	O
of	O
the	O
prtoein	O
(	O
nonsnese	O
,	O
spliicng	O
,	O
inseritons	O
and	O
deeltions	O
)	O
and	O
just	O
2	O
%	O
leading	O
to	O
substtiution	O
of	O
one	O
amnio	O
aicd	O
by	O
another	O
(	O
misesnse	O
)	O
.	O

The	O
extraordinary	O
conservatoin	O
of	O
the	O
PXA6	O
portein	O
at	O
the	O
aimno	O
aicd	O
lveel	O
amongst	O
vertebrtaes	O
predicts	O
that	O
pathologcial	O
missesne	O
mutaitons	O
should	O
in	O
fact	O
be	O
common	O
even	O
though	O
they	O
are	O
hardly	O
ever	O
seen	O
in	O
aniirdia	B-Disease
ptaients	O
.	O

This	O
indicates	O
that	O
there	O
is	O
a	O
haevy	O
acsertainment	O
bais	O
in	O
the	O
seleciton	O
of	O
patinets	O
for	O
PXA6	O
mutatoin	O
anaylsis	O
and	O
that	O
the	O
missing	O
PXA6	O
missesne	O
mutatinos	O
frequently	O
may	O
underlie	O
phenotyeps	O
distinct	O
from	O
tetxbook	O
aniriida	B-Disease
.	O

Here	O
we	O
present	O
four	O
novel	O
PXA6	O
missnese	O
mutatinos	O
,	O
two	O
in	O
assocaition	O
with	O
aytpical	O
phentoypes	O
ectoipa	B-Disease
pupilale	I-Disease
(	O
displaced	B-Disease
puplis	I-Disease
)	O
and	O
congeniatl	B-Disease
nystagums	I-Disease
(	O
searching	B-Disease
gzae	I-Disease
)	O
,	O
and	O
two	O
in	O
assocaition	O
with	O
more	O
recognizable	O
aniirdia	B-Disease
phenoytpes	O
.	O

Strikingly	O
,	O
all	O
four	O
mutatinos	O
are	O
located	O
within	O
the	O
PXA6	O
paired	O
domian	O
and	O
affect	O
amnio	O
acdis	O
which	O
are	O
highly	O
conserved	O
in	O
all	O
known	O
paired	O
dmoain	O
protenis	O
.	O

Our	O
rseults	O
support	O
the	O
hpyothesis	O
that	O
the	O
under	O
-	O
rperesentation	O
of	O
misesnse	O
muttaions	O
is	O
caused	O
by	O
ascetrainment	O
bais	O
and	O
suggest	O
that	O
a	O
substantial	O
budren	O
of	O
PXA6	B-Disease
-	I-Disease
related	I-Disease
dsiease	I-Disease
remains	O
to	O
be	O
uncovered	O
.	O
.	O

The	O
chromsoomal	O
order	O
of	O
gnees	O
controlling	O
the	O
major	O
histocopmatibility	O
compelx	O
,	O
proeprdin	O
fcator	O
B	O
,	O
and	O
deficiecny	B-Disease
of	I-Disease
the	I-Disease
second	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
.	O

The	O
relaitonship	O
of	O
the	O
gnees	O
coidng	O
for	O
HLA	O
to	O
those	O
coidng	O
for	O
proeprdin	O
Facotr	O
B	O
allotpyes	O
and	O
for	O
deficiecny	B-Disease
of	I-Disease
the	I-Disease
second	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C2	O
)	O
was	O
studied	O
in	O
faimlies	O
of	O
patietns	O
with	O
conncetive	O
tisuse	O
disordres	O
.	O

Patinets	O
were	O
selected	O
because	O
they	O
were	O
heteroyzgous	O
or	O
homozyogus	O
for	O
C2	B-Disease
deficeincy	I-Disease
.	O

12	O
faimlies	O
with	O
15	O
mtaings	O
inforamtive	O
for	O
C2	B-Disease
deficiecny	I-Disease
were	O
found	O
.	O

Of	O
57	O
infomrative	O
mieoses	O
,	O
two	O
corssovers	O
were	O
noted	O
between	O
the	O
C2	B-Disease
dfeiciency	I-Disease
gnee	O
and	O
the	O
HLA	O
-	O
B	O
gnee	O
,	O
with	O
a	O
reocmbinant	O
fratcion	O
of	O
0	O
.	O

035	O
.	O

A	O
lod	O
socre	O
of	O
13	O
was	O
calculated	O
for	O
liknage	O
between	O
C2	B-Disease
defiicency	I-Disease
and	O
HLA	O
-	O
B	O
at	O
a	O
maixmum	O
lieklihood	O
value	O
of	O
the	O
recobminant	O
fractoin	O
of	O
0	O
.	O

04	O
.	O

18	O
famiiles	O
with	O
21	O
informaitve	O
matnigs	O
for	O
both	O
propredin	O
Fatcor	O
B	O
alltoype	O
and	O
HLA	O
-	O
B	O
were	O
found	O
.	O

Of	O
72	O
infromative	O
meioess	O
,	O
three	O
recomibnants	O
were	O
found	O
,	O
giving	O
a	O
reocmbinant	O
farction	O
of	O
0	O
.	O

042	O
.	O

A	O
lod	O
scroe	O
of	O
16	O
between	O
HLA	O
-	O
B	O
and	O
Fcator	O
B	O
allotpyes	O
was	O
calculated	O
at	O
a	O
maxiumm	O
lkielihood	O
value	O
of	O
the	O
recombniant	O
frcation	O
of	O
0	O
.	O

04	O
.	O

A	O
crsosover	O
was	O
shown	O
to	O
have	O
occurred	O
between	O
gnees	O
for	O
Fatcor	O
B	O
and	O
HLA	O
-	O
D	O
,	O
in	O
which	O
HLA	O
-	O
D	O
segregared	O
with	O
HLA	O
-	O
A	O
and	O
B	O
.	O

These	O
stduies	O
suggest	O
that	O
the	O
geens	O
for	O
Facotr	O
B	O
and	O
C2	B-Disease
deficinecy	I-Disease
are	O
located	O
outside	O
those	O
for	O
HLA	O
,	O
that	O
the	O
order	O
of	O
genese	O
is	O
HLA	O
-	O
A	O
,	O
-	O
B	O
,	O
-	O
D	O
,	O
Fcator	O
B	O
allotype	O
,	O
C2	B-Disease
defiicency	I-Disease
,	O
that	O
the	O
geens	O
coidng	O
for	O
C2	B-Disease
defiicency	I-Disease
and	O
Fcator	O
B	O
allotpyes	O
are	O
approximately	O
3	O
-	O
-	O
5	O
cnetimorgans	O
from	O
the	O
HLA	O
-	O
A	O
and	O
HLA	O
-	O
B	O
lcoi	O
,	O
and	O
that	O
the	O
appaernt	O
lcak	O
of	O
recmobinants	O
between	O
the	O
Fatcor	O
B	O
gnee	O
and	O
C2	B-Disease
deifciency	I-Disease
gnee	O
suggests	O
that	O
these	O
two	O
geens	O
lie	O
in	O
close	O
proixmity	O
to	O
one	O
another	O
.	O

Distriubtion	O
of	O
eemrin	O
and	O
lmains	O
in	O
the	O
haert	O
and	O
implications	O
for	O
Eemry	B-Disease
-	I-Disease
Dreiufss	I-Disease
muscluar	I-Disease
dytsrophy	I-Disease
.	O

Eemrin	O
is	O
a	O
nucelar	O
membrnae	O
portein	O
which	O
is	O
missing	O
or	O
defcetive	O
in	O
Emrey	B-Disease
-	I-Disease
Dreifsus	I-Disease
muscluar	I-Disease
dystorphy	I-Disease
(	O
EMDD	B-Disease
)	O
.	O

It	O
is	O
one	O
member	O
of	O
a	O
faimly	O
of	O
lamnia	O
-	O
associated	O
prtoeins	O
which	O
includes	O
LPA1	O
,	O
LPA2	O
and	O
laimn	O
B	O
rceeptor	O
(	O
LBR	O
)	O
.	O

A	O
panel	O
of	O
16	O
monocloanl	O
anitbodies	O
(	O
mbAs	O
)	O
has	O
been	O
mpaped	O
to	O
six	O
specific	O
sties	O
throughout	O
the	O
emrein	O
moleclue	O
using	O
phgae	O
-	O
displayed	O
petpide	O
lbiraries	O
and	O
has	O
been	O
used	O
to	O
locailze	O
eemrin	O
in	O
huamn	O
and	O
rabibt	O
herat	O
.	O

Several	O
mbAs	O
against	O
different	O
eemrin	O
eiptopes	O
did	O
not	O
recognize	O
intecralated	O
dicss	O
in	O
the	O
haert	O
,	O
though	O
they	O
recognized	O
cardiomycoyte	O
nculei	O
strongly	O
,	O
both	O
at	O
the	O
rim	O
and	O
in	O
itnranuclear	O
sptos	O
or	O
channels	O
.	O

A	O
polylconal	O
rbabit	O
antsierum	O
against	O
emrein	O
did	O
recognize	O
both	O
nulcear	O
membrnae	O
and	O
itnercalated	O
dicss	O
but	O
,	O
after	O
affintiy	O
purificaiton	O
against	O
a	O
pure	O
-	O
emrein	O
bnad	O
on	O
a	O
westren	O
bolt	O
,	O
it	O
stianed	O
only	O
the	O
nuclaer	O
membrnae	O
.	O

These	O
rseults	O
would	O
not	O
be	O
expected	O
if	O
immunostianing	O
at	O
intercaltaed	O
dsics	O
were	O
due	O
to	O
a	O
proudct	O
of	O
the	O
eemrin	O
gnee	O
and	O
,	O
therefore	O
,	O
csat	O
some	O
doubt	O
upon	O
the	O
hyptohesis	O
that	O
cadriac	B-Disease
deefcts	I-Disease
in	O
EMDD	B-Disease
are	O
caused	O
by	O
absnece	O
of	O
eemrin	O
from	O
intercaalted	O
dsics	O
.	O

Although	O
emrein	O
was	O
abundnat	O
in	O
the	O
membraens	O
of	O
cardiomycoyte	O
nuceli	O
,	O
it	O
was	O
absnet	O
from	O
many	O
non	O
-	O
moycyte	O
clels	O
in	O
the	O
herat	O
.	O

This	O
dsitribution	O
of	O
emeirn	O
was	O
similar	O
to	O
that	O
of	O
lmain	O
A	O
,	O
a	O
candidate	O
gnee	O
for	O
an	O
autosoaml	O
form	O
of	O
EMDD	B-Disease
.	O

In	O
contrast	O
,	O
laimn	O
B1	O
was	O
absnet	O
from	O
caridomyocyte	O
nuceli	O
,	O
showing	O
that	O
lmain	O
B1	O
is	O
not	O
essenital	O
for	O
localiaztion	O
of	O
emrein	O
to	O
the	O
nulcear	O
laimna	O
.	O

Lmain	O
B1	O
is	O
also	O
almost	O
completely	O
asbent	O
from	O
skeeltal	O
msucle	O
nulcei	O
.	O

In	O
EMDD	B-Disease
,	O
the	O
additional	O
asbence	O
of	O
laimn	O
B1	O
from	O
haert	O
and	O
skelteal	O
muslce	O
nculei	O
which	O
already	O
lcak	O
eemrin	O
may	O
offer	O
an	O
alternaitve	O
explanation	O
of	O
why	O
these	O
tisseus	O
are	O
particularly	O
affected	O
.	O
.	O

Gneetic	O
mpaping	O
of	O
the	O
copepr	B-Disease
toxiocsis	I-Disease
loucs	O
in	O
Bdelington	O
terirers	O
to	O
dog	O
chrmoosome	O
10	O
,	O
in	O
a	O
rgeion	O
sytnenic	O
to	O
huamn	O
chroomsome	O
rgeion	O
2p13	O
-	O
p16	O
.	O

Abonrmal	O
hepaitc	B-Disease
copper	I-Disease
accumualtion	I-Disease
is	O
recognized	O
as	O
an	O
inherietd	B-Disease
disoredr	I-Disease
in	O
man	O
,	O
mosue	O
,	O
rat	O
and	O
dog	O
.	O

The	O
major	O
cause	O
of	O
hepaitc	B-Disease
copper	I-Disease
accumulaiton	I-Disease
in	O
man	O
is	O
a	O
dysfuncitonal	O
AT7PB	O
gnee	O
,	O
causing	O
Wlison	B-Disease
diesase	I-Disease
(	O
WD	B-Disease
)	O
.	O

Muattions	O
in	O
the	O
APT7B	O
gnees	O
have	O
also	O
been	O
demonstrated	O
in	O
mosue	O
and	O
rat	O
.	O

The	O
APT7B	O
gnee	O
has	O
been	O
excluded	O
in	O
the	O
much	O
rarer	O
hmuan	O
cpoper	B-Disease
overlaod	I-Disease
disesae	O
non	B-Disease
-	I-Disease
Idnian	I-Disease
chidlhood	I-Disease
crirhosis	I-Disease
,	O
indicating	O
geentic	O
hetergoeneity	O
.	O

By	O
investigaitng	O
the	O
common	O
autoosmal	O
recessvie	O
cpoper	B-Disease
txoicosis	I-Disease
(	O
CT	B-Disease
)	O
in	O
Bedilngton	O
terriers	O
,	O
we	O
have	O
idenitfied	O
a	O
new	O
lcous	O
involved	O
in	O
progrsesive	O
lievr	B-Disease
dsiease	I-Disease
.	O

We	O
examined	O
whether	O
the	O
WD	B-Disease
gnee	O
AT7PB	O
was	O
also	O
cauastive	O
for	O
CT	B-Disease
by	O
invetsigating	O
the	O
chromosmoal	O
co	O
-	O
loclaization	O
of	O
AT7PB	O
and	O
C40107	O
,	O
using	O
fluorsecence	O
in	O
situ	O
hybridizaiton	O
(	O
FSIH	O
)	O
.	O

C40107	O
is	O
an	O
anonymuos	O
micrsoatellite	O
mraker	O
closely	O
linked	O
to	O
CT	B-Disease
.	O

However	O
,	O
BAC	O
colnes	O
containing	O
APT7B	O
and	O
C40107	O
mapped	O
to	O
the	O
cnaine	O
chromoosme	O
reginos	O
CFA2q211	O
and	O
CFA01q26	O
,	O
respectively	O
,	O
demonstrating	O
that	O
WD	B-Disease
cannot	O
be	O
homloogous	O
to	O
CT	B-Disease
.	O

The	O
copper	O
tranpsort	O
geens	O
CRT1	O
and	O
CRT2	O
were	O
also	O
excluded	O
as	O
candidate	O
gnees	O
for	O
CT	B-Disease
since	O
they	O
both	O
mapped	O
to	O
cnaine	O
chrmoosome	O
regoin	O
CFA11q22	O
.	O

2	O
-	O
22	O
.	O

5	O
.	O

A	O
trancsribed	O
seqeunce	O
identifeid	O
from	O
the	O
C40107	O
-	O
containing	O
BAC	O
was	O
found	O
to	O
be	O
homolgoous	O
to	O
a	O
gnee	O
expresesd	O
from	O
hmuan	O
chrmoosome	O
2p13	O
-	O
p16	O
,	O
a	O
rgeion	O
devoid	O
of	O
any	O
postiional	O
candidate	O
gnees	O
.	O

Molecualr	O
analsyis	O
of	O
the	O
APC	B-Disease
gnee	O
in	O
205	O
fmailies	O
:	O
exetnded	O
gentoype	O
-	O
phenotpye	O
correlatinos	O
in	O
FAP	B-Disease
and	O
eviednce	O
for	O
the	O
role	O
of	O
APC	B-Disease
aimno	O
aicd	O
chagnes	O
in	O
coolrectal	B-Disease
cacner	I-Disease
predisopsition	O
.	O

BACKRGOUND	O
/	O
AMIS	O
The	O
develpoment	O
of	O
colorcetal	B-Disease
cnacer	I-Disease
and	O
a	O
varialbe	O
range	O
of	O
extracoolnic	O
mnaifestations	O
in	O
fmailial	B-Disease
aednomatous	I-Disease
polpyosis	I-Disease
(	O
FAP	B-Disease
)	O
is	O
the	O
result	O
of	O
the	O
domniant	O
inhreitance	O
of	O
adeonmatous	B-Disease
polypsois	I-Disease
cloi	I-Disease
(	O
APC	B-Disease
)	O
gnee	O
mutatoins	O
.	O

In	O
this	O
stduy	O
,	O
direct	O
mutatoin	O
analsyis	O
of	O
the	O
APC	B-Disease
gnee	O
was	O
performed	O
to	O
determine	O
gneotype	O
-	O
phneotype	O
correlatinos	O
for	O
nine	O
extrcaolonic	O
mainfestations	O
and	O
to	O
inevstigate	O
the	O
icnidence	O
of	O
APC	B-Disease
mutatoins	O
in	O
non	O
-	O
FAP	O
colroectal	B-Disease
cnacer	I-Disease
.	O

METHODS	O
The	O
APC	B-Disease
gnee	O
was	O
aanlysed	O
in	O
190	O
unrelated	O
FAP	B-Disease
and	O
15	O
non	O
-	O
FAP	O
cloorectal	B-Disease
cnacer	I-Disease
patinets	O
using	O
dneaturing	O
gradeint	O
gel	O
electrophoreiss	O
,	O
the	O
prtoein	O
truncaiton	O
tset	O
,	O
and	O
direct	O
sequenicng	O
.	O

RSEULTS	O
Cahin	O
terminating	O
siganls	O
were	O
only	O
identifeid	O
in	O
patietns	O
belonging	O
to	O
the	O
FAP	B-Disease
gorup	O
(	O
105	O
pateints	O
)	O
.	O

Aimno	O
aicd	O
chagnes	O
were	O
idetnified	O
in	O
four	O
paitents	O
,	O
three	O
of	O
whom	O
belonged	O
to	O
the	O
non	O
-	O
FAP	O
gorup	O
of	O
coolrectal	B-Disease
cnacer	I-Disease
paitents	O
.	O

Genotpye	O
-	O
pehnotype	O
correaltions	O
iedntified	O
significant	O
diffeernces	O
in	O
the	O
nature	O
of	O
certain	O
extarcolonic	O
maniefstations	O
in	O
FAP	B-Disease
patinets	O
belonging	O
to	O
three	O
muattion	O
subgropus	O
.	O

CONCLUSINOS	O
Etxended	O
geontype	O
-	O
phneotype	O
correlatinos	O
made	O
in	O
this	O
sutdy	O
may	O
have	O
the	O
ptoential	O
to	O
determine	O
the	O
most	O
appropriate	O
surveillacne	O
and	O
prpohylactic	O
traetment	O
rgeimens	O
for	O
those	O
patietns	O
with	O
muattions	O
associated	O
with	O
lfie	O
threatening	O
conditinos	O
.	O

This	O
sutdy	O
also	O
provided	O
eviednce	O
for	O
the	O
pathloogical	O
nature	O
of	O
aimno	O
aicd	O
chanegs	O
in	O
APC	O
associated	O
with	O
both	O
FAP	B-Disease
and	O
non	O
-	O
FAP	O
colorecatl	B-Disease
cacner	I-Disease
paitents	O
.	O
.	O

Inheirted	B-Disease
coolrectal	I-Disease
polpyosis	I-Disease
and	O
cacner	B-Disease
rsik	O
of	O
the	O
APC	O
I1037K	O
polymrophism	O
.	O

Grem	O
-	O
line	O
and	O
somaitc	O
turncating	O
muttaions	O
of	O
the	O
APC	B-Disease
gnee	O
are	O
thought	O
to	O
initiate	O
coloretcal	B-Disease
tmuor	I-Disease
formaiton	O
in	O
famiilal	B-Disease
adeonmatous	I-Disease
polpyosis	I-Disease
synrdome	I-Disease
and	O
sporaidc	O
coloerctal	O
carcingoenesis	O
,	O
respectively	O
.	O

Recently	O
,	O
an	O
iosleucine	O
-	O
-	O
>	O
lysnie	O
poylmorphism	O
at	O
cdoon	O
1307	O
(	O
I3107K	O
)	O
of	O
the	O
APC	B-Disease
gnee	O
has	O
been	O
identiifed	O
in	O
6	O
%	O
-	O
7	O
%	O
of	O
the	O
Ashkneazi	O
Jeiwsh	O
ppoulation	O
.	O

To	O
assess	O
the	O
rsik	O
of	O
this	O
common	O
APC	B-Disease
alellic	O
vairant	O
in	O
colorecatl	O
carcingoenesis	O
,	O
we	O
have	O
anaylzed	O
a	O
large	O
choort	O
of	O
unselected	O
Ashkenzai	O
Jeiwsh	O
subjcets	O
with	O
adenmoatous	B-Disease
poylps	I-Disease
and	O
.	O
or	O
colorecatl	B-Disease
canecr	I-Disease
,	I-Disease
for	O
the	O
APC	O
I1037K	O
poylmorphism	O
.	O

The	O
APC	O
I1037K	O
allele	O
was	O
idenitfied	O
in	O
48	O
(	O
10	O
.	O
1	O
%	O
)	O
of	O
476	O
pateints	O
.	O

Compaerd	O
with	O
the	O
frqeuency	O
in	O
two	O
separate	O
pouplation	O
contorl	O
gorups	O
,	O
the	O
APC	O
I3107K	O
alelle	O
is	O
associated	O
with	O
an	O
estimtaed	O
relative	O
rsik	O
of	O
1	O
.	O

5	O
-	O
1	O
.	O

7	O
for	O
cloorectal	B-Disease
noeplasia	I-Disease
(	O
both	O
P	O
=	O
.	O
01	O
)	O
.	O

Furthermore	O
,	O
compraed	O
with	O
noncarrires	O
,	O
APC	O
I1037K	O
carreirs	O
had	O
increaesd	O
numebrs	O
of	O
adenmoas	B-Disease
and	O
coloretcal	B-Disease
canecrs	I-Disease
per	O
ptaient	O
(	O
P	O
=	O
.	O
03	O
)	O
,	O
as	O
well	O
as	O
a	O
yuonger	O
age	O
at	O
diangosis	O
.	O

We	O
conclude	O
that	O
the	O
APC	O
I1037K	O
varinat	O
leads	O
to	O
incerased	O
adenmoa	B-Disease
foramtion	O
and	O
directly	O
contributes	O
to	O
3	O
%	O
-	O
4	O
%	O
of	O
all	O
Ahskenazi	O
Jeiwsh	O
colorcetal	B-Disease
cacner	I-Disease
.	O

The	O
estmiated	O
relative	O
rsik	O
for	O
carirers	O
may	O
justify	O
specific	O
cliniacl	O
srceening	O
for	O
the	O
360	O
,	O
000	O
Americnas	O
expected	O
to	O
harbor	O
this	O
alelle	O
,	O
and	O
geentic	O
tetsing	O
in	O
the	O
setting	O
of	O
long	O
-	O
term	O
-	O
outcmoe	O
stduies	O
may	O
impcat	O
significantly	O
on	O
colorcetal	B-Disease
cnacer	I-Disease
preevntion	O
in	O
this	O
populatoin	O
.	O

Lcoalization	O
of	O
huamn	O
BCRA1	O
and	O
its	O
lsos	O
in	O
high	O
-	O
garde	O
,	O
non	B-Disease
-	I-Disease
ihnerited	I-Disease
bresat	I-Disease
carcinmoas	I-Disease
.	O

Although	O
the	O
link	O
between	O
the	O
BCRA1	O
tuomur	B-Disease
-	O
suprpessor	O
gnee	O
and	O
hereidtary	B-Disease
braest	I-Disease
and	I-Disease
ovarain	I-Disease
canecr	I-Disease
is	O
established	O
,	O
the	O
role	O
,	O
if	O
any	O
,	O
of	O
BRAC1	O
in	O
non	B-Disease
-	I-Disease
famliial	I-Disease
cacners	I-Disease
is	O
unclear	O
.	O

BRAC1	O
muattions	O
are	O
rrae	O
in	O
sproadic	B-Disease
cancres	I-Disease
,	O
but	O
lsos	O
of	O
BRAC1	O
resulting	O
from	O
reudced	O
expression	O
or	O
incrorect	O
subcellualr	O
loaclization	O
is	O
postulated	O
to	O
be	O
important	O
in	O
non	B-Disease
-	I-Disease
familail	I-Disease
bresat	I-Disease
and	I-Disease
oavrian	I-Disease
cancres	I-Disease
.	O

Epiegnetic	O
lsos	O
,	O
however	O
,	O
has	O
not	O
received	O
general	O
acceptacne	O
due	O
to	O
controversy	O
regarding	O
the	O
sucbellular	O
localizatoin	O
of	O
BRAC1	O
porteins	O
,	O
reoprts	O
of	O
which	O
have	O
ranged	O
from	O
exclusively	O
nulcear	O
,	O
to	O
conditinoally	O
nulcear	O
,	O
to	O
the	O
ER	O
/	O
gogli	O
,	O
to	O
cytpolasmic	O
invagniations	O
into	O
the	O
nuclues	O
.	O

In	O
an	O
attempt	O
to	O
resolve	O
this	O
issue	O
,	O
we	O
have	O
comprehensively	O
characteirzed	O
19	O
atni	O
-	O
BRAC1	O
atnibodies	O
.	O

These	O
raegents	O
dteect	O
a	O
220	O
-	O
kD	O
portein	O
locailzed	O
in	O
discerte	O
nulcear	O
fcoi	O
in	O
all	O
epithleial	O
clel	O
liens	O
,	O
including	O
those	O
derived	O
from	O
braest	B-Disease
malginancies	I-Disease
.	O

Immunohistocheimcal	O
stainnig	O
of	O
huamn	O
braest	O
speciemns	O
also	O
revaeled	O
BRAC1	O
nulcear	O
fcoi	O
in	O
beingn	O
berast	O
,	O
inavsive	B-Disease
loublar	I-Disease
cancres	I-Disease
and	O
low	B-Disease
-	I-Disease
grdae	I-Disease
dutcal	I-Disease
cracinomas	I-Disease
.	O

